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Summary 
Viral infections, specifically those caused by RNA viruses such as Human 
Immunodeficiency virus (HIV), Hepatitis C virus (HCV) or Influenza, are among the most 
important public health concerns to humans due to their high prevalence and 
associated mortality. Prevention and treatment campaigns against these viruses 
usually had limited efficacy, partly because their biological features allow them to 
reach very high levels of diversity, both at the within- and between-host levels.  
Research focused on understanding the processes and mechanisms involved in 
the evolution of RNA viruses, and on the clinical and/or epidemiological consequences 
of their diversification, is important for improving the management of their epidemics. 
The aim of this PhD thesis is to study different aspects of the mid- and long-term 
evolution of RNA viruses, with special interest in molecular epidemiology. For this, 
different datasets (viral alignments, obtained either from public databases or by 
sequencing patient’s derived samples from the studied populations) were obtained 
and analyzed by means of evolutionary and statistical approaches.  
Firstly, phylogenetic, coalescent and statistical analyses were performed to 
depict the HIV epidemic in two different Spanish regions: Euskadi (Basque Country) 
and Comunitat Valenciana (Valencian Community). A significant number of patients 
from both regions, especially those from the Comunitat Valenciana, were included in 
local transmission clusters. Men who have unprotected sex with men (MSM) were 
significantly more prone to form transmission clusters than other risk groups. The high 
vulnerability of MSM to HIV infection was also evidenced by the detection of an 
extraordinarily large transmission cluster, affecting more than 100 patients solely in 
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the city of Valencia. Interestingly, the recent expansion of the highly pathogenic HIV 
CRF19_cpx among local Valencian MSM was also reported, for the first time outside 
Cuba.  
Secondly, by means of Bayesian coalescent analyses, the genomic evolutionary 
rates of different HIV-1 subtypes (A1, B, C, D, G) and CRFs (CRF01_AE, CRF02_AG) were 
estimated and compared. The results obtained revealed that HIV-1 A1, C and 
CRF01_AE evolve significantly faster than subtypes B, D, G and CRF02_AG. 
Thirdly, datasets containing sequences from the 6 major genotypes causing the 
HCV pandemic were analyzed, inferring the prevalence, evolutionary history and 
genetic barrier of naturally-occurring resistance mutations (RAVs) to direct acting 
antivirals (DAAs) in these genotypes. The obtained results demonstrate that RAVs are 
common in all HCV genotypes, and that there is an overall low genetic barrier for the 
selection of RAVs. Interestingly, some of these resistance mutations present a high 
potential to be transmitted between patients at risk.  
In the fourth place, the distribution of positively selected sites along the 
genomes of HCV subtypes 1a and 1b was analyzed. The results show that positive 
selection is acting in all HCV genes, and that positively selected sites are associated 
with the presence of CD8 epitopes, while conserved sites are associated with RNA 
secondary structure and CD4 epitopes. 
Finally, the effect of using RNA substitution models on the phylogenetic 
inference of viroids and RNA viruses was assessed. Such models were found to fit best 
for all the species analyzed. Compared to viral phylogenies inferred only from DNA 
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models, using RNA models usually leads to significantly longer tree length estimates, 
while has no significant effect on tree topology inference. 
The results obtained from this work will not only have direct applications to HIV 
control campaigns in Spain and HCV treatment refinement, but also provide new 
insights into different aspects of the evolution of RNA viruses. 
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Resum  
Les infeccions víriques, específicament aquelles causades per virus d’ARN com 
el Virus de la Inmunodeficiència humana (VIH), el Virus de la Hepatitis C (VHC) i els 
virus de la grip, es troben entre els problemes de salut pública més importants per als 
humans, a causa de la seua alta prevalença i mortalitat associada. Les campanyes de 
prevenció i tractament contra aquests virus solament han tingut una eficàcia limitada, 
en part perquè les seues característiques biològiques els permeten aconseguir nivells 
molt alts de diversitat, tant a nivell intra- com al inter- hoste. 
La recerca centrada a entendre els processos i mecanismes involucrats en 
l’evolució dels virus d’ARN, i en les conseqüències clíniques i/o epidemiològiques de la 
seua diversificació, és important per a millorar la gestió de les epidèmies que causen. 
L’objectiu d’aquesta tesi doctoral és estudiar diversos aspectes relacionats amb 
l’evolució de virus d’ARN a mitjà i llarg termini, amb especial interès en epidemiologia 
molecular. Per a açò, diferents conjunts de dades (alineaments, obtinguts de bases de 
dades públiques o per seqüenciació de mostres obtingudes a partir de pacients 
provinents de les poblacions estudiades) van ser obtingudes i analitzades per mitjà 
d’aproximacions evolutives i estadístiques. 
En primer lloc, es van realitzar diferents anàlisi filogenètics, de coalescència i 
estadístics per a descriure la epidèmia de VIH en dues regions espanyoles: Euskadi i la 
Comunitat Valenciana. Un nombre rellevant de pacients de les dues regions, 
especialment d’aquells de la Comunitat Valenciana, estaven associats amb grups de 
transmissió local. Els homes que practiquen sexe amb altres homes sense protecció 
(HSH) tenien major predisposició a formar grups de transmissió que altres grups de 
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risc. L’alta vulnerabilitat dels HSH a la infecció per VIH va ser evidenciada amb la 
detecció d’un grup de transmissió extraordinàriament gran, que afecta a més de 100 
individus només a la ciutat de València. També es va reportar, per primera vegada fora 
de Cuba, l’expansió recent d’una variant altament patògena de VIH (CRF19) entre HSH 
valencians. 
En segon lloc, les taxes d’evolució genòmica de diferents subtipus de VIH-1 (A1, 
B, C, D, G) i CRFs (CRF01_AE, CRF02_AG) van ser estimades, per mitjà d’anàlisi de 
coalescència bayesiana, i comparades. Els resultats obtinguts van revelar que VIH-1 A1, 
C i CRF01_AE evolucionen significativament més ràpid que els subtipus B, D, G i 
CRF02_AG. 
En tercer lloc, es va analitzar conjunts de dades que contenien seqüències dels 
6 genotips principals que causen la pandèmia d’hepatitis C, per a estimar la 
prevalença, història evolutiva i la barrera genètica de diferents mutacions associades 
amb resistència a antivirals d’acció directa en aquests genotips. Els resultats van 
demostrar que les mutacions de resistència són comunes en tots els genotips del VHC i 
que, en general, hi ha una barrera genètica baixa per a la seua selecció. Algunes 
d’aquestes mutacions, tenen un alt potencial per a ser transmeses entre pacients de 
risc. 
En quart lloc, es va analitzar la distribució de codons seleccionats positivament 
al llarg dels genomes del VHC subtips 1a i 1b. Els resultats mostren que la selecció 
positiva actua en tots el gens de VHC, y que la presència de epítops CD8 està associada 
amb selecció positiva, mentre que els epítops CD4 i l’estructura secundaria d’ARN ho 
estan amb conservació. 
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Finalment, es va avaluar l’efecte de l'ús de models de substitució d’ARN a la 
inferència filogenètica dels virus d’ARN i viroids. L’ús d’aquests models s’ajustava 
millor que la seua exclusió en totes les espècies analitzades, i en la majoria dels casos 
resultava en arbres amb branques significativament més llargues encara que no tenia 
un efecte significatiu en la topologia. 
Els resultats obtinguts en aquest treball tenen una aplicació directa, relacionada 
amb el desenvolupament de campanyes de control de VIH a Espanya i amb el 
refinament de tractaments efectius contra HCV. També aporten coneixements nous 
sobre diferents aspectes relacionats amb l’evolució dels virus d’ARN. 
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Glossary 
AIDS: Acquired immune deficiency syndrome. 
CRF: Circulating recombinant form. 
CV: Comunitat Valenciana. 
DAA: Direct acting antiviral. 
dN: Number of non-synonymous nucleotide substitutions per non-synonymous 
site. 
DNA: Deoxyribonucleic acid. 
DRC: Democratic Republic of Congo. 
ds: Double-stranded. 
dS: Number of synonymous nucleotide substitutions per synonymous site. 
HAART: Highly Active Antiviral Therapy. 
HCV: Hepatitis C virus. 
HIV: Human immunodeficiency virus. 
HKAT: Hudson-Kreitman-Aguadé test. 
HPD: High Posterior Density. 
HT: Heterosexual. 
IDU: Intravenous drug user. 
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MCMC: Markov chain Monte Carlo. 
ML: Maximum Likelihood. 
MSM: Men who have sex with men. 
NGS: Next-generation sequencing. 
PP: Posterior probability.  
PR/RT: Protease/retrotranscriptase. 
P/R: Pegylated interferon + ribavirin. 
RAV: Resistance associated variant. 
RNA: Ribonucleic acid. 
SIV: Simian immunodeficiency virus. 
ss: Single-stranded. 
s/s/y: Substitutions per site per year. 
tMRCA: Time to the most recent common ancestor. 
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1. Introduction and objectives 
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1.1- RNA viruses: evolution and molecular epidemiology fundamentals 
Viruses are the most abundant and diverse biological entities on Earth 
(Abecasis et al. 2013; Edwards and Rohwer 2005; Holmes 2011). Unlike cellular life 
forms (cellular organisms), viral genomes can be based either on DNA or RNA, which 
can form single-stranded (ss, either sense or antisense) or double-stranded (ds) 
molecules. They also display a broad variety of genomic strategies, replicating and 
transcribing either RNA or DNA, with some viral species being able to perform the 
reverse transcription of RNA to DNA (Koonin & Dolja 2012). Hence, although all these 
genome properties are used to classify viruses into seven groups (Baltimore 1971) the 
broadest way to classify viruses is differentiating between viruses with a DNA genome 
(DNA viruses) and those with a RNA genome (RNA viruses).  
RNA viruses account for most of the known viruses. They are characterized by 
extremely high mutation rates, the highest among all living beings. Only ssDNA viruses 
such as Phi X174 present similar rates (~1x10-5 to 1x10-4 
substitutions/nucleotide/generation) (Drake & Holland 1999; Holmes 2003; Raney et 
al. 2004; Holmes & Drummond 2007; Duffy et al. 2008; Sanjuán 2012). These high 
error rates, enhanced by the lack of proofreading activity of their replicases, have been 
proposed to be important factors limiting their genome size, which are generally 
smaller than that of DNA viruses.  
RNA viruses are also characterized by short generation times, which usually 
generate a large population size in the infected individuals. All these characteristics, 
along with recombination and reassortment, are responsible for the high genetic 
variability and evolutionary rates of between hosts and intrahost viral populations 
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(Moya et al. 2000; Trifonov & Rabadan 2010). As a counterpart, viral variability is 
limited by two different phenomena: i) the selective constraints that the host’s 
immune response imposes to the virus, and ii) bottlenecks at transmission between 
hosts, which will determine the viral diversity transmitted to other hosts (Grenfell 
2004). 
The fast evolutionary rates of RNA viruses, which have been estimated to be 
between 10-4 and 10-3 substitutions per site per year(s/s/y) (Jenkins et al. 2002), make 
them good experimental models for studying evolution: they have been used as model 
systems to address basic questions in evolutionary biology, such as the Red Queen’s 
hypothesis (Clarke et al. 1994) or the phenomenon of convergent evolution (Moya et 
al. 2004). Their quick pace of change has also important public health implications: 
whereas DNA viruses establish persistent infections more often (in which the virus is 
not cleared but remains in the infected individuals), RNA viruses are more commonly 
associated with emerging diseases (those caused by viruses that jump species barriers, 
causing infections in different host species) (Holmes 2004). Their capability to emerge 
in new hosts could be explained by different factors, such as their high capability to be 
transmitted, and the fact that fast-evolving organisms are more successful at exploiting 
new niches (Cleaveland et al. 2001). The fast evolutionary rates of RNA viruses also 
play an important role in other public health concern: RNA viruses can develop 
antigenic variation and/or resistance to antiviral agents quickly as a result of natural 
selection acting on their continuously generated genetic variation (Holmes 2003; Moya 
et al. 2004). In this way, RNA viruses have a high potential to evade antiviral 
treatments and vaccines, exemplified by HIV, HCV or Influenza viruses. 
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It is possible to combine viral molecular data with clinical and epidemiological 
information from the host  by means of a discipline called molecular epidemiology, a 
term coined by Edwin D. Kilbourne in 1973 (Kilbourne 1973). By means of evolutionary 
analyses, this branch of epidemiology aims to answer different questions, such as the 
typing of viral populations, the reconstruction of the history of an epidemic, the study 
of the dynamics of variants associated to resistance against antivirals as well as the 
detection of groups of individuals most vulnerable to a certain infection (Moya et al. 
2004). Molecular epidemiology analyses often involve the detection of transmission 
clusters (groups of individuals infected by viral variants that derive from a common, 
recent ancestor, which evidences that they are epidemiologically related), which can 
be used to infer the minimum number of introductions of the virus in a given 
population. Their detection is usually performed by means of phylogenetic analyses, as 
clades of high support in the phylogenetic tree obtained with the sequences derived 
from the infecting viruses (Hué et al. 2005). Alternatively, transmission clusters can 
also be detected as groups of individuals of low genetic distance (Wertheim et al. 
2014).  
Often, transmission clusters are studied within population groups sharing a 
specific practice or behavior which enhances the risk of viral transmission. In the 
context of this thesis I will call them “risk groups” and, considering the transmission 
routes of HIV and HCV, “MSM” will be used to refer to men who have unprotected sex 
with other men, “IDUs” to users of intravenous drugs who share needles, “HTs” to 
people who have unprotected heterosexual sex, and so on. 
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1.2- Evolutionary analyses for molecular epidemiology 
Phylogenetic reconstruction is a basic procedure in the molecular epidemiology 
of RNA viruses. There are different phylogenetic methods: i) based on distance 
matrices: neighbor-joining and UPGMA phylogenetic reconstruction; and ii) based on 
an optimality criterion: parsimony, maximum-likelihood (ML) or Bayesian phylogenetic 
inference. The later are usually known as statistical methods, because they seek to 
maximize a statistical parameter (the likelihood of the data or the posterior 
probability) by explicitly modelling the molecular evolutionary processes involved in 
the phylogenetic reconstruction using stochastic processes. 
Statistical phylogenetic reconstructions are currently the most widely used 
methods in molecular epidemiology, because they allow the rigorous testing of 
phylogenetic hypotheses, such as evolutionary models, the quality of the trees or the 
confidence values assigned to subtrees (Whelan et al. 2001). Furthermore, they tend 
to resolve more accurately the evolutionary relationships of highly divergent 
sequences (Huelsenbeck & Hillis 1993). In the case of ML inference (Felsenstein 1981), 
the aim is to find the evolutionary tree and model which yields the highest probability 
of observing the empirical data (sequence alignment) under the chosen model of 
evolution. Assuming independence of evolution at each site in the alignment, the 
probability of a given alignment arising on a given tree is computed site by site, and all 
the probabilities obtained are multiplied to yield the sought likelihood of the 
alignment. As the number of analyzed taxa increases, the number of possible tree 
topologies grows exponentially. In order to make the process more computationally 
affordable, tree search of the potential ML trees (which usually starts with an initial 
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tree obtained by a distance-based method which is then modified and improved) is 
performed heuristically using different tree-pruning algorithms; this means that the 
chosen tree is the “best known” ML tree, but not necessarily the global ML tree (which 
may be not found). Thus, computation time is one of the main limitations in ML 
phylogenetics (Guindon & Gascuel 2003).  
Bayesian phylogenetics (Rannala & Yang 1996) is based on Bayes’ theorem and 
probabilities of tree states are calculated as posterior probabilities (PP), which are 
probabilities conditioned on the DNA alignment and the prior information provided by 
the user, and can be used as a measure of the reliability of the model (including the 
priors) given the data. PPs are calculated considering both the likelihoods of the tree 
states and their prior probability (“prior”), a probability which derives from prior 
information on the evolutionary parameters to be estimated. Whereas the phylogeny 
with the highest PP could be chosen as the best estimate of the evolutionary 
relationships, results are usually shown as a set of most probable trees (High posterior 
density distribution -HPD-), thus retaining uncertainty. 
In Bayesian phylogenetics, as well as in ML, computing the PPs of all possible 
trees that may arise from a given dataset would be computationally unbearable, even 
at relatively small datasets. This problem is addressed, generally, by using the Markov 
chain Monte Carlo (MCMC) algorithm which generates a posterior distribution of 
candidate phylogenetic trees, in which those trees with higher PPs are sampled more 
frequently (Yang & Rannala 1997). With the implementation of MCMC, Bayesian 
phylogenetics became faster than ML, a factor that had a key influence on the current 
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popularity of this phylogenetic approach among molecular epidemiologists of RNA 
viruses. 
A critical concern in Bayesian phylogenetics, absent in ML, is the sensitivity of 
PP to the specified prior distributions.  When there is enough information in the 
alignment, the PP is mainly determined by the likelihood (Rannala & Yang 1996), but 
specifying inappropriate priors could bias our results. Thus, it is important to take into 
account that informative prior distributions should only be set if there is prior 
information on the evolutionary parameters to be estimated. If not, an uninformative 
prior (e.g., uniform distribution) should be used. It is important to point out that the 
impact of the priors in phylogenetic analyses should always be assessed. 
Importantly, in phylogenetics the inference of evolutionary distances between 
taxa only from their observed nucleotide differences usually leads to underestimate 
the actual number of substitutions that have occurred. These errors are corrected by 
using models of nucleotide (or amino acid) evolution, which are assumptions about the 
process of nucleotide substitution, such as the existence of differences in base 
frequencies, in the substitution rates between nucleotides (Posada & Crandall 2001) or 
codon positions (Shapiro et al. 2006). Furthermore, models which account for the 
influence of RNA secondary structures on sequence evolution have been developed 
(Savill et al. 2001; Allen & Whelan 2014). In this thesis, the impact of RNA models on 
viral evolution has been assessed: whereas RNA viruses present conserved, RNA 
secondary structures of considerable length along their genomes, these models have 
never been applied in their phylogenetic analyses. 
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1.3- The coalescent: applications to molecular epidemiology of viruses 
If mutations are fixed in a viral population on the same time scale as the 
ecological and epidemiological processes that are responsible for its genetic diversity, 
the divergence times from the common ancestor of the sampled individuals in a 
population can be associated with its demographic history (Holmes 2008) . This can be 
done by incorporating the coalescent theory of population genetics (Kingman 1982; 
Donnelly & Tavaré 1995) into ML or Bayesian phylogenetics. Assuming that a 
population accomplishes the Fisher-Wright assumptions (generations are discrete and 
non-overlapping, there is no effect of natural selection, recombination is absent, 
population remains constant along generations), the coalescence process starts with a 
sample of n lineages from a population and goes backwards in a genealogical process, 
linking these lineages when they share a common ancestor (this is called a coalescence 
event). The number of lineages decreases until there is only one left, the common 
ancestor to all the individuals analysed (Figure 1A). Coalescent times are directly 
proportional to the number lineages and inversely proportional to population size 
(Figure 1B). In this way, applying the coalescent model to viral phylogenetics allows 
estimating the times when new viral lineages were established in a host population. 
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Figure 1.A graphical interpretation of the coalescent process. A) Black lines trace the ancestries of three 
contemporaneous lineages back to a single ancestor. B) Coalescent tree of these for these three 
lineages: coalescent times will depend on the sample size (retrieved from Rosenberg & Nordborg 2002).  
The dynamics of demographic change affects coalescent times. Given that 
population sizes usually change over time, alternative growth models to the constant 
population size have been designed. Hence, coalescent phylogenetic analyses can also 
be used to estimate how the number of infected individuals changes along the 
epidemic (Kuhner et al. 1995; Hué et al. 2005). The most widely used demographic 
models are: 
 Exponential growth model: It assumes an exponential growth of the 
population.  
 Logistic growth model: Exponential growth would only be possible if 
there is no limitation by the availability of resources. It takes into 
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account that population size growth is limited by the competence 
between the individuals from the population. 
 The Skyline Plot framework (Pybus et al. 2000): Unlike previous 
demographic models, this is a non-parametric model. Assuming that 
population sizes can change only at coalescent events but remain 
constant between coalescent events, it allows estimating the different 
evolutionary parameters without the need of a priori restrictions on 
demographic trends. Refined variations of the Skyline Plot, such as the 
Bayesian skyride, which assumes that population sizes change gradually 
(Minin et al. 2008) or the Extended Bayesian Skyline, which allows 
multilocus analyses (Heled & Drummond 2008) have been designed.  
Phylogenetic methods which use the coalescent also allow estimating the rate 
at which a population evolves, taking into account the number of substitutions that 
have occurred between the dated coalescent events. For this goal, the initial 
assumption to consider is the presence of a molecular clock: the number of differences 
between taxa should be proportional to their divergence times. Ideally, the 
evolutionary rate remains constant (fixed) along the different lineages in the genealogy 
(Zuckerkandl & Pauling 1962). The molecular clock is then calibrated with information 
added by the researcher (e.g., sampling date of each sequence or tMRCA of an internal 
node). However, in reality, many organisms, including RNA viruses, evolve at rates 
which significantly deviate from the fixed molecular clock assumptions. They undergo, 
along their evolution, accelerations or decelerations in their pace of evolution caused 
by changes in selective pressures and/or population sizes (Jenkins et al. 2002). For this 
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reason, alternative molecular clock models taking into account such changes in the 
evolutionary rate have been generated:  
 Auto-correlated relaxed molecular clock: A model that allows the rate to 
vary in an auto-correlated manner across the tree, in which the rate in 
each branch is drawn from a distribution of rates, whose mean is a 
function of the rate of the parental branch. Hence, the rate along a 
given branch is more similar to its parent branch than a branch chosen 
at random (Lepage et al. 2006; Thorne et al. 1998). 
 Uncorrelated relaxed molecular clock (Drummond et al. 2006): It does 
not assume correlation between rates in neighbouring branches. Rates 
at each lineage are drawn independently from the same distribution 
(e.g., Gamma, exponential or lognormal). Under this model, each 
lineage will have a distinct rate. In the case of rapidly evolving 
organisms, such as RNA viruses, it appears to fit better than the 
autocorrelated model (Drummond et al. 2006). 
 Local clock (Drummond & Suchard 2010): It allows different lineages in 
the tree to have different evolutionary rates, but in some adjacent 
lineages the evolutionary rate can be similar (Yoder & Yang 2000). 
Drummond & Suchard (2010) created a “random local clock” model, 
which proposes and compares a series of alternative local molecular 
clocks, which can arise on any branch of the phylogeny and then extend 
along adjacent lineages. This model has been proven to be the most 
powerful model in finding rate shifts along phylogenies (Fourment & 
Holmes 2014).   
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Undoubtedly, the most popular program for estimating dates of divergence 
events and evolutionary rates is BEAST (Drummond & Rambaut 2007). It infers dated 
phylogenies using a Bayesian MCMC coalescent method, providing the 
aforementioned demographic and molecular clock models. Alternatively, other 
programs based on ML such as r8s (Sanderson 2002) or Physher (Fourment & Holmes 
2014) can be used. 
1.4- Analyzing the evolutionary constraints of RNA viruses 
  The high mutation rate of RNA viruses produces new viral variants constantly 
(Elena & Sanjuán 2005). This compromises viral fitness, because most mutations are 
lethal, and such effect is intensified with the occurrence of bottlenecks at transmission 
events, which cause a fast accumulation of deleterious mutations. Despite this 
handicap, the survival of viral populations can be explained by a mutation-selection 
equilibrium, in which the action of positive and negative selection leads to a changing 
population composed by a large amount of different, yet related, viral variants (also 
called viral quasispecies) (Domingo et al. 1978; Manrubia et al. 2005). In this way, 
although the high mutation rates of RNA viruses could increase their adaptive capacity, 
the effect of negative selection has been demonstrated to be very strong, even 
stronger than for DNA viruses (Hughes & Hughes 2007). 
  Human RNA viruses are subjected to selective pressures at different levels: RNA 
and protein secondary structures have been previously reported to be associated with 
conservation, which would facilitate persistent infection by masking the viral genome 
from its degradation be RNAse L and innate antiviral defenses (Washenberger et al. 
2007; Li & Lemon 2013; Snoeck et al. 2011; Sanjuán & Bordería 2011; Mauger et al. 
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2015). On the other hand, epitopes are usually associated with positive selection, thus 
favoring escape mutants from immune system cells (Snoeck et al. 2011; Fares et al. 
2001). Interestingly, several studies have observed very conserved epitopes in 
different viruses which, at least in the case of HIV, have been associated with a benefit 
from immune activation (Sanjuán et al. 2013; Sarobe et al. 2001; Snoeck et al. 2011). 
  There are different types of tests that (considering neutral evolution as the null 
hypothesis) can be used for detecting genes or positions within a given gene evolving 
under selection, either at within-species (population) level or between-species.  
  Tests based in allele frequencies consider that, in a given population, positive 
selection changes the patterns of genetic variation with respect to the expected 
variation under a neutral model, and such an effect would skew the allele frequency 
distribution, reduce genetic variability and increase the level of linkage disequilibrium 
(Biswas & Akey 2006). Some of the most frequently used methods are Tajima’s D 
(Tajima 1989), Fu and Li’s D and F (Fu & Li 1993) and linkage disequilibrium decay 
(Sabeti et al. 2002) calculations. One of the main caveats of these methods is that the 
changes associated to selection could also be caused by demographic fluctuations, and 
it is generally recommended to analyze different loci along the genome to distinguish 
between the two alternatives.  
  Another test used for detecting selection at population level is the Hudson-
Kreitman-Aguadé test (HKAT; Hudson et al. 1987). It is a goodness-of-fit which 
compares the levels polymorphism that exist within a given species with the 
divergence from an outgroup. This test analyzes at least two loci in order to determine 
significant variations from neutrality.  
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  dN/dS tests can be used for the detection of selection either at the population 
level (comparing levels of polymorphism) or between-species (comparing levels of 
divergence). These tests assume that in protein-coding sequences an excess of non-
synonymous nucleotide substitutions per non-synonymous site (dN) with respect to 
the number of synonymous nucleotide substitutions per synonymous site (dS) is a 
signature of positive selection. The rationale is that synonymous substitutions are 
assumed to be always neutral (they do not alter the amino acid), but non-synonymous 
substitutions can be subjected to evolutionary constraints. If non-synonymous 
substitutions are neutral, dN and dS should be similar. Consequently, an excess of dN 
as compared to dS suggests that natural selection promotes amino acid changes 
(positive selection). On the other hand, and excess of dS respect dS would suggest that 
natural selection discards amino acid changes (purifying selection).  
  dN/dS tests are commonly used either comparing dN and dS at individual 
branches of a phylogenetic tree (“branch methods”; Yang and Nielsen 1998) or 
searching for codons with dN/dS > 1 (“codon-based methods”;Yang 1998; Kosakovsky 
Pond and Frost 2005). Other approaches search for codons with dN/dS >1 at certain 
lineages (“branch-site methods”; Zhang et al. 2005; Pond & Frost 2005). It is also worth 
mentioning the McDonald-Kreitman test (McDonald & Kreitman 1991), which is similar 
to the HKAT but differentiating between synonymous and nonsynonymous sites. This 
test checks for the presence of positive selection within a species comparing its 
amount of variation with the divergence between species at synonymous (neutral) and 
non-synonymous sites from a given locus, assuming that positive selection leads to an 
increase in non-synonymous divergence (dN/dS within species < dN/dS between 
species). One of the potential problems associated to dN/dS tests is that a number of 
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codons may present dN > dS just by chance, thus producing false positives (Hughes & 
Friedman 2005). 
1.5- HIV: Phylodynamics and epidemiology 
HIV, the causing agent of acquired immune deficiency syndrome (AIDS), is an 
enveloped virus, a retrovirus (family Retroviridae) of the genus Lentivirus. Its single-
stranded positive-sense RNA genome comprises >9,700 nucleotides that encode 8 
different genes: gag, pol, vif, vpr, tat, rev, vpu, env and nef (Figure 2).
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Figure 2. Structure of the HIV-1 genome (reference sequence HXB2, Genbank accession number K03455). The start and end of each open reading frame (shown as 
rectangles) are indicated in the upper left and lower right corners, respectively (Modified from Kuiken et al. 1999).
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The HIV genome is characterized by a very high genetic diversity. There are two 
types of HIV: HIV-1 and HIV-2, the former being more pathogenic and the main cause 
of the AIDS pandemic. HIV-1 comprises four phylogenetically distinct groups: M, N, O, 
and P. Groups N and O are confined almost exclusively to West-Central Africa (Hahn et 
al. 2000). Only two strains from group P have been reported so far, both in Cameroon 
(Plantier et al. 2009; Vallari et al. 2011). The HIV pandemic is mainly driven by HIV-1 
group M. Within this group, there are nine subtypes (denoted as A, B, C, D, F, G, H, J, 
and K) and at least 61 circulating recombinant forms (Kuiken et al. 2012) (Figure 3). 
 
Figure 3. Evolutionary relationships of different lentiviruses infecting mammals, including HIV: HIV-1 
(groups O, N and different pure subtypes from group M) and HIV-2. The phylogenetic tree reveals that 
HIV-1 N and M are more closely related to SIVcpz than they are to HIV-1 O, and  HIV-2 is more closely 
related to SIVmm (SIV infecting sooty mangabey) than it is to HIV-1 (Retrieved from Kuiken et al. 1999). 
Evolutionary analyses have revealed that HIV-1 lineages do not have a 
monophyletic origin: HIV-1 M and N are more closely related to SIVcpz (Simian 
immunodeficiency Virus of chimpanzees) than they are to HIV-1 O or P (Gifford et al. 
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2008). Furthermore, different recombination events occurred in the SIV lineages that 
gave rise to HIV-1 (Courgnaud et al. 2002; Bailes et al. 2003; Paraskevis et al. 2003; 
Heeney et al. 2006). Thus, AIDS is an emerging infectious disease: HIV-1 had a zoonotic 
origin, occurring from cross-species transmission events between chimpanzees and 
humans (Figure 3) (Hahn et al. 2000). 
Faria et al. (2014) inferred the common ancestor of HIV-1 M to have occurred 
in the 1920s in Kinshasa (Democratic Republic of Congo, DRC), which subsequently 
diversified and expanded resulting in different variants (subtypes and recombinant 
forms) across Africa and the rest of the world. Phylogenetic analyses of HIV-1 subtype 
B, the most widespread HIV-1 subtype, revealed that it jumped from Africa to Haiti in 
the 60s, and then to other American countries and the rest of the world from the late 
60s (Gilbert et al. 2007). Nevertheless, the most prevalent HIV subtype worldwide is C, 
accounting for around 50% of all the infections. Its expansion occurred mainly from 
Kinshasa to other DRC regions in the 1930s and then expanded around Africa and from 
there to Asia (Faria et al. 2014; Wilkinson et al. 2015) (Figure 4). 
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Figure 4. The global distribution of the HIV-1 subtypes and CRFs (Retrieved from Hemelaar 2012).  
Thus, HIV-1 spread for > 50 years before the first AIDS case was recognized in 
1981 and its subsequent discovery as the causative agent of this disease in 1983. In 
1997, the AIDS pandemic had already caused more than 11.7 million of deaths in the 
world, and 30.6 million people were living with HIV, most of them in sub-Saharan 
Africa (UNAIDS 1998). In 1996, Highly Active Antiviral Therapy (HAART) was introduced 
as a therapeutic option in economically developed countries. This treatment consists 
of a combination of at least three drugs that inhibit HIV replication. Consequently, 
since then the global incidence of new HIV cases and AIDS deaths has slowed down, 
especially in those countries with high HAART coverage. In 2003 the number of people 
living with HIV was 38 million (UNAIDS 2004) and by 2012 it was estimated to be 35.3 
million (UNAIDS 2013). 
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In Spain, as in other western countries, the first AIDS case was reported in 
1981, and since then its incidence grew year by year until reaching a maximum in 
1996, when HAART was introduced. In that year, the incidence started to decrease: by 
the end of 1997, the estimated number of people living with HIV in Spain reached 
120,000 (UNAIDS 1998) while in 2012 the estimated number of people living with HIV 
was around 150,000 (UNAIDS 2013).  
 Despite that in western countries, such as Spain, IDU was considered the main 
transmission route from the beginning of the pandemic to the first years of the 21st 
century, a change has occurred lately. In contrast to IDUs and HTs, the number of new 
HIV diagnosis among MSM in the European Union and European Economic Area has 
increased, and this has become the main transmission route (ECDC 2013).  
Although the HIV epidemic in Europe, particularly among MSM, is driven by the 
B subtype of the virus (Abecasis et al. 2013), with transmission clusters being reported 
frequently (Hué et al. 2005; Lewis et al. 2008; Kouyos et al. 2010; Leigh Brown et al. 
2011; Bezemer et al. 2015), there is evidence for an increased introduction of non-B 
subtypes (Paraskevis et al. 2006), and several non-B HIV transmission clusters affecting 
MSM have been reported recently (Thomson et al. 2012; Antoniadou et al. 2014; 
Bracho et al. 2014). The vulnerability of MSM to HIV infection is also reflected in their 
shorter time between infections compared to that of HTs (Hughes et al. 2009). 
 Whereas the introduction of HAART had a clear impact on the control of the 
AIDS pandemic, and the combination of different drugs tries to prevent the raise of 
resistance mutations, drug efficacy is hampered by their emergence in treated patients 
(Costagliola et al. 2007). Genotypic tests of resistance to antiretroviral drugs, based on 
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sequencing the protease and reverse transcriptase (PR/RT) regions, are carried out 
routinely in many countries, including Spain, both for the design of individualized 
antiretroviral treatments and for the assessment of the frequency of certain resistance 
mutations in the population (Costagliola et al. 2007). The widespread use of these tests 
has led to large, publicly accessible datasets of HIV-1 sequences that, by means of 
molecular epidemiology studies, allow depicting the epidemic in a given population as 
well as characterizing its phylodynamics (Hué et al. 2004; Bello et al. 2010; Kouyos et 
al. 2010). 
 In the Spanish regions of Euskadi (Basque Country) and Comunitat Valenciana 
(Valencian Community), these genotypic tests of resistance have been carried out, for 
all HIV diagnosed patients, for over 10 years. These tests have generated HIV datasets 
comprising hundreds, even thousands, of sequences from different patients. In this 
thesis these datasets were used aiming at depicting the local epidemics occurring in 
these regions, by inferring the local subtype distribution and by detecting the existence 
of transmission clusters (which represent outbreaks) by means of phylogenetic and 
coalescent analyses. Some of the results from these analyses are very difficult to 
obtain by means of traditional epidemiological analysis: in the particular case of the 
Comunitat Valenciana the detection of transmission clusters is especially helpful, since 
no outbreaks had been detected by the Public Health Institutions until 2016 
(unpublished results). 
Another question addressed in this thesis is the evolutionary rate of the 
different HIV-1 subtypes and CRFs. Generally, diversification dates and evolutionary 
rates estimates for the different HIV-1 subtypes have been inferred only from single 
genes (Abecasis et al. 2009; Hemelaar 2012; Wertheim et al. 2012), thus ignoring 
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possible differences in mutation rate and/or selective constraints existing in other 
genomic regions. The genomic tMRCAs and evolutionary rates of some of the most 
prevalent HIV-1 subtypes and CRFs were estimated, expecting to obtain more accurate 
estimates thanks to the higher phylogenetic signal that is usually associated with 
longer nucleotide sequences. For this project, different HIV datasets that were 
representative of each HIV-1 subtype/CRF were retrieved from public databases, and 
then analyzed them by means of Bayesian coalescent phylogenetics. 
1.6- HCV: Phylodynamics and epidemiology 
  HCV is an enveloped, positive-sense, single-stranded RNA virus which belongs 
to the family Flaviviridae, genus Hepacivirus. The HCV genome is about 9,600 
nucleotides long and encodes a 3,011 amino acid polyprotein which is cleaved into 
three structural (Core, E1, E2) and six nonstructural proteins (P7, NS2, NS3, NS4A, 
NS5A, NS5B) (Figure 5). It also encodes an alternate reading frame protein (F/ARFP) of 
unclear function, which is synthesized by ribosomal frameshift (Xu et al. 2001).  
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Figure 5. Structure of the HCV genome (reference sequence H77, accession NC_004102). The genomic RNA contains an open reading frame (shown in yellow), flanked by 
the 5’ and 3’ untranslated regions 5’ (5’UTR and 3’UTR). The polyprotein generated after translation is cleaved into the 10 different HCV prote ins (shown as rectangles). 
Numbers located in the upper left and lower left corners of each rectangle represent, respectively, the position of the first nucleotide (with respect to the HCV genome) and 
amino acid (with respect to the polyprotein) of each HCV protein. The Protein F/ARFP starts 4 nucleotides after the start of CORE, and continues for 201 codons (603 
nucleotides) (modified from the Los Alamos HCV database, hcv.lanl.gov; Kuiken et al. 2005).
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  HCV is classified in 7 genotypes (denoted as 1-7) and 67 subtypes (Smith et al. 
2014; Figure 6). Nucleotide divergence between complete genomes of different genotypes 
is >30%, and between subtypes of the same genotype it ranges between 20% and 25% 
(Simmonds et al. 1993; Simmonds 2004). 
 
Figure 6. Phylogenetic tree of the different HCV genotypes and subtypes (Retrieved from Smith et al. 2014). 
  HCV genotype 1 (including subtypes 1a and 1b) is the most prevalent worldwide 
(46.2%), followed by genotype 3 (30.1%). Genotypes 2, 4 and 6 account for around 23% of 
all cases, and genotype 5 comprises <1%. Only one infection with genotype 7 has been 
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reported so far, and it corresponds to a case of a Central African migrant living in Canada 
(Messina et al. 2015). 
  There are important epidemiological differences between HCV 
genotypes/subtypes, along with differences in prevalence. HCV genotypes are 
differentially distributed geographically: genotypes 1, 2 in West Africa, 4 in Central Africa 
and the Middle East, and genotypes 3, 5 and 6 in South Asia, South Africa and East Asia, 
respectively (Smith et al. 1997; Murphy et al. 1996). Also, there are differences in the 
transmission routes associated to different variants: Subtypes 1a, and 3a are linked to 
IDUs in Western countries, while subtypes 1b, 2a and 2b are more frequently linked to 
blood transfusions and other nosocomial infections (Simmonds 2013) and genotype 4 with 
unsafe injections in Egypt (Frank et al. 2000).  
  Differences between HCV genotypes also exist at the clinical level: sustained 
virological response to the traditional pegylated interferon + ribavirin treatment (P/R) 
differs significantly between genotypes, ranging between 80% (genotype 2) to 46% 
(genotype 1) (Mangia et al. 2005; Pang et al. 2009). P/R inefficacy and toxicity urged to 
search for new HCV treatments, which has resulted in the development of direct-acting 
antiviral drugs (DAAs). These drugs target three viral proteins: the NS3/4A protease , NS5A  
and the NS5B polymerase) and have been demonstrated to overcome P/R limitations 
(AASLD/IDSA HCV Guidance Panel 2015; European Association for Study of Liver 2015). 
However, naturally occurring DAA resistance-associated variants (RAVs) have already been 
reported in DAA-naïve patients, with some RAVs showing differential prevalence between 
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genotypes and subtypes (López-Labrador et al. 2008; Di Maio et al. 2014). Thus, DAA 
efficacy is potentially hampered by the virus variability. 
  Unlike HIV-1, no closely related animal virus homologue to HCV has been 
identified. To date, the most closely-related known virus to HCV infects horses (Lyons et 
al. 2012). However, the high divergence between both species suggests that a zoonosis to 
humans from horses is unlikely to have occurred. The other hepaciviruses discovered, 
which infect dogs (Kapoor et al. 2011), rodents (Kapoor et al. 2013) and bats (Quan et al. 
2013) are even more distantly related to HCV. While the scientific community is searching 
for new viruses, more closely related to HCV than the equine hepacivirus, to uncover the 
origin of HCV, the hypothesis that this virus has been always infecting humans is also 
plausible. Such hypothesis would be supported by evidences of long-term virus/host co-
adaptations, such as the specific expression of microRNA 122 in human liver, which 
enhances virus replication (Jopling et al. 2005; Simmonds 2013). Furthermore, 
evolutionary analyses estimates suggest that HCV has been infecting humans for at least 
500-2,000 years (Smith et al. 1997). For instance, the origin of genotype 6 has been 
estimated to have occurred from 600 years ago to 3,000 years ago (Pybus et al. 2009). 
Although these estimates are far from the tMRCA of humans (100,000- 200,000 years), 
inferring the true date of old viruses is hampered by the loss of signal due to substitution 
saturation and convergent evolution, which leads to underestimate the tRMCA 
(Aiewsakun & Katzourakis 2016). An alternative hypothesis, supported by the high genetic 
distance between genotypes and their geographic delimitations, is that the different HCV 
genotypes arose from independent zoonotic events (Pybus & Thézé 2016). 
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  Interestingly, despite being older to humans than HIV, HCV was not discovered 
until 1989. The main epidemic HCV subtypes (1a, 1b and 3a) started their global spread in 
the early 1,900s, and then grew exponentially from the second half of the 20th century 
(Magiorkinis et al. 2009; Pybus et al. 2005). Sharing medical or surgical equipment, blood 
transfusions and injecting drug use facilitated its pandemic spread. 25 years after its 
discovery, HCV is considered a major public health problem: the estimated number of 
chronically infected people surpasses 170 million (>900,000 in Spain), with the consequent 
risk of developing liver diseases such as cirrhosis and liver cancer, which can eventually 
cause death (Hajarizadeh et al. 2013; Mohd Hanafiah et al. 2013). Although most cases 
occur through parenteral transmission, there is an increasing trend of sexual transmission 
among HIV-positive MSM (most commonly of HCV genotypes 4 and 1), despite the known 
low efficacy of sexual transmission of HCV (Bradshaw et al. 2013). 
  The high diversity that characterizes HCV raises several questions about this virus 
which have been addressed in this thesis: i) Several epidemiological and clinical 
differences have been identified between the most prevalent HCV subtypes (HCV-1a and 
1b). Do these subtypes also present differences in genetic variability and in the selective 
constraints they are subjected to at the genome level? ii) Almost all DAAs have been 
designed to act against HCV-1, but there is little information on the effectiveness of these 
antivirals against the other 6 HCV genotypes. Do the different HCV genotypes present the 
same susceptibility towards DAAs? Public databases allow accessing to thousands of HCV 
sequences, which were retrieved in order to obtain representative datasets of each 
genotype/subtype. 
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1.7- Objectives 
This PhD thesis is aimed at studying different aspects of the long-term evolution of RNA 
viruses by means of evolutionary and statistical approaches, with special interest in the 
molecular epidemiology of HIV-1 and HCV. The specific objectives are the following: 
 To depict, by means of evolutionary analyses, the HIV epidemic in different 
Spanish regions, with especial interest in the Comunitat Valenciana. 
 To analyze the diversity of HIV, and detect the existence of local 
transmission clusters. The results obtained will help to detect the 
emergence of new HIV variants, not detected in the Comunitat Valenciana 
before, as well as the most vulnerable groups of people towards this virus. 
 To compare the tMRCAs and evolutionary rates of the main HIV-1 variants, 
by using nearly-complete genomes instead of individual genes. 
 To analyze the prevalence and evolutionary history of HCV resistant 
mutations to DAAs, focusing on the potential differences between 
genotypes and subtypes. 
 To analyze and compare the effect of positive selection on the genomic 
evolution of HCV subtypes 1a and 1b, analyzing how the presence of 
epitopes and RNA and protein secondary structures influence the 
distribution of positively selected and conserved sites along their genomes. 
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 To investigate whether RNA models outperform the use of DNA models in 
different sets of genomic alignments from RNA viruses and viroids, and 
assess the effect of such models on phylogenetic inference. 
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2.2- Chapter 2: The molecular epidemiology of 
HIV-1 in the Comunitat Valenciana (Spain): analysis 
of transmission clusters 
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Abstract 
A total of 1806 HIV-1 sequences comprising protease and reverse transcriptase 
(PR/RT) coding regions, sampled between 2004 and 2014 in the Comunitat Valenciana 
(CV, Spain), were subtyped and subjected to phylogenetic analyses in order to detect 
transmission clusters. Also, univariate and multinomial comparisons were performed to 
detect epidemiological differences between HIV-1 subtypes and risk groups. 
The HIV epidemic in the CV during the studied period is dominated by subtype B 
infections among local men who have sex with men (MSM). It also affects 
disproportionally to immigrants. We identified 270 transmission clusters of sizes ranging 
from 2 to 111 patients, representing more than 57% of the dataset. 12 clusters included 
more than 10 patients; 11 of subtype B (9 affecting MSM) and one (n=21) of CRF14, 
affecting predominately intravenous drug users (IDUs). Dated phylogenies revealed that 
these large clusters originated from the mid-80’s to the early 21st century. After 2000, the 
only clusters originated were of MSM.  
Univariate comparisons indicate that subtype B is more likely to form transmission 
clusters than non-B variants. MSM were also more likely to cluster than other risk groups. 
Multinomial analysis revealed an association between non-B variants and different groups 
of immigrants and people of foreign origin. Furthermore, CRF14 was associated to 
patients over 50 years of age and those forming large clusters. 
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In conclusion, the HIV epidemic in the CV is characterized by a majority of local 
HIV-1 B transmissions occurring among MSM. Non-B variants are not yet established in 
the local population, and mostly affect immigrants. 
 
Introduction 
Of the four phylogenetic groups which comprise HIV-1 (M, N, O, P), group M is the 
causal agent of the AIDS pandemic (Hahn et al. 2000; Plantier et al. 2009). The latest 
UNAIDS/WHO report (2016) estimated in almost 37 million the number of persons 
infected with HIV globally, with approximately 2.1 million new infections in 2015 (UNAIDS 
2016). 
Although the rate of new HIV diagnosis has stabilized from the early 2000s in the 
European Union and European Economic Area (EU/EEA), transmissions among men who 
have sex with men (MSM) have experienced a sustained increase, thus following a 
different trend to other risk groups(ECDC 2013). This is evident in Spain: during the late 
90s, most HIV new diagnoses were associated to intravenous drug use (IDU). However, in 
2013, 51% of the infections occurred among MSM (UNAIDS 2002; DGSP 2014). This 
increasing incidence among MSM is remarkably high in the age range 20-35 years (DGSP 
2014). HIV infections in Spain also affect disproportionally the foreign population: in 2012, 
35% of the new diagnosis corresponded to immigrants or persons of foreign origin (DGSP 
2014).  
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Within HIV-1 group M, there exist nine subtypes (denoted as A, B, C, D, F, G, H, J 
and K) and at least 61 circulating recombinant forms (CRFs) (Kuiken et al. 2012). There are 
differences among HIV-1 variants in several biological features. For instance, some 
subtypes and CRFs are associated to a faster progression to AIDS than others (Kaleebu et 
al. 2002; Kouri et al. 2015). Genetic, and also antigenic, differences among HIV-1 subtypes 
and CRFs are also a challenge for the development of an effective HIV-1 vaccine (Nickle et 
al. 2007).  
Worldwide, the most prevalent HIV-1 subtype is C, accounting for around 50% of 
all cases. However, the HIV epidemic in Europe, particularly among MSM, is mainly driven 
by subtype B (Abecasis et al. 2013), with frequent reported transmission clusters affecting 
them (Kouyos et al. 2010; Lewis et al. 2008; Leigh Brown et al. 2011; M. T. Cuevas et al. 
2009; Zehender et al. 2010; Hué et al. 2005; Bezemer et al. 2015). However, there is 
evidence for an increased introduction of non-B subtypes (Paraskevis et al. 2006). For 
instance, in a sample of 206 patients from Spain, Abecasis el al. (2013) found that 
CRF02_AG was the second most prevalent HIV-1 variant after subtype B (prevalence < 
2%). 
The Comunitat Valenciana (CV) is the fourth largest region in Spain (~5 million 
inhabitants), representing >10% of the total population. Genotypic tests of resistance to 
antiviral drugs are performed routinely for the design of individualized antiretroviral 
treatments. Between 2004 and 2014, more than 1800 HIV-1 pol sequences have been 
obtained from different patients at eight public hospitals and HIV testing and counselling 
centers from the CV. Phylogenetic analyses of this large dataset, combined with 
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epidemiological data, are a powerful tool for depicting the HIV-1 epidemic in the CV and 
were used in this study to infer the distribution of HIV-1 subtypes, to analyze the 
introductions (and further local expansion) of this virus in the CV, to identify the 
emergence of new viral variants to this region, and also to analyze which population 
groups are currently more vulnerable to HIV infection. The results obtained from this work 
may be useful in establishing and reinforcing preventive measures in specific target 
groups. 
 
Materials and methods 
Dataset 
A total of 1806 PR/RT sequences were obtained from newly HIV diagnosed people 
at six different hospitals and two HIV counseling and testing centers (CIPS) from the three 
provinces in the CV between 2004 and 2014. The sequences comprised the complete PR 
and the first 1005 nucleotides (335 amino acids) of the RT (1302 nt in total), and were 
obtained through viral RNA extraction followed by RT-PCR and direct sequencing using 
amplification and procedures described previously (Holguin et al., 2005). All sequences 
were subtyped using the Rega HIV-1 Subtyping Tool Version 3.0 (Pineda-Peña et al. 2013), 
the COMET HIV-1 Subtyping tool (http://comet.retrovirology.lu/) and an initial 
phylogenetic tree obtained with FastTree 2.1 (Price et al. 2010) which also included 133 
reference sequences downloaded from the Los Alamos HIV Database 
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(http://www.hiv.lanl.gov), representing the diversity of HIV-1 group M. Nucleotide 
alignments were obtained with MAFFT version 7 (Katoh & Standley 2013). 
Detection of local transmission clusters 
Independent alignments were generated for each HIV-1 subtype and CRF detected, 
which included the CV sequences and those sequences from the same variant retrieved 
from the Los Alamos HIV database, spanning the analyzed PR/RT region and used as 
references. Phylogenetic analyses were initially performed with FastTree 2.1 (GTR+ Γ, 
4CAT) in order to detect potential transmission clusters, which were defined as clades 
with SH-like support ≥ 0.70, and containing ≥ 90% sequences from the CV dataset.  
The potential clusters identified in the first step were then validated as follows. All 
sequences from the CV in a potential cluster were used as query for a BLASTN search at 
the NCBI server (https://blast.ncbi.nlm.nih.gov/Blast.cgi). The 10 sequences with the 
highest similarity to each CV sequence were downloaded and included into the 
alignments. Then, ML phylogenies were obtained with PhyML 3.0 (Guindon et al. 2010) 
using the GTR+ Γ(4 CAT) model, and only those potential clusters which contained more 
than 90% of sequences from the CV and grouped in the ML tree with aLRT support ≥ 0.98 
were considered as confirmed. Clusters were then classified depending on the major risk 
of transmission (≥50%) for the corresponding patients. 
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Dated phylogenies 
The molecular clock signal for the transmission cluster containing at least 10 
patients from the CV was assessed by performing linear regression analyses between the 
parameters “root-to-tip divergence” and “sampling date” with the software Path-O-Gen 
v1.4 (now renamed as TempEST; Rambaut et al. 2016). As input, we used the phylogenetic 
trees from each transmission cluster obtained as subtrees from the ML tree. 
Dated phylogenies for each of these clusters were obtained using a Bayesian 
MCMC coalescent method as implemented in BEAST v1.8.1 (Drummond & Rambaut 
2007), using the GTR112+Γ112 (4 CAT) model in all the analyses. In those clusters with low 
root-to-tip divergence vs sampling date correlation (R<0.4), a log-normal prior (median = 
0.0025 per site and year, s/s/y, 95% HPD upper limit = 0.0035 s/s/y) was placed on the 
ucld.mean parameter (Hué et al. 2005). Under an uncorrelated relaxed molecular clock 
model, the most appropriate demographic model [either the exponential growth, logistic 
growth or Bayesian Skyline Plot (BSP)] was determined as the one with the lowest Akaike 
Information Criterion (AICM) value (Baele et al. 2012). 
For each transmission cluster, at least two independent runs of Bayesian MCMC 
with chain lengths of at least 10 million states were performed. These runs were sampled 
every 1000 generations and then combined after discarding a 10% burn-in. All the 
evolutionary parameters were estimated from an effective sampling size > 200 
determined with Tracer version 1.4. The retained trees were summarized using 
TreeAnnotator (http://beast.bio.ed.ac.uk/). 
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Statistical analyses 
A multinomial logistic regression analysis was performed in order to identify the 
main predictors of HIV-1 subtype/CRF group distribution, considering relevant 
epidemiologic variables: country of origin, sex, risk group, collection date, age and 
clustering status. Due to the lack of epidemiological data for many sequences from the 
dataset, only 907 of the 1806 sequences were included in this analysis. Seven groups of 
different HIV-1 subtypes and CRFs were used: A1 (n = 14), B (n = 753), F1 (n = 13), G (n = 
11), 02_AG (n = 42) and 14_BG (n = 15). All HIV-1 variants with fewer than 10 patients 
sampled were pooled as “Other variants” (n = 59). Prior to the multinomial analysis, 
univariate analyses (Fisher’s Exact Tests) were performed for the aforementioned 
variables, in order to exclude from the multinomial analysis those with non-significant p-
values. Only the variable “collection date” (p-value > 0.70) was excluded. In the 
multinomial analysis, the most representative category of each variable was used as 
“baseline category” (Subtype B, Spaniard, male, MSM, age between 21 and 29 years and 
not clustering; Supplementary Table S.1). All the statistical analyses were performed using 
R (R Core Team 2014). The mlogit R package (Croissant 2015) was used for the 
multinomial analysis.  
 
Results 
1514 of the 1806 sequences analyzed (83.8%) belonged to subtype B. Among the 
292 non-B sequences, the most prevalent HIV-1 variant was CRF02_AG (n = 66, overall 
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prevalence = 3.6%), followed by subtypes A1, F1 (both n = 34, 1.9%), CRF14_BG (n = 28, 
1.6%) and subtype G (n =20, 1.1%). Other variants (n =110) were present with a 
prevalence lower than 1.0%. Considering those patients for whom epidemiological 
information was available, 83.05% (931/1121) were male vs 16.95% (190/1121) female; 
66.77% (633/948) were native from Spain vs 33.22% (315/948) immigrants or of foreign 
origin; 66.88% (638/954) were MSM, 21.28% (204/954) heterosexual (HT) and 11.53% 
(110/954) IDUs. One patient was infected vertically and other one was hemophiliac. The 
mean age was 34.84 years (range 0 to 76) (Table 1). MSM were more likely to be 
Spaniards than non-MSM (Fisher’s Exact test, FET: p-value=6x10-6, odds-ratio, OR = 2 
(1.47-2.70). 
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Table 1. Distribution of HIV cases in the dataset (n=1806) classified by viral subtype, gender, nationality, risk group, age and clustering status. 
  B (n=1514) A1 (n=34) F1 (n=34) G (n=20) 
CRF02_AG 
(n=66) 
CRF14_BG 
(n=28) Others (n=110)* Total (n=1806) 
Gender                 
Male 819 10 13 5 24 11 49 931 
Female 115 6 6 8 25 6 24 190 
UNK 580 18 15 7 17 11 37 685 
Nationality                 
Spain 575 6 5 3 11 8 25 633 
Other 202 10 11 10 33 8 41 315 
UNK 737 18 18 7 22 12 44 858 
Risk group                 
HT 124 8 6 9 29 2 26 204 
MSM 587 3 6 0 11 1 30 638 
IDU 85 3 0 2 3 12 5 110 
Other 2 0 0 0 0 0 0 2 
UNK 716 20 22 9 23 13 49 852 
Clustering                 
No cluster 622 22 24 13 32 5 49 767 
Small cluster 
(2-3) 371 12 5 7 25 2 39 461 
Medium 
cluster (4-9) 240 0 5 0 9 0 22 276 
Large cluster 
(>=10) 281 0 0 0 0 21 0 302 
Age: mean 
(min - max) 35.24 (14-76) 32.8 (19-56) 33.5 (18-62) 28.9 (21-41) 30.6 (19-49) 38.11 (22-65) 33.2 (0-62) 34.84 (0-76) 
 
*The “Others” subset includes 10 subtype C, 2 subtype D, 13 CRF19_cpx, 12 CRF12_BF, 9 CRF06_cpx, 7 CRF47_BF and 57 other  (mostly unassigned) 
recombinant sequences. 
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Phylogenetic analyses revealed the existence of 270 transmission clusters, with 
sizes ranging from 2 to 111 patients (Figure 1.A). In total, 1039 patients from the dataset 
were included in a transmission cluster (57.5%), 302 of them (16.7%) were included in 
large clusters of 10 or more patients (Table 1; Figure 1.A). Among the 892 patients 
clustering in transmission groups of subtype B, 407 were MSM, 56 HTs, 38 IDUs and 391 of 
unknown transmission route. On the other hand, of the 147 patients clustering in non-B 
clusters 29 were HTs, 29 MSM, 15 IDUs and 74 of unknown transmission route (Figure 
1.B). The most prevalent transmission clusters of subtype B were those classified as MSM, 
followed by IDUs, but for non-B transmission clusters of HTs were the most frequent ones, 
followed by those of MSM (Figure 1.C). Subtype B sequences were more likely to be part 
of a transmission cluster than non-B sequences (FET: p-value = 0.008, OR = 1.41, 95% CI = 
1.09-1.83). Also, MSM were more likely to be part of a transmission cluster than groups 
other risk groups (FET: p-value = 1.68x10-4, OR = 1.56, 95% CI = 1.23-1.99).  
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Figure 1. (A) Distribution of sizes (log10 scale) of the 270 transmission clusters found in the CV (2004-2014) 
through phylogenetic analysis. Block letters indicate the 12 clusters that were analyzed with BEAST. (B) Total 
number of patients for each risk group included in transmission clusters (n=1039). (C) Number of 
transmission clusters depending on the risk group in which they were classified. *: >1/4 patients shared a 
known risk group, but they were not enough to classify the cluster. 
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12 transmission clusters included at least 10 patients from the CV (Figure 2). 11 of 
them were from subtype B and included a total of 281 patients (Figure 2.A). One cluster of 
21 patients corresponded to CRF14_BG (Cluster K, Figure 2.B). Patients infected with 
subtype B were more likely to form large transmission clusters than those infected with 
non-B variants (FET: p-value = 3.4x10-7, OR = 2.94, 95% CI = 1.84-4.92).  
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Figure 2. Maximum likelihood trees with the 12 largest transmission clusters highlighted in red. (A) Subtype B tree (clusters A-J, L). (B) Subtype G and CRF14_BG 
tree (cluster K).
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9 of the largest clusters were classified as MSM; the other three included mostly 
IDUs, although in a proportion lower than 50% (Table 2). Dated phylogenies of these 
clusters revealed they originated between the years 1984 (cluster G, unclassified 
transmission route) and 2005 (cluster B, MSM). All the clusters originated since 2000 
included MSM as the main transmission risk (Table 2; Supplementary Figure 1). Bagplots 
(bivariate representations of boxplots; Rousseeuw et al. 1999) representing tree height 
(the time elapsed between tMRCA and the sampling date of the last sequence) and 
evolutionary rate estimates from the posterior distribution of each large cluster are shown 
in Figure 3. A significant, negative correlation between median tree height and 
substitution rate estimates of these large clusters was obtained (R = -0.70, p-value = 
0.013).   
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# Time measured in years. 
*Substitutions per site and year.
Table 2. Size (n, number of patients), risk group, range of sampling dates and root-to-tip vs sampling date correlation coefficient for each 
transmission cluster (R), and estimates of their tMRCAs (median) and substitution rates as obtained with BEAST under the best-fitting 
demographic model (EXPO: exponential growth; BSP: Bayesian Skyline Plot; LOG: logarithmic growth). 
Cluster n risk group range # R Model tMRCA (95% HPD)# Substitution rate (95% HPD)* 
A 10 MSM 2004 - 2011 (-0.08) EXPO 1984.7 (1971.2 - 1994.5) 0.0014 (0.0009 - 0.0021) 
B 13 MSM 2007 - 2013 0.61 BSP 2005.9 (2003.8 - 2006.9) 0.0043 (0.0016 -0.0087) 
C 15 UNK/IDU 2004 - 2014 (-0.18) BSP 1988.0 (1969.0 - 1999.2) 0.0015 (0.0007 - 0.0025) 
D 16 MSM 2011- 2013 (-0.05) LOG 1994.9 (1982.4 -2006.3) 0.0022 (0.0012 - 0.0034) 
E 18 UNK/MSM 2010 - 2014 0.25 EXPO 2002.2 (1995.9 -2006.8) 0.0018 (0.0011 - 0.0027) 
F 18       MSM 2008 - 2013 0.40 LOG 1999.3 (1989.6 - 2005.0) 0.0013 (0.0005 -0.0023) 
G 19 UNK 2004 - 2013 (-0.05) EXPO 1984.3 (1966.9 -1997.0) 0.0011 (0.0006 - 0.0019) 
H 19 MSM 2008 -2014 0.58 BSP 2002.1 (1995.9 -2006.2) 0.0019 (0.0010. 0.0029) 
I 21 MSM 2004 - 2012 0.58 LOG 1994.6 (1982.2 -2001.3) 0.0012 (0.0005 -0.0020) 
J 21 MSM 2004 - 2013 0.76 LOG 1999.5 (1993.2 - 2003.4) 0.0023 (0.0010 - 0.0045) 
K 21 UNK/IDU 2004 -2014 0.62 BSP 1990.6 (1979.6 -1998.1) 0.0010 (0.0005 - 0.0016) 
L 111 MSM 2006 - 2014 0.61 EXPO 2001.8 (1998.6 -2004.8) 0.0028 (0.0022 - 0.0035) 
 
78 
 
 
Figure 3. Bagplots representing tree height and evolutionary rate estimates, obtained from the posterior 
distribution of the 12 largest transmission clusters detected (A to L). 
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 Despite most patients infected with subtype B being Spanish natives (575 
Spaniards vs 202 foreigners), a majority of those infected with non-B variants were 
foreigners (58 vs 113; FET: p-value < 2.2x10-16, OR = 5.50, 95% CI = 3.81-8.01). This 
difference was also observed when considering only patients belonging to a transmission 
cluster (subtype B: 370 vs 121; non-B: 31 vs 47; FET: p-value = 1.1x10-9; OR = 4.62, 95% CI= 
2.74 – 7.89). Other univariate analyses for the variables considered for the multinomial 
analysis revealed differences between subtypes: subtype B sequences were 
disproportionally more present in males compared to females (FET: p-value < 2.2x10-16, 
OR = 4.76, 95% CI = 3.30-6.87), in MSM with respect to HTs and IDUs (p-value < 2.2x10-16, 
OR = 7.4, 95% CI = 4.88-11.32 and p-value =2x10-5, OR = 3.37, 95% CI = 1.9 – 5.9, 
respectively), and in IDUs compared to HTs (p-value = 0.0038, OR=2.19, 95% CI = 1.26-
3.88). There were also intersubtype differences regarding age distributions (Kruskal-Wallis 
test: P = 0.0013, Chi2 = 21.8, df = 6), with CRF02_AG patients being significantly younger 
than B patients (Games-Howell post-hoc test result for this comparison: p = 0.0049, t = 
3.88, df = 56). Given that no significant differences were found between subtypes in the 
distribution of collection dates (P > 0.70), this variable was excluded from the multinomial 
analysis. 
Multinomial analyses were performed using a subset of 907 patients for whom 
there was information on all the different variables analyzed (sex, risk group, country of 
origin, clustering status and age) considering as baseline the most frequent category for 
each variable (Subtype B, Spaniard, male, MSM, age between 21 and 29 years and not 
clustering), and a significant model was obtained (McFadden R2 = 0.32, Chi2 = 414.55, p-
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value < 2.2x10-16)). We checked that this subset was representative of the global set 
(n=1806) by means of FETs, and the p-values obtained for all the analyzed variants were > 
0.05. The multivariate model shows that the chance of being infected with all non-B 
groups increased in foreign patients, coming from Eastern Europe (A1, F1, 14_BG and the 
pooled, rare, variants), Africa and the Middle East (F1, G, 02_AG and the rare variants) and 
Latin America (rare variants), with all p-values < 0.01, all ORs > 3.0. The likelihood of being 
infected with CRF14_BG also increased in patients older than 50 years (p-value = 0.028, 
OR = 36.2, 95% CI = 1.45 – 904.0), in IDUs (p-value = 9.43x10-5, OR = 257, 95% CI = 15.9 – 
4160) and in those patients forming large transmission (p-value = 1.6x10-4, OR = 36.9, 95% 
CI = 5.67 – 240) (Table 3). 
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***: P<0.001; **: 0001 < P < 0.01; *: 0.01 < P < 0.05; $: 0.05 < P < 0.1. 
Table 3. Results of the multinomial analysis (only significant associations between each HIV 
variant and the categories compared at each variable are shown) 
Coefficients          
  Estimate 
Std 
error 
t-
value Pr(>|t|)    OR 2.50% 97.50% 
14_BG:Age(>50) 3.59 1.64 2.188 0.028696 *  36.2 1.45 904 
14_BG:RISK(HT) 2.39 1.43 1.673 0.094242 $  11.0 0.664 181 
02_AG:RISK(HT) 1.07 0.579 1.850 0.064354 $  2.92 0.938 9.08 
14_BG:RISK(UDI) 5.55 1.42 3.905 9.43E-05 ***  257.0 15.9 4.16E+03 
14_BG:Eastern 
Europe 3.29 1.09 3.023 0.002502 **  26.9 3.18 227 
F:Eastern Europe 3.51 1.08 3.251 0.001151 **  33.6 4.04 280 
OTHERS: Eastern 
Europe 2.01 0.584 3.500 0.000561 ***  7.49 2.39 23.5 
A1:Eastern Europe 2.78 0.795 3.494 0.000476 ***  16.1 3.39 76.5 
F1:Africa and Middle 
East 3.51 1.05 3.355 0.000793 ***  33.3 4.30 259 
G:Africa and Middle 
East 3.78 1.17 3.236 0.001215 **  43.7 4.43 431 
OTHERS:Africa and 
Middle East 2.77 0.554 5.013 5.37E-07 ***  16.0 5.42 47.5 
A1:Africa and 
Middle East 1.92 0.993 1.934 0.053091 $  6.82 0.975 47.8 
02_AG:Africa and 
Middle East 3.76 0.580 6.481 9.11E-11 ***  43.0 13.8 134 
14_BG:Latin 
America 2.71 1.38 1.956 0.050527 $  15.0 0.994 225 
OTHERS:Latin 
America 1.20 0.352 3.401 0.000672 **  3.31 1.66 6.60 
14_BG:ClusterLARGE 3.61 0.955 3.776 0.000159 ***   36.9 5.67 240 
          
          
82 
 
 Discussion 
We have studied the HIV epidemic in the Comunitat Valenciana by analyzing with 
molecular and evolutionary tools 1806 sequences obtained between 2004 and 2014 from 
different patients. Our results indicate that the HIV epidemic in the CV is dominated by 
HIV-1 subtype B infections among local MSM. However, non-B infections represented an 
important number of cases, with a prevalence higher than 15%, being CRF02_AG the most 
prevalent non-B variant (prevalence = 3.6%), in agreement with previous estimates for 
Spain obtained by Abecasis et al. (2013) and Yebra et al. (2012). 
Immigrants were disproportionally represented in the dataset (almost 1/3 of the 
patients were of non-Spanish origin), reflecting their higher vulnerability to HIV infection. 
Multinomial analyses evidenced the significant association between all non-B groups 
analyzed and different foreign populations: Eastern Europe (subtypes A1, F1, CRf14_BG 
and the rare variants), Africa and the Middle East (subtypes F1, G, CRF02_AG and rare 
variants) and Latin America (rare variants). These associations were in agreement with the 
geographical distributions of these variants (Hemelaar 2012; Buonaguro et al. 2007; Bello 
et al. 2012). These results, along with the fact that most non-B patients, either clustering 
or not, were of non-Spanish origin (CRF14_BG was the only exception) suggest that along 
the analyzed time-span non-B HIV variants were not well established among Spanish locals 
in this region. Furthermore, non-B patients clustered in a significantly lower proportion 
than patients infected with subtype B, especially when considering clusters with at least 
10 patients, thus displaying significantly lower local transmission efficiency. The significant 
association between non-B HIV variants and immigrants reported in this work and in 
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previous molecular epidemiology analyses of HIV-1 in Madrid, Spain (González-Alba et al. 
2011; Yebra et al. 2013), suggest that high migration and tourism rates existing in some 
Spanish regions may explain the high genetic diversity of their HIV-1 epidemics. 
Overall, the detection of transmission clusters demonstrates the importance of the 
domestic spread of HIV-1 in the CV. Most patients from the whole dataset (>57%) were 
included in local transmission clusters, of sizes ranging from 2 to 111 individuals. Local 
transmission was especially important among MSM, who were more likely to belong to a 
transmission cluster, as well as for Spanish natives, than other risk groups. Considering the 
12 largest clusters (size ≥ 10 patients), this transmission risk was the most prevalent in 9 of 
them. Excluding cluster A (MSM, tRMCA= 1984.7), MSM clusters were of more recent 
origin as estimated using Bayesian coalescent analyses, especially clusters B (n=13), E 
(n=18), H (n=19) and L (n=111), which originated after year 2000. Although previous 
analyses in the Spanish regions of Madrid (Yebra et al. 2013) and the Basque Country 
(Patiño-Galindo et al. 2016) detected lower proportions of clustering patients (18 and 27% 
of their analyzed sequences, respectively), suggesting that the importance of local 
transmissions may not be the same in different Spanish regions, they also found evidences 
for an increased vulnerability to HIV of the Spanish MSM community in recent years.  
Although 11 of the 12 largest transmission clusters were of subtype B, one of the 
largest clusters found (n=21, median tMRCA= 1990.6) corresponded to the CRF14_BG, and 
included a high number of IDUs from Spain. CRF14 has been associated to a predominance 
of CXCR4 tropism, which usually leads to faster AIDS onset (Bártolo et al. 2011; Pérez-
Álvarez et al. 2014). The multinomial analysis of our dataset showed that this highly 
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pathogenic variant is significantly associated to IDUs, immigrants from Eastern Europe, 
older than 50 years and/or forming large transmission clusters. Previous phylogeographic 
analyses have suggested that CRF14_BG originated in the Iberian Peninsula (Bártolo et al. 
2011), and its prevalence is increasing in some Eastern European countries, such as 
Romania, boosted by migration events between these countries and Spain (Niculescu et 
al. 2015).  
We also detected two other transmission clusters of smaller size (n=5 and n=4) 
affecting Spanish-native MSM of another highly pathogenic variant (CRF19_cpx), which we 
previously reported as the first evidence of expansion of this variant outside Cuba (Patiño 
Galindo et al. 2015). Despite the prevalence of these CRFs remaining low in the CV, the 
effective expansion of these highly pathogenic HIV variants, evidenced by the detection of 
transmission clusters, is of especial interest because it may hamper the control of the local 
HIV epidemic, especially among vulnerable populations such as IDUs or MSM. 
 One potential difficulty in the analysis of this dataset was the number of sequences 
for which no epidemiological information (sex, transmission risk, or country of origin) was 
available. However, the number of cases with available information for all the variables 
was > 900. Furthermore, the distributions of all the variables included in the multinomial 
analysis were not significantly different to those from the whole dataset, including cases 
with incomplete information. In consequence, the results reported are representative of 
the sampled population and represent one of the most comprehensive analysis of the HIV 
pandemics in Spain (cf. González-Alba et al. 2011; Yebra et al. 2012; Yebra et al. 2013; 
Yebra et al. 2014). 
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It is noteworthy to mention the significant, negative correlation found between 
tree height and evolutionary rate estimates obtained when comparing the 12 largest 
clusters. Several publications have addressed this time-dependency on the evolutionary 
rate (TDRP), that is, virus lineages estimated to have a recent origin yield higher estimated 
evolutionary rates than older viruses (Ho et al. 2015; Aiewsakun & Katzourakis 2015; 
Aiewsakun & Katzourakis 2016). Although temporal changes in selective pressure and/or 
viral biology could be a reason for TDRP, in our study the most plausible explanation for 
this phenomenon is the overestimation of evolutionary rates in the most recent clusters, 
caused by the presence of deleterious mutations over which purifying selection has not 
had time to act. This phenomenon might be potentiated by the effect of the bottlenecks 
that occur at viral transmission, which usually cause a fast accumulation of deleterious 
mutations. Other possible causes, such as errors in calibration, were excluded after 
repeating the correlation tests between tree height and evolutionary rate without those 
clusters with low molecular clock signal, because similar results were obtained. Finally, the 
presence of skewed rate distributions was excluded by checking them graphically. 
Consequently, these results suggest that TDRP is an important factor to consider in 
molecular epidemiology, even when datasets are obtained from the same, short timescale 
(in this case 10 years, from 2004 to 2014).  
 It is also important to mention that many works on the molecular epidemiology of 
HIV-1 remove resistance-associated positions from the analysis. This is usually done 
because the selection of resistant variants caused by the selective pressures imposed by 
antivirals may produce spurious clustering by convergent evolution. In our analysis we did 
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not remove these positions, because their impact on the detection of transmission 
clusters has been demonstrated to be irrelevant (Hué et al. 2004). Furthermore, a great 
majority of our sequences were known to derive from treatment-naïve patients (only 66 
patients were known to have been treated), and none of the large transmission clusters 
was defined by a shared resistant mutation.  
 In conclusion, our results evidence that the HIV-1 epidemic in the CV is dominated 
by subtype B, especially among local MSM. Although there were an important number of 
non-B cases, they occurred mostly among immigrants. This suggests that non-B infections 
are not well established in the local population. However, the detection of transmission 
clusters of non-B variants associated to a higher pathogenicity and affecting Spanish 
patients, urge to increase efforts on HIV testing and prevention campaigns to prevent 
their further expansion.  
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Supplementary material 
Supplementary Table S.1. Distribution of HIV cases in the dataset subjected to multinomial analysis 
(n=907), regarding the variables subtype, gender, age, nationality, risk group and clustering status 
  
B 
(n=753) 
A1 
(n=14) 
F1 
(n=13) 
G 
(n=11) 
CRF02_AG 
(n=42) 
CRF14_BG 
(n=15) 
Others 
(n=59) 
Total 
(n=907) 
Gender                 
Male 673 9 8 4 22 9 41 766 
Female 80 5 5 7 20 6 18 141 
Age                 
<=20 30 1 2 0 1 0 1 35 
21-29 246 5 3 9 24 2 25 314 
30-35 195 4 2 1 9 6 14 231 
36-50 252 3 6 1 8 4 18 292 
>50 30 1 0 0 0 3 1 35 
Nationality               
Spain 556 6 4 3 11 8 20 608 
W.Europe and N 
America 27 0 0 0 1 0 1 29 
Eastern Europe 15 5 3 0 0 4 6 33 
Africa and M. East 13 2 3 8 23 0 11 60 
Latin America 141 1 3 0 7 3 20 175 
Others 1 0 0 0 0 0 1 2 
Risk group               
HT 119 8 7 9 29 2 24 198 
MSM 565 3 6 0 11 1 30 616 
IDU 67 3 0 2 2 12 5 91 
Other 2 0 0 0 0 0 0 2 
Clustering               
No 278 10 10 5 23 3 34 363 
Small cluster (2-3) 170 4 1 6 14 2 18 215 
Medium cluster (4-
9) 142 0 2 0 5 0 7 156 
Large cluster (>=10) 163 0 0 0 0 10 0 173 
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Supplementary Figure S1. Dated phylogenetic trees of the 12 largest transmission clusters (A to L) analyzed with BEAST, Branch lengths represent years. Nodes 
with Posterior Probabilities ≥0.90 are represented with black dots. 
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Supplementary Figure S1 (cont). Dated phylogenetic trees of the 12 largest transmission clusters (A to L) analyzed with BEAST, Branch lengths represent years. 
Nodes with Posterior Probabilities ≥0.90 are represented with black dots. 
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Supplementary Figure S1 (cont). Dated phylogenetic trees of the 12 largest transmission clusters (A to L) analyzed with BEAST, Branch lengths represent years. 
Nodes with Posterior Probabilities ≥0.90 are represented with black dots. 
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Supplementary Figure S1 (cont). Dated phylogenetic trees of the 12 largest transmission clusters (A to L) analyzed with BEAST, Branch lengths represent years. 
Nodes with Posterior Probabilities ≥0.90 are represented with black dots. 
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Supplementary Figure S1 (cont). Dated phylogenetic trees of the 12 largest transmission clusters (A to L) analyzed with BEAST, Branch lengths represent years. 
Nodes with Posterior Probabilities ≥0.90 are represented with black dots. 
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Supplementary Figure S1 (cont). Dated phylogenetic trees of the 12 largest transmission clusters (A to L) analyzed with BEAST, Branch lengths represent years. 
Nodes with Posterior Probabilities ≥0.90 are represented with black dots. 
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Supplementary Figure S1 (cont). Dated phylogenetic trees of the 12 largest transmission clusters (A to L) analyzed with BEAST, Branch lengths represent years. 
Nodes with Posterior Probabilities ≥0.90 are represented with black dots. 
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Supplementary Figure S1 (cont). Dated phylogenetic trees of the 12 largest transmission clusters (A to L) analyzed with BEAST, Branch lengths represent years. 
Nodes with Posterior Probabilities ≥0.90 are represented with black dots. 
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Supplementary Figure S1 (cont). Dated phylogenetic trees of the 12 largest transmission clusters (A to L) analyzed with BEAST, Branch lengths represent years. 
Nodes with Posterior Probabilities ≥0.90 are represented with black dots. 
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Supplementary Figure S1 (cont). Dated phylogenetic trees of the 12 largest transmission clusters (A to L) analyzed with BEAST, Branch lengths represent years. 
Nodes with Posterior Probabilities ≥0.90 are represented with black dots. 
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Supplementary Figure S1 (cont). Dated phylogenetic trees of the 12 largest transmission clusters (A to L) analyzed with BEAST, Branch lengths represent years. 
Nodes with Posterior Probabilities ≥0.90 are represented with black dots.
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Supplementary Figure S1 (cont). Dated phylogenetic trees of the 12 largest transmission clusters (A to L) 
analyzed with BEAST, Branch lengths represent years. Nodes with Posterior Probabilities ≥0.90 are 
represented with black dot
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2.3- Chapter 3: Identification of a large, fast-
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Supplementary material 
Supplementary material (Supplementary Files S1 and S2) is freely available at 
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0171062 
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Abstract  
Background: HIV-1 M causes most infections in the AIDS pandemic. This viral 
group presents a huge genetic diversity, with at least 10 pure subtypes and about 60 
recombinant forms. We have performed a comparative analysis of the evolutionary 
rate of five pure subtypes (A1, B, C, D, and G) and two recombinant forms (CRF01_AE 
and CRF02 AG) using data obtained from nearly complete genome coding sequences.  
Materials and methods: tMRCAs and evolutionary rates of these HIV genomes, 
and their genes, were estimated by Bayesian coalescent analyses. Genomic 
evolutionary rate estimates were compared between the HIV-1 datasets analyzed by 
means of randomization tests. 
Results: Significant differences in the rate of evolution were found between 
subtypes, with subtypes C, A1 and CRF01_AE displaying the higest rates. On the other 
hand, CRF02_AG and subtype D had the lowest rates. Using a different molecular clock 
model at each genomic partition led to more accurate tMRCA estimates than when 
linking a same clock model along the HIV genome. Overall, the earliest tMRCA 
corresponded to subtype A1 (median=1941, 95%HPD= 1943-1955) whereas the most 
recent tMRCAs corresponded subtype G and CRF01_AE subset 3 (median =1971, 95% 
HPD= 1967-1975 and median = 1972, 95%HPD= 1970- 1975 respectively). 
Discussion: These results suggest that both biological and epidemiological 
differences among HIV-1 M subtypes are reflected in their evolutionary dynamics. The 
obtained tMRCA and evolutionary rate estimates provide information that can be used 
as prior distributions in future Bayesian coalescent analyses of specific HIV -1 
subtypes/CRFs and genes. 
 
 132 
 
Background  
HIV is a retrovirus of the genus Lentivirus and is characterized by a very high 
genetic diversity. There exist two types of HIV: HIV-1 and HIV-2. The former causes the 
AIDS pandemics and comprises four phylogenetically distinct groups: M, N, O, and P. 
Groups N, O are found almost exclusively in West-Central Africa (Hahn et al. 2000). 
Only two strains from group P have been reported so far, both in Cameroon (Plantier 
et al. 2009; Vallari et al. 2011). HIV-1 group M is the main driver of the HIV pandemics. 
Within this group, nine subtypes exist (denoted A, B, C, D, F, G, H, J, and K) and at least 
61 circulating recombinant forms (Kuiken et al. 2012).  
High mutation and evolutionary rates favor the genetic diversity of HIV. These 
are due to three main causes: (i) polymerization errors of the reverse transcriptase 
(Roberts et al. 1988); (ii) genetic recombination that produces viral chimeras (Temin 
1993); and (iii) an explosive within-host proliferation and a large, and still growing, 
number of infected persons that lead to very large population sizes (Pennings et al. 
2014). These factors facilitate the action of natural selection, favoring those mutations 
that increase the biological fitness of the virus and the elimination of disadvantageous 
alleles (Moya et al. 2004). Other factors act in the opposite direction. For instance, 
Simon-Loriere et al. (2013) showed that gene overlapping, which affects to all genes in 
the HIV genome, is inversely correlated to the rate of RNA virus evolution due to a 
reduction in the number of synonymous substitutions, although it would be less 
relevant in cases of terminal gene overlaps, which are the predominant type of overlap 
in HIV. Genetic bottlenecks during transmission also act slowing the pace of evolution 
in this virus, because many mutations accumulated within a host are lost after 
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transmission. The fact that adaptive changes at the within-host level are lost or 
reverted after transmission explains the consistently reported higher intra-host than 
between-host evolutionary rates of HIV-1 (Alizon & Fraser 2013; Duchêne et al. 2014; 
Lin et al. 2015). The speed of spread of HIV in an epidemic also influences its 
evolutionary rate (Maljkovic Berry et al. 2007). Hence, differences in selective 
pressures, mutation rates, replication capacity and/or epidemics dynamics may explain 
differences in the evolutionary rate among subtypes.  
There are important differences in the prevalence of the different subtypes 
around the world. Subtype C is the most prevalent variant of HIV-1, occurring mainly in 
Africa (which presents the highest diversity of HIV-1) and Asia and accounting for 
almost 50% of the infections, but subtype B is the most widespread one, mainly 
affecting developed countries. Subtypes A, D, F, G, H, J and K display their highest 
prevalence in Sub-Saharan Africa. It is important to mention the increasing prevalence 
of circulating recombinant forms, especially CRF01_AE and CRF02_AG, which cause 
most of the infections in South-East Asia and Western Africa, respectively (Buonaguro 
et al. 2007).  
Differences among subtypes in the intensity of selection have also been 
reported (Choisy et al. 2004). Its importance on the differential pace at which HIV-1 M 
subtypes evolve has been addressed by analyses of partial genes (Abecasis et al. 2009; 
Wertheim et al. 2012), thus ignoring the differences in the mutation rate and/or 
selective constraints that are known to exist between genomic regions (Geller et al. 
2015).  
 134 
 
Here, we present a comparative analysis of the evolution of the main HIV-1 
subtypes using Bayesian coalescent reconstructions. The primary goal of our study was 
to compare the evolutionary rates of the main HIV-1 subtypes from a genomic 
perspective, by using near-full viral coding sequences, which should be more 
informative for the inference of the evolutionary rates and diversification dates than 
the individual genomic regions used so far.  
 
Materials and methods  
Datasets  
Full coding-region sequences (CDS) were retrieved from the Los Alamos HIV 
Sequence Database, LANL (http://www.hiv.lanl.gov/) on October, 2015. Independent 
datasets were obtained for subtypes A1, B, C, D and G, and the CRF01_AE and 
CRF02_AG circulating recombinant forms. Although subtype F1 was initially 
considered, it was excluded from the study due to the low number of sequences 
retrieved. The first criterion for the selection of these sequences was the absence of 
problematic sequences (defined in LANL as sequences with a high proportion of non-
ACTG characters or stop codons, presenting hypermutations, deletions or being either 
contaminants, synthetic constructs or reverse complements), the presence of only one 
sequence per patient and the exclusion of sequences with large deletions or 
undetermined regions (>5% of the sequence length). Sequences without known 
sampling date were also excluded. In order to exclude recombinant or incorrectly 
subtyped sequences the retained sequences were re-subtyped with the Comet HIV-1 
(http://comet.retrovirology.lu) and REGAv3 HIV-1 subtyping tools (Pineda-Peña et al. 
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2013). All the sequences were also analyzed with five methods of recombination 
detection implemented in the RDP4 software, RDP, Geneconv, Bootscan, Maxchi and 
Chimaera (Smith 1992; Posada 2002; Padidam et al. 1999; Martin & Rybicki 2000; 
Martin et al. 2005; Martin et al. 2015). Sequences in which at least one method 
suggested recombination, with a P value <0.05, were considered for exclusion. In order 
to remove redundant sequences, alignments of the concatenated sequences were 
processed with CD-HIT (Huang et al. 2010) using a similarity threshold at 0.98. One 
sequence from each of the clusters found at this level was retained for further analysis. 
Independent alignments of the non-overlapping regions from all genes were 
obtained, including the  region spanning vpr to vpu, using MAFFT version 7 (“auto” 
strategy; Katoh & Standley 2013) Subsequently, regions of poor homology (gappy sites) 
were trimmed with trimAl (Capella-Gutiérrez et al. 2009). The final alignment lengths 
were: gag- 1295 nts, pol – 2746 nts, vif – 464 nts, vpr-to-vpu- 743 nts, env – 2316 nts, 
nef – 609 nts. Consequently, up to 8173 nts of the 8627 bp spanning the HIV-1 CDS 
were analyzed. 
Due to the high number of B, C and CRF01_AE sequences that accomplished 
the selection criteria, and the computational limitations associated with the analysis of 
large genomic datasets, three different random subsets (n=100) for each of these HIV- 
1groups were generated with replacement. These subsets also allowed to check the 
robustness of the obtained estimates for these subtypes.  
Molecular clock signal analysis  
We checked the clock-likeness of our datasets by performing linear regression 
analyses between the parameters “root-to-tip divergence” and “sampling date” with 
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TempEST (Rambaut et al. 2016). For each subtype and CRF, a tree reconstructed with 
Fasttree2.1 (Price et al. 2010) was used as input, and the root was chosen as the 
branch that maximized the coefficient of correlation (R), under the assumption of a 
strict molecular clock. 
Evolutionary analyses  
tMRCA and genomic evolutionary rate estimates of each HIV-1 subtype and CRF 
were obtained by independent Bayesian Markov Chain Monte Carlo (MCMC) 
coalescent analyses, as implemented in BEAST v1.8.1 (Drummond & Rambaut 2007). 
Initially, the same partition tree and clock models were applied to all gene regions. All 
the analyses were performed with the HKY + Γ (4 categories) substitution model, 
combined with either an uncorrelated lognormal relaxed or the strict molecular clock 
model and three different demographic models (Bayesian Skyline Plot, and exponential 
or logistic demographic change). The best demographic model was chosen as that with 
the lowest Akaike’s Information Criterion value (AICM) (Baele et al. 2012). We 
repeated the coalescent analyses using the GTR + Γ model, obtaining identical tMRCA 
and evolutionary rates results (data not shown). 
For each viral group, we also estimated its tMRCA and the evolutionary rate of 
each gene partition by repeating the BEAST analyses by assigning a different molecular 
clock model to each gene partition.  
At least two independent runs of BEAST were performed for each alignment, 
with MCMC chain lengths ranging between 30x106 and 20x107 states. Convergence of 
the estimated parameters was confirmed with Tracer 
(http://tree.bio.ed.ac.uk/software/tracer/) checking that effective sample sizes (ESS) 
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were larger than 200 for the estimated parameters.  
Because substitutions in external branches may include recent, deleterious 
mutations leading to overestimates of the actual evolutionary rates, we compared the 
genomic evolutionary rates in internal and external branches for each subtype/CRF, 
using a Perl script (available upon request) to estimate the evolutionary rate 
(“ucld.mean”) parameter independently for internal and external branches. As the 
estimates for internal and external branches were almost identical, tMRCA and 
evolutionary rate estimates reported in this work correspond to values estimated from 
both external and internal branches (data not shown). 
Pairwise comparisons of genomic evolutionary rates 
We tested whether the genomic evolutionary rate distributions estimated from 
BEAST were significantly different among subtypes/CRFs comparing pairwise posterior 
distributions by means of randomization tests, in which p-values were calculated by 
counting the number times that one evolutionary rate was lower than the other, 
considering 5000 tree states chosen randomly (with replacement) of each 
subtype/CRF. The obtained value (v) divided by 5000 (number of comparisons) was 
considered as the probability that the compared values belong to different 
distributions (Abecasis et al. 2009). P-values were obtained as “P=1-v”, and were 
adjusted with the false discovery rate method (FDR; Benjamini & Hochberg 1995). 
These comparisons were performed using an in-home R script available upon request 
(R Core Team 2014). 
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Results  
Datasets 
Of the 2399 HIV-1 M sequences initially retrieved from LANL, 1441 (A1: 96, B: 
580, C: 450, D: 45, G: 32, AE: 208, AG: 30) were kept for further analyses. As 
mentioned in Material and Methods, three different random subsets (n=100) were 
obtained with replacement for subtypes B and C and CRF01_AE. In total, 248 subtype 
B, 234 subtype C and 177 01_AE sequences were included in the analyses. 
Consequently, 862 different sequences from the seven HIV-1 subtypes/CRFs were 
analyzed. Information on HIV-1 subtype/CRF, country of origin, sampling year and 
accession number of the sequences used in each dataset is shown in Supplementary 
Table S1. 
Molecular clock signal analyses 
The clock-like signal present in the analyzed datasets was evaluated by 
calculating the correlation coefficients (R) between the root-to-tip divergence and 
sampling date. R ranged between 0.50 (CRF02_AG) and 0.90 (subtype G) (Table 1). The 
possible existence of over dispersion of the HIV-1 molecular clock, which could be a 
major limitation for our comparisons, was rejected by ensuring that plots produced in 
the linear regression analyses of root-to-tip divergence vs sampling date for the 
concatenates did not present large dispersed clouds of points around the regression 
line. Residual mean squared values, which estimate the variance of the rates, for all 
the subtypes were lower than 2x10-4 (Table 1). 
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Table 1. Molecular clock signal of each HIV-1 dataset analyzed: correlation coefficient (R) 
and residual mean squared value obtained in the root-to-tip divergence vs sampling date 
correlation analyses 
Dataset R Residual mean squared values 
A1 0.65 8.50E-05 
B-1 0.80 6.60E-05 
B-2 0.70 6.80E-05 
B-3 0.70 1.50E-04 
C-1 0.62 7.80E-05 
C-2 0.55 6.10E-05 
C-3 0.59 6.30E-05 
D 0.77 2.00E-05 
G 0.90 1.40E-05 
01_AE-1 0.89 2.50E-05 
01_AE-2 0.82 3.00E-05 
01_AE-3 0.86 4.60E-05 
02_AG 0.50 1.00E-04 
 
Evolutionary rate and tMRCA estimates and comparisons 
Genomic evolutionary rate estimates of each HIV-1 subtype and CRF were 
obtained by Bayesian Markov Chain Monte Carlo (MCMC) coalescent analyses, as 
implemented in BEAST. The best-fitting demographic and molecular clock models for 
each HIV-1 subtype/CRF is shown in Table 2, and dated phylogenetic trees obtained 
from the near full CDS of each dataset under the best-fitting demographic and clock 
model are shown in Supplementary Figure S1. 
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Table 2. Akaike's Information Criterion values (AICM) obtained with the three demographic models (under a relaxed molecular clock model) and the strict lock 
model for each HIV-1 subtype/CRF. Values in brackets represent standard deviation values. The best fitting-model is highlighted in black 
  A1 B# C# D G CRF01_AE# CRF02_AG 
BSP 273384.5 (0.4) 333487.0 (0.1) 323525.1 (2.3) 155726.5 (0.2) 123944.8 (0.2) 230898.6 (0.6) 110222.6 (0.2) 
Expo 273353.9 (0.8) 333463.2 (0.7) 323525.9 (1.5) 155744.4 (0.2) 123948.2 (0.2) 230907.8 (0.6) 110224.7 (0.2) 
Logistic 273338.5 (0.5) 333466.4 (0.9) 323528.4 (0.7) 155733.4 (0.2) 123946.7 (0.4) 230925.9 (0.6) 110224.4 (0.2) 
Strict* 273612.1 (0.3) 333785.6 (0.3) 323748.2 (0.2) 155882.3 (0.1) 123992.4 (0.1) 231026.6 (0.7) 110283.0 (0.2) 
*AICM value obtained using the best-fitting demographic model. 
 
# For subtypes B, C and CRF01_AE, only the subdataset with highest molecular clock signal was subjected to model comparison. 
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Genomic HIV-1 evolutionary rates ranged between 1.3x10-3 s/s/y (95% HPD = 
0.7 -1.8x10-3 s/s/y) for CRF02_AG and 3.5·10-3 s/s/y (95% HPD = 2.9 – 4.1x10-3 s/s/y) 
for subtype C dataset 2 (Figue 1A; Table 3). Randomization tests revealed significant 
inter-subtype differences, with subtypes A, C and CRF01_AE displaying significantly 
higher genomic evolutionary rates than CRF02_AG and subtypes B, D and G. 
Importantly, no significant intrasubtype differences were found between the 
random subsets of subtypes B, C and CRF01_AE (Figure 1B).  
 
Figure 1. Comparison of the genomic evolutionary rate and tMRCA estimates of HIV-1 subtypes, as 
obtained with BEAST with the best-fitting demographic and molecular clock models: 1A) Plots of the 
median and 95% HPD intervals for the evolutionary rate (ucld.mean parameter); 1B) pairwise 
comparisons of the posterior distributions estimated for the evolutionary rate of each HIV-1 subtype, 
as obtained with a randomization test. Red: significantly different intervals (P value <0.05 after FDR 
correction). Green: not significantly different intervals.
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Table 3. Estimates (median and 95% HPD lower and upper limit) for the tMRCA, and for the evolutionary rates (value x 10-3) of each genomic 
partition of the HIV-1 datasets analyzed, as obtained using the best-fitting demographic and molecular clock models 
Dataset 
(time-span) 
tMRCA  
(unlinked clock 
model) 
tMRCA  
(linked clock 
model) Rate (CDS) Rate (gag) Rate (pol) Rate (vif) 
Rate (vpr-
to-vpu) Rate (env) Rate (nef) 
A1 (1985 - 2011) 1949(1943-1955) 1953(1944-1960) 3.0(2.5-3.5) 2.3(2.0-2.6) 1.5(1.4-1.7) 2.5(2.1-2.9) 2.8(2.4-3.1) 4.1(3.6-4.5) 3.9(3.4-4.4) 
B-1 (1983 - 2014) 1955(1950-1959) 1953(1945-1960) 2.6(2.3-3.0) 2.4(2.1-2.7) 1.5(1.3-1.7) 2.4(2.1-2.8) 3.0(2.6-3.5) 3.8(3.4-4.3) 3.2(2.8-3.6) 
B-2 (1984 - 2014) 1949(1939-1957) 1944(1923-1958) 2.1(1.5-2.7) 1.7(1.5-2.0) 1.2(1.0-1.4) 2.0(1.7-2.3) 2.1(2.3-3.1) 3.0(2.6-3.5) 3.3(2.8-3.8) 
B-3 (1983 - 2014) 1950(1944-1955) 1944(1930-1956) 2.2(1.7-2.6) 1.7(1.5-1.9) 1.3(1.2-1.5) 2.2(1.9-2.5) 2.9(2.6-3.2) 3.2(2.8-3.5) 2.8(2.5-3.2) 
C-1 (1989 - 2011) 1965(1960-1969) 1965(1958-1970) 3.5(2.9-4.1) 3.5(3.0-4.0) 1.7(1.5-1.9) 3.0(2.5-3.5) 3.5(3.0-4.0) 4.8(4.1-5.4) 3.8(3.3-4.4) 
C-2 (1989 - 2012) 1964(1959-1969) 1965(1957-1971) 3.6(2.9-4.2) 3.1(2.7-3.6) 1.7(1.5-2.0) 2.5(2.1-3.0) 3.5(3.0-4.0) 5.1(4.4-5.8) 4.0(4.0-4.7) 
C-3 (1989 - 2011) 1961(1955-1966) 1962(1955-1969) 3.2(2.6-3.8) 3.0(2.6-3.4) 1.6(1.4-1.8) 2.3(1.9-2.7) 3.0(2.6-3.6) 4.6(4.0-5.3) 3.5(3.0-4.1) 
D (1983 - 2011) 1953(1946-1960) 1956-1927-1961) 1.9(1.3-2.6) 1.9(1.5-2.2) 1.2(1.0-1.4) 1.9(1.5-2.4) 2.9(2.3-3.6) 3.4(2.8-4.1) 2.8(2.3-3.4) 
G (1992 - 2014) 1971(1967-1975) 1969(1961-1974) 2.4(1.9-2.9) 2.4(2.0-2.7) 1.6(1.3-1.8) 2.6(2.0-3.1) 2.6(2.2-3.1) 4.2(3.6-4.9) 3.1(2.6-3.6) 
AE-1 (1990 - 2012) 1971(1969-1974) 1970(1967-1974) 3.4(3.0-3.7) 3.1(2.7-3.4) 1.4(1.3-1.6) 3.4(2.9-3.8) 4.0(3.5-4.5) 4.6(4.1-5.0) 4.2(3.7-4.8) 
AE-2 (1990 - 2012) 1971(1967-1974) 1971(1965-1975) 3.3(2.9-3.8) 3.0(2.7-3.5) 1.5(1.3-1.6) 3.4(2.9-3.9) 4.0(3.5-4.6) 4.2(3.7-4.6) 4.4(3.8-5.0) 
AE-3 (1990 - 2011) 1972(1970-1975) 1972(1968-1975) 3.5(3.1-3.8) 3.2(2.9-3.6) 1.5(1.3-1.6) 4.0(3.5-4.6) 4.3(3.7-4.8) 4.6(4.1-5.0) 4.3(3.8-4.9) 
AG (1991 - 2012) 1954(1939-1965) 1948(1913-1969) 1.3(0.7-1.8) 1.2(0.9-1.5) 0.8(0.6-1.1) 1.5(1.0-2.0) 1.6(1.2-2.1) 2.1(1.6-2.7) 2.0(1.4-2.6) 
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Bayesian coalescent analyses were also performed, unlinking the molecular 
clock models of the different genomic partitions. Median tMRCAs estimated from 
this approach were very similar to those obtained when an only clock model was 
used (largest difference = 6 years, for subtype B subset 3 and CRF02_AG). However, 
95% HPDs were more accurate (narrower) than when applying the same molecular 
clock model along the whole CDS (Table 3). 95%HPDs of tMRCAs estimated unlinking 
the molecular clock models were narrower than 15 years for all datasets, with 
subtype B dataset 2 (19 years) and CRF02_AG (27 years) as the only exceptions. 
However, when applying the same clock model along the whole CDS, 95% HPDs 
narrower than 15 years were only obtained for subtype C (all three datasets), G and 
CRF1_AE (all three datasets). Regarding the tMRCAs estimated obtained from the 
different subsets of subtypes B and C and CRF01_AE, the largest difference between 
medians of a same HIV-1 variant was found that between B0 and B3 subsets (6 
years).  
Overall, the earliest tMRCA corresponded to subtype A1 (median=1941, 
95%HPD= 1943-1955) whereas the most recent tMRCAs corresponded subtype G 
and CRF01_AE subset 3 (median =1971, 95% HPD= 1967-1975 and median = 1972, 
95%HPD= 1970- 1975 respectively).  
In all cases, the evolutionary rates of the 5’ half of HIV-1 genome (gag, pol 
and vif) were lower than the 3’ half (vpr-to-vpu, env and nef). Concretely, pol 
presented the lowest evolutionary rate and env the highest in all HIV-1 
subtypes/CRFs (Table 3).  
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Discussion  
We have estimated, and compared, the genomic evolutionary rates of 
different HIV-1 subtypes (A1, B, C, D and G) and CRFs (CRF01_AE and CRF02_AG). To 
obtain representative datasets of the publicly available genomes for each HIV-1 
variant we included sequences from the most complete geographical, temporal and 
genetic range as possible and removed epidemiologically related variants, including 
those obtained from the same patient. 
Our analyses, performed by using tip-dates of heterochronous samples as the 
only calibration method, have revealed differences in the evolutionary rates 
between the analyzed subtypes and CRFs. Subtypes C and A1, and CRF01_AE 
presented the fastest evolutionary rates among the studied HIV-1 datasets, with 
CRF02_AG and subtype D being the slowest-evolving groups.  
As expected, evolutionary rates estimates for the different subtypes and CRFs 
differed from previous analyses working with partial pol and/or env regions 
(Abecasis et al. 2009; Wertheim et al. 2012). Abecasis et al. (2009) analyzed partial 
pol and env sequences of up to 799 and 931 bp respectively and found that subtype 
G and CRF02_AG had the highest evolutionary rate, and subtype D the lowest, for 
these two genes. On the other hand, Wertheim et al. (2012) analyzed complete pol 
sequences and found subtype B to be evolving faster than subtypes D and C. These 
incongruences between different studies can be explained by the different genomic 
regions that they analyzed, focusing on the evolutionary rates of short genomic 
regions, but ignoring differences in selective constraints or mutation rates that exist 
along the whole HIV CDS (Geller et al. 2015). These discrepancies could also be 
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explained by the different dataset sizes: Although, compared to our datasets, larger 
datasets have been previously analyzed for CFR02_AG and subtype G (Abecasis et al. 
2009), and for subtype D (Wertheim et al. 2012), we analyzed larger datasets than 
previous works for the remaining HIV-1 groups.  
All the analyzed HIV-1 subtypes and CRFs, displayed a similar pattern, 
regarding the evolutionary rates estimated along their genomes: genes gag, pol and 
vif presented lower rates than the vpr-to-vpu segment and env and nef genes, with 
pol and env presenting the slowest and fastest evolutionary rates, respectively. Li et 
al. (2015) found higher levels of amino acid diversity in the proteins encoded by tat, 
rev, vpu, env and nef genes, and associated their higher levels of variability to 
different factors: firstly, it could be associated with the presence of CD4 T cell and 
antibody epitopes, which would favor diversifying selective pressures. Secondly, 
these proteins were found to present higher numbers of HIV-human associations, 
which may lead these proteins to present higher structural flexibility. 
Using nearly complete genome coding regions, the 95% HPD intervals 
obtained for the tMRCA of each subtype and gene were in most cases in agreement 
with previous estimates obtained (Abecasis et al. 2009; Gray et al. 2009; Yebra et al. 
2016). However, tMRCA estimates for subtypes B, C and were discordant with 
respect those obtained by Faria et al. (2014), who estimated the tMRCA of subtype B 
to have occurred in the 40s, and that of subtype C in the late 30s. The most plausible 
reasons for such discrepancies is that Faria et al. (2014) disposed of older sequences, 
obtained from samples existing in the late 50s-early 60s in Kinsasha (Democratic 
Republic of the Congo), while our oldest sequences were obtained in the 80s, at the 
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beginning of the AIDS pandemic. Indeed, the tMRCA of our subtype C datasets are 
more similar to that obtained by (Wilkinson et al. 2015) for the origin of the southern 
African epidemic (median: year 1960), the geographic region from which most of our 
sequences were obtained. In this way, such discrepancies can be explained by the 
different time-spans sampled between these previous estimates and ours.  
tMRCA estimated for CRF02_AG presented the broadest 95%HPD among all 
the HIV subtypes/CRFs analyzed in this work, probably because it was also the 
dataset with the lowest molecular clock signal. However, the median tMRCA 
obtained for this CRF was only 8 years older than that estimated by Yebra et al. 
(2016) in West Africa (median tMRCA between 1962 and 1963 as estimated from PR 
and gp41, respectively). These tMRCA estimates obtained for CRF02_AG suggest an 
earlier origin than that of HIV-1 subtype G, which was supposed to be one of its 
parental subtypes. These estimates support previous results revealing that, indeed, 
CRF02_AG is the parent of subtype G, which is not an actual pure subtype although it 
remains classified as one (Abecasis et al. 2007) . 
Overall, analyzing nearly complete coding regions has produced more 
accurate tMRCA and evolutionary rate estimates than others obtained previously 
(Abecasis et al. 2009; Gray et al. 2009; Wertheim et al. 2012), especially when 
different molecular clock models are used for the different gene partitions 
comprising the CDS. However, is noteworthy that for some HIV-1 groups (subtypes 
D, G and CRF02_AG), the number of available genomes was much lower than for the 
others. This work aimed to obtain the most representative CDS datasets as possible, 
and the analyzed datasets represent the genome availability at public databases for 
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each HIV-1 subtype/CRF. However, it is possible that the limited number of complete 
CDS sequences available for subtypes D, G and CRF02_AG may have affected our 
estimates. Despite this potential caveat, estimating tMRCA and evolutionary rate 
estimates from independent datasets for each genome partition would lack the 
statistical power that confers the information present in the different genome 
partitions in BEAST. Furthermore, it would introduce other bias, such as sampling 
differences between genomic regions from a same HIV subtype/CRF. 
 It is also important to mention other possible bias in the estimates, such as 
those caused by the time-dependency of the evolutionary rates. Rates can be very 
different when analyzing viral datasets from different timescales, with shorter 
timescales associated with higher estimates (Duchêne et al. 2014; Aiewsakun & 
Katzourakis 2015; Aiewsakun & Katzourakis 2016). Meyer et al. (2015) assessed the 
effect of time dependence of the evolutionary rate of influenza during the 2009 
pandemic outbreak, and found that at least 9 months of temporal divergence was 
needed for precise estimates for long term values. In our work, we have used 
datasets with similar scales for the sampling time-spans, which ranged between 21 
and 31 years. For this reason, such phenomenon should not bias our comparisons. 
In conclusion, we have estimated and compared the tMRCAs and genomic 
evolutionary rates of the main HIV-1 M subtypes and CRFs from a genomic 
perspective, using the longest non-overlapping coding regions as possible. The 
results obtained show that evolutionary rates differ significantly among HIV-1 
subtypes and CRFs, and that the accuracy of the estimated evolutionary parameters 
increases when independent molecular clock models are applied at each genomic 
148 
 
 
 
partition. The obtained results provide information that can be used as prior 
distributions in future Bayesian coalescent analyses of specific HIV -1 subtypes/CRFs 
and genes, given that the evolutionary rates of HIV-1 varies between subtypes/CRFs 
and genomic regions. 
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Supplementary Table S1. Subtype, country of origin, 
isolation date and accession number of the HIV-1 
sequences from each dataset analyzed  
Subtype/CRF Country Isolation date Accession number 
A1 Uganda 1985 M62320  
A1 Kenya 1986 AF539405  
A1 Uganda 1992 AB098332  
A1 Uganda 1992 AB253428  
A1 Rwanda 1992 AB253421  
A1 Rwanda 1992 AB287376  
A1 Rwanda 1993 AB287378  
A1 Rwanda 1993 AY713406  
A1 Sweden 1994 AF069670  
A1 Kenya 1994 AF004885  
A1 Sweden 1994 AF069671  
A1 Sweden 1995 AF069669  
A1 Kenya 1997 AY322193  
A1 Tanzania 1997 AF361873  
A1 Tanzania 1997 AF361872  
A1 DR Congo 1997 AM000054  
A1 DR Congo 1997 AM000053  
A1 Uganda 1998 AF484507  
A1 Uganda 1998 AF484509  
A1 Uganda 1998 AF484512  
A1 Kenya 1999 AF457063  
A1 Kenya 1999 AF457075  
A1 India 1999 KT152841  
A1 Kenya 1999 AF457065  
A1 Kenya 2000 AF457089  
A1 Kenya 2000 AF457055  
A1 Kenya 2000 AF457068  
A1 Kenya 2000 AF457069  
A1 Kenya 2000 AF457086  
A1 Kenya 2000 AF457070  
A1 Kenya 2000 AF457066  
A1 India 2000 KT152846  
A1 Kenya 2000 AF457081  
A1 Kenya 2000 AF457080  
A1 Kenya 2000 AF457053  
A1 Ukraine 2000 AF413987  
A1 Russia 2000 EF545108  
A1 Kenya 2001 EU110087  
A1 Tanzania 2001 AY253305  
A1 Tanzania 2001 AY253314  
A1 Senegal 2001 AY521629  
A1 Ukraine 2001 DQ823358  
A1 Ukraine 2001 DQ823359  
A1 Ukraine 2001 DQ823365  
A1 Ukraine 2001 DQ823361  
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A1 Ukraine 2001 DQ823366  
A1 Ukraine 2001 DQ823357  
A1 Kenya 2002 EU110092  
A1 Russia 2002 JQ292892  
A1 Kazakhstan 2002 EF589043  
A1 Kazakhstan 2002 EF589042  
A1 Uzbekistan 2002 AY829210  
A1 Italy 2002 EU861977  
A1 Australia 2003 DQ676872  
A1 Switzerland 2003 JQ403028  
A1 Russia 2003 AY500393  
A1 South Africa 2004 KT183312  
A1 Russia 2005 JQ292895  
A1 Spain 2005 FJ670519  
A1 Kenya 2006 FJ623480  
A1 Kenya 2006 FJ623477  
A1 Kenya 2006 FJ623485  
A1 Kenya 2006 FJ623486  
A1 Kenya 2006 FJ623478  
A1 Kenya 2006 FJ623475  
A1 Kenya 2006 FJ623484  
A1 Kenya 2006 FJ623481  
A1 Kenya 2006 FJ623476  
A1 Kenya 2006 FJ623487  
A1 Kenya 2006 FJ623479  
A1 Kenya 2006 FJ623483  
A1 Kenya 2006 FJ623488  
A1 Russia 2006 JQ292900  
A1 Russia 2006 JQ292899  
A1 Russia 2006 JQ292897  
A1 Russia 2006 JQ292896  
A1 Russia 2006 JQ292898  
A1 Uganda 2007 JX236676  
A1 Rwanda 2007 KP223844  
A1 Cameroon 2007 KP718918  
A1 Uganda 2007 JX236669  
A1 Uganda 2007 JX236671  
A1 Russia 2007 JQ292891  
A1 Cameroon 2008 KP718928  
A1 Russia 2008 KF716492  
A1 Russia 2008 JQ292894  
A1 Russia 2008 JQ292893  
A1 Russia 2008 KF716491  
A1 Russia 2008 FJ864679  
A1 Uganda 2009 KF716478  
A1 Russia 2010 JX500695  
A1 Russia 2010 JX500696  
A1 Uganda 2011 KF859745  
A1 Kenya 2011 KF716475  
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A1 Russia 2011 JX500694  
A1 Uganda 2011 KF716486  
B-1 Great Britain 1983 D10112  
B-1 USA 1983 M17451  
B-1 USA 1983 K02007  
B-1 South Africa 1985 FJ647145  
B-1 USA 1990 AY173954  
B-1 USA 1991 AB485638  
B-1 Soth Korea 1992 KJ140247  
B-1 Soth Korea 1992 KJ140267  
B-1 Soth Korea 1992 KJ140266  
B-1 Australia 1995 AF538304  
B-1 Thailand 1996 DQ354118  
B-1 Georgia 1998 DQ207943  
B-1 USA 1998 AY331294  
B-1 USA 1998 EF175209  
B-1 CA 1998 AY779550  
B-1 USA 1998 AY560108  
B-1 Australia 1999 AF538303  
B-1 Cuba 1999 AY586542  
B-1 Cuba 1999 AY586543  
B-1 Japan 2000 AB289587  
B-1 USA 2000 JN944930  
B-1 USA 2000 EF363122  
B-1 USA 2000 FJ496167  
B-1 Switzerland 2000 KC797171  
B-1 USA 2001 FJ496151  
B-1 UA 2001 DQ823364  
B-1 Denmark 2001 EF514711  
B-1 Denmark 2001 EF514707  
B-1 Colombia 2001 AY561237  
B-1 Brazil 2002 JN692431  
B-1 Brazil 2002 JN692444  
B-1 Brazil 2002 JN692432  
B-1 USA 2002 FJ469741  
B-1 USA 2002 FJ496072  
B-1 Brazil 2002 DQ358805  
B-1 Soth Korea 2003 JQ316131  
B-1 Brazil 2003 EF637048  
B-1 Switzerland 2003 JQ403045  
B-1 USA 2003 FJ469731  
B-1 Brazil 2003 EF637056  
B-1 Georgia 2003 DQ207942  
B-1 Georgia 2003 DQ207940  
B-1 Brazil 2004 FJ195090  
B-1 Soth Korea 2004 DQ295196  
B-1 Germany 2004 JQ403038  
B-1 Argentina 2004 DQ383750  
B-1 Japan 2004 AB480692  
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B-1 Denmark 2004 EF514701  
B-1 Russia 2004 AY682547  
B-1 Australia 2004 AY818644  
B-1 USA 2004 JN024203  
B-1 Japan 2004 AB221125  
B-1 Spain 2005 KT200351  
B-1 Japan 2005 AB428556  
B-1 Brazil 2005 JN692474  
B-1 Thailand 2005 JN248347  
B-1 USA 2005 FJ496081  
B-1 USA 2005 JF320361  
B-1 USA 2006 JQ403095  
B-1 USA 2006 JF320120  
B-1 USA 2006 JF320615  
B-1 USA 2006 FJ495937  
B-1 USA 2006 FJ469696  
B-1 Spain 2006 KT200350  
B-1 Peru 2006 JF320241  
B-1 USA 2006 JF320564  
B-1 USA 2006 JF320036  
B-1 USA 2006 JF689865  
B-1 China 2007 JF932469  
B-1 China 2007 JF932490  
B-1 USA 2007 JF689885  
B-1 USA 2007 JQ403056  
B-1 China 2007 JF932493  
B-1 USA 2007 JQ403060  
B-1 China 2007 JF932487  
B-1 China 2007 JF932489  
B-1 China 2007 JF932470  
B-1 Soth Korea 2007 JQ341411  
B-1 Spain 2008 FJ853620  
B-1 Spain 2008 KT200358  
B-1 USA 2008 JF689896  
B-1 USA 2008 JQ403088  
B-1 Spain 2009 GU362885  
B-1 Spain 2009 KC473841  
B-1 USA 2010 KC473826  
B-1 USA 2010 JN397365  
B-1 Brazil 2010 KJ849808  
B-1 Brazil 2010 KJ849784  
B-1 China 2010 JX140658  
B-1 Russia 2010 JX500707  
B-1 Russia 2011 JX500708  
B-1 USA 2011 KF384806  
B-1 USA 2011 KF384805  
B-1 USA 2011 KF384804  
B-1 USA 2011 KF384807  
B-1 USA 2011 KF384799  
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B-1 China 2012 KP109511  
B-1 Spain 2014 KT276262  
B-1 Spain 2014 KT276263  
B-1 Spain 2014 KT276268  
B-2 USA 1984 AY835779  
B-2 USA 1986 M38429  
B-2 Great Britain 1986 AJ271445  
B-2 Thailand 1990 AY173951  
B-2 Brazil 1990 AB485641  
B-2 USA 1990 AY173954  
B-2 Soth Korea 1992 KJ140257  
B-2 USA 1993 DQ487188  
B-2 USA 1994 AY713410  
B-2 USA 1995 JN024274  
B-2 Australia 1995 AF538307  
B-2 Soth Korea 1995 KJ140250  
B-2 USA 1997 AY331289  
B-2 Argentina 1998 AY037268  
B-2 Uruguay 1999 JN235959  
B-2 Japan 2000 AB289587  
B-2 USA 2000 JN944917  
B-2 USA 2000 FJ496167  
B-2 Switzerland 2000 KC797171  
B-2 Denmark 2001 EF514711  
B-2 China 2002 DQ007901  
B-2 Paraguay 2002 JN251901  
B-2 Japan 2002 AB428553  
B-2 Brazil 2002 JN692470  
B-2 Australia 2003 DQ676880  
B-2 Brazil 2003 JN692445  
B-2 Australia 2003 DQ676877  
B-2 USA 2003 FJ469764  
B-2 Switzerland 2003 JQ403045  
B-2 Brazil 2003 EF637056  
B-2 China 2003 JF932492  
B-2 USA 2003 FJ469731  
B-2 Paraguay 2003 JN251906  
B-2 Brazil 2004 JN692457  
B-2 Thailand 2004 JN248329  
B-2 Russia 2004 AY751407  
B-2 Soth Korea 2004 DQ295195  
B-2 USA 2004 JQ403107  
B-2 Great Britain 2004 HM586198  
B-2 Russia 2004 AY682547  
B-2 USA 2004 FJ469695  
B-2 Denmark 2004 EF514698  
B-2 Switzerland 2004 JQ403042  
B-2 Brazil 2004 FJ195090  
B-2 USA 2004 JN024100  
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B-2 Brazil 2004 FJ195086  
B-2 Germany 2004 JQ403038  
B-2 USA 2005 JF320054  
B-2 Spain 2005 KT200351  
B-2 USA 2005 DQ886037  
B-2 USA 2005 JF689854  
B-2 Thailand 2005 JN248353  
B-2 USA 2005 JF689857  
B-2 Japan 2005 AB287363  
B-2 China 2005 DQ990880  
B-2 USA 2005 FJ469724  
B-2 Spain 2005 EU786672  
B-2 USA 2005 JF689852  
B-2 USA 2006 JF320044  
B-2 USA 2006 JF320169  
B-2 USA 2006 JF689871  
B-2 USA 2006 JF689874  
B-2 USA 2006 FJ495818  
B-2 USA 2006 FJ495937  
B-2 Spain 2006 EU786675  
B-2 USA 2006 JF320145  
B-2 Spain 2006 EU786674  
B-2 Peru 2006 JF320186  
B-2 Peru 2006 JF320196  
B-2 China 2006 JF932482  
B-2 USA 2006 JF689864  
B-2 USA 2006 JF689872  
B-2 Hong Kong 2006 FJ460501  
B-2 Peru 2006 JF320008  
B-2 USA 2007 JQ403078  
B-2 USA 2007 JF320150  
B-2 USA 2007 JF689890  
B-2 China 2007 JF932493  
B-2 USA 2007 FJ469689  
B-2 USA 2007 JF689889  
B-2 Spain 2008 FJ670531  
B-2 China 2008 JF932479  
B-2 USA 2008 JQ403087  
B-2 USA 2008 JQ403035  
B-2 USA 2008 JQ403062  
B-2 USA 2008 JF689896  
B-2 China 2008 JF932478  
B-2 France 2009 KF716494  
B-2 Spain 2010 JX140659  
B-2 Brazil 2010 KJ849808  
B-2 Brazil 2010 KJ849780  
B-2 Spain 2010 KT200356  
B-2 Japan 2011 KF716497  
B-2 USA 2011 KF384806  
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B-2 USA 2011 KF384798  
B-2 USA 2011 KF384807  
B-2 USA 2011 KF526174  
B-2 Japan 2012 KF716498  
B-2 Spain 2013 KT200348  
B-2 Spain 2014 KT276267  
B-3 USA 1983 K02007  
B-3 Great Britain 1983 D10112  
B-3 USA 1984 M17449  
B-3 South Africa 1985 FJ647145  
B-3 USA 1985 AY835769  
B-3 USA 1986 M93258  
B-3 Germany 1986 U43141  
B-3 USA 1988 AF286365  
B-3 Thailand 1990 AY173951  
B-3 USA 1991 AF069140  
B-3 Soth Korea 1992 KJ140266  
B-3 Soth Korea 1992 KJ140261  
B-3 Great Britain 1994 KJ019215  
B-3 USA 1996 AY331292  
B-3 USA 1999 JQ403100  
B-3 Australia 1999 AF538303  
B-3 USA 1999 AY331296  
B-3 USA 2000 JN944930  
B-3 Japan 2001 AB289589  
B-3 Uruguay 2001 AY781127  
B-3 USA 2002 FJ469760  
B-3 USA 2002 FJ469758  
B-3 USA 2002 FJ469687  
B-3 USA 2002 FJ496072  
B-3 Australia 2002 DQ676883  
B-3 Brazil 2002 JN692433  
B-3 Brazil 2002 JN692432  
B-3 South Africa 2003 DQ396398  
B-3 USA 2003 FJ469764  
B-3 Switzerland 2003 JQ403045  
B-3 Brazil 2003 EF637056  
B-3 Brazil 2003 JN692445  
B-3 USA 2004 FJ469733  
B-3 Germany 2004 JQ403050  
B-3 Thailand 2004 JN248337  
B-3 Soth Korea 2004 DQ295195  
B-3 Japan 2005 AB287364  
B-3 Thailand 2005 JN248346  
B-3 USA 2005 FJ469682  
B-3 USA 2005 JF689854  
B-3 USA 2005 JF689859  
B-3 USA 2005 KF990605  
B-3 Spain 2005 EU786672  
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B-3 USA 2005 JF320185  
B-3 USA 2005 FJ469683  
B-3 Brazil 2005 JN692463  
B-3 Thailand 2005 JN248344  
B-3 Brazil 2005 JN692473  
B-3 Brazil 2005 JN692475  
B-3 USA 2006 JF320615  
B-3 CA 2006 JF320427  
B-3 USA 2006 KF990608  
B-3 USA 2006 JF320120  
B-3 China 2006 JF932482  
B-3 USA 2006 JF689862  
B-3 USA 2006 JN944897  
B-3 Brazil 2006 JN692479  
B-3 Peru 2007 JF320189  
B-3 USA 2007 JF689892  
B-3 Peru 2007 JF320018  
B-3 USA 2007 JQ403060  
B-3 USA 2007 JF320559  
B-3 USA 2007 JF320150  
B-3 China 2007 JF932485  
B-3 China 2007 JF932493  
B-3 USA 2007 JF689879  
B-3 Soth Korea 2007 JQ341411  
B-3 USA 2007 JF320197  
B-3 USA 2008 JQ403061  
B-3 USA 2008 JQ403069  
B-3 USA 2008 JQ403035  
B-3 France 2008 JX140654  
B-3 Thailand 2008 JN860769  
B-3 USA 2008 JQ403062  
B-3 Spain 2008 GQ372988  
B-3 USA 2009 JX140657  
B-3 France 2009 KF716494  
B-3 China 2009 KC899011  
B-3 China 2009 KC596066  
B-3 Spain 2010 KT200356  
B-3 Brazil 2010 KJ849784  
B-3 USA 2010 JN397365  
B-3 USA 2010 KC473825  
B-3 USA 2010 KC473829  
B-3 USA 2010 KC473826  
B-3 USA 2010 KC473830  
B-3 Spain 2010 KT200353  
B-3 Brazil 2010 KJ849814  
B-3 Brazil 2010 KJ849812  
B-3 Brazil 2010 KJ849767  
B-3 USA 2011 KF384798  
B-3 USA 2011 KF384805  
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B-3 USA 2011 KC473831  
B-3 USA 2011 KF526261  
B-3 USA 2011 KF384803  
B-3 USA 2011 JN397362  
B-3 China 2012 KP109512  
B-3 China 2012 KP109511  
B-3 Spain 2014 KT276256  
B-3 Spain 2014 KT276267  
C-1 Somalia 1989 AY713415  
C-1 South Africa 1990 JN188292  
C-1 Malawi 1993 AY713413  
C-1 India 1993 AB023804  
C-1 Botswana 1996 AF443075  
C-1 Tanzania 1997 AF361875  
C-1 South Africa 1998 AX455929  
C-1 South Africa 1998 AY043176  
C-1 Tanzania 1998 AF286234  
C-1 Botswana 1998 AF443076  
C-1 Botswana 1999 AF443083  
C-1 Botswana 1999 AF443087  
C-1 South Africa 1999 AF411967  
C-1 India 1999 KP109487  
C-1 Botswana 2000 AF443097  
C-1 South Africa 2000 AY463233  
C-1 South Africa 2000 AY463232  
C-1 South Africa 2000 AY463217  
C-1 South Africa 2000 AY463231  
C-1 India 2000 KP109483  
C-1 Botswana 2000 AF443113  
C-1 South Africa 2000 AY585265  
C-1 Botswana 2000 AF443109  
C-1 Botswana 2000 AF443094  
C-1 Botswana 2000 AF443090  
C-1 Kenya 2000 AF457054  
C-1 South Africa 2000 AY463234  
C-1 Tanzania 2001 AY253308  
C-1 Tanzania 2001 AY253317  
C-1 Tanzania 2001 AY253313  
C-1 Brazil 2002 JN692434  
C-1 Zambia 2002 AB254143  
C-1 Zambia 2002 AB254149  
C-1 South Africa 2003 DQ351216  
C-1 South Africa 2003 DQ396369  
C-1 South Africa 2003 DQ351223  
C-1 South Africa 2003 DQ396395  
C-1 South Africa 2003 DQ396374  
C-1 South Africa 2003 AY878061  
C-1 South Africa 2003 DQ396377  
C-1 India 2003 EF469243  
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C-1 South Africa 2003 DQ396380  
C-1 South Africa 2003 DQ396386  
C-1 South Africa 2003 DQ275656  
C-1 South Africa 2003 DQ275653  
C-1 South Africa 2003 AY901981  
C-1 South Africa 2003 DQ369985  
C-1 South Africa 2003 KT183301  
C-1 South Africa 2003 DQ396391  
C-1 South Africa 2003 DQ275660  
C-1 South Africa 2003 DQ093592  
C-1 South Africa 2003 DQ396375  
C-1 South Africa 2004 DQ056415  
C-1 South Africa 2004 DQ093604  
C-1 South Africa 2004 DQ011180  
C-1 Brazil 2004 AY727523  
C-1 South Africa 2004 DQ093590  
C-1 South Africa 2004 AY878059  
C-1 Brazil 2004 AY727522  
C-1 South Africa 2004 DQ164126  
C-1 South Africa 2004 AY772699  
C-1 Brazil 2004 AY727525  
C-1 South Africa 2004 AY901978  
C-1 Brazil 2004 AY727524  
C-1 South Africa 2004 DQ056406  
C-1 South Africa 2004 DQ164119  
C-1 South Africa 2004 DQ056416  
C-1 South Africa 2004 AY878072  
C-1 South Africa 2004 DQ011173  
C-1 South Africa 2004 DQ164110  
C-1 South Africa 2004 DQ011174  
C-1 South Africa 2005 GQ999991  
C-1 South Africa 2005 GQ999982  
C-1 South Africa 2005 GQ999988  
C-1 South Africa 2005 GQ999989  
C-1 South Africa 2005 GQ999979  
C-1 South Africa 2007 JX974245  
C-1 South Africa 2007 KT183089  
C-1 South Africa 2007 KT183264  
C-1 Malawi 2007 KC156213  
C-1 South Africa 2007 KT183208  
C-1 China 2007 KF835522  
C-1 South Africa 2007 KC156127  
C-1 Sweden 2007 KP411832  
C-1 South Africa 2008 KT183218  
C-1 South Africa 2008 KT183135  
C-1 South Africa 2008 KT183250  
C-1 South Africa 2008 KT183155  
C-1 Spain 2008 EU786681  
C-1 South Africa 2008 KT183274  
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C-1 Tanzania 2008 KC156220  
C-1 South Africa 2008 KT183188  
C-1 China 2009 KC898996  
C-1 Zambia 2009 KR820367  
C-1 Malawi 2009 KP109527  
C-1 Sweden 2009 KP411836  
C-1 Zambia 2009 KR820326  
C-1 China 2009 KC898995  
C-1 Zambia 2011 KP109494  
C-1 Zambia 2011 KP109495  
C-2 Somalia 1989 AY713415  
C-2 Zambia 1989 AB485645  
C-2 India 1993 AF067158  
C-2 India 1993 AB023804  
C-2 India 1994 AF067159  
C-2 Botswana 1996 AF110972  
C-2 Botswana 1996 AF443074  
C-2 Botswana 1996 AF110969  
C-2 Botswana 1996 AF110967  
C-2 South Africa 1997 AY118166  
C-2 South Africa 1997 AF286227  
C-2 Tanzania 1997 AF361874  
C-2 South Africa 1998 AY043173  
C-2 South Africa 1998 AX455929  
C-2 South Africa 1998 AY162225  
C-2 South Africa 1998 AY158535  
C-2 South Africa 1999 EU293445  
C-2 India 1999 KP109487  
C-2 Botswana 2000 AF443105  
C-2 Botswana 2000 AF443114  
C-2 Botswana 2000 AF443092  
C-2 Botswana 2000 AF443094  
C-2 Botswana 2000 AF443093  
C-2 South Africa 2001 AY463237  
C-2 Tanzania 2001 AY253312  
C-2 Denmark 2001 EF514713  
C-2 South Africa 2002 DQ351235  
C-2 Zambia 2002 AB254148  
C-2 Zambia 2002 AB254141  
C-2 Tanzania 2002 AY734551  
C-2 South Africa 2003 DQ351224  
C-2 South Africa 2003 DQ093592  
C-2 South Africa 2003 DQ093593  
C-2 South Africa 2003 AY878068  
C-2 South Africa 2003 DQ445635  
C-2 South Africa 2003 DQ011175  
C-2 South Africa 2003 DQ396390  
C-2 South Africa 2003 DQ275656  
C-2 South Africa 2003 DQ351228  
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C-2 South Africa 2003 DQ275660  
C-2 South Africa 2003 DQ369987  
C-2 South Africa 2003 DQ396368  
C-2 South Africa 2003 DQ275657  
C-2 South Africa 2003 AY772695  
C-2 South Africa 2003 DQ011176  
C-2 South Africa 2003 DQ396375  
C-2 South Africa 2003 DQ351216  
C-2 South Africa 2003 DQ275646  
C-2 South Africa 2003 DQ369990  
C-2 South Africa 2003 DQ011169  
C-2 South Africa 2003 DQ275645  
C-2 South Africa 2003 DQ351226  
C-2 South Africa 2003 DQ351219  
C-2 South Africa 2003 DQ396369  
C-2 South Africa 2003 DQ351230  
C-2 South Africa 2003 DQ275655  
C-2 South Africa 2003 AY878060  
C-2 South Africa 2003 AY878061  
C-2 South Africa 2003 DQ396380  
C-2 South Africa 2003 DQ369980  
C-2 South Africa 2003 DQ275650  
C-2 South Africa 2003 AY772700  
C-2 South Africa 2003 DQ275664  
C-2 Zambia 2003 FJ496195  
C-2 South Africa 2003 AY878065  
C-2 South Africa 2003 DQ056404  
C-2 South Africa 2003 DQ396386  
C-2 South Africa 2004 DQ445637  
C-2 South Africa 2004 DQ056413  
C-2 South Africa 2004 DQ093600  
C-2 South Africa 2004 AY878059  
C-2 South Africa 2004 DQ011170  
C-2 South Africa 2004 DQ093587  
C-2 South Africa 2004 DQ275659  
C-2 South Africa 2004 DQ164115  
C-2 South Africa 2004 DQ351217  
C-2 South Africa 2004 DQ093595  
C-2 South Africa 2004 DQ011177  
C-2 South Africa 2004 AY703911  
C-2 South Africa 2004 DQ093605  
C-2 South Africa 2004 DQ011166  
C-2 South Africa 2004 AY901973  
C-2 South Africa 2004 DQ093604  
C-2 South Africa 2004 AY703909  
C-2 South Africa 2004 AY878062  
C-2 South Africa 2005 GQ999990  
C-2 South Africa 2005 GQ999981  
C-2 India 2005 KF766540  
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C-2 South Africa 2007 KT183094  
C-2 South Africa 2007 KT183208  
C-2 South Africa 2007 KT183089  
C-2 South Africa 2007 KT183196  
C-2 Malawi 2008 KF527172  
C-2 South Africa 2008 KT183201  
C-2 Malawi 2008 KC156216  
C-2 South Africa 2008 KT183172  
C-2 South Africa 2009 JX140668  
C-2 China 2009 KC898995  
C-2 India 2009 KC156210  
C-2 South Africa 2012 KP109516  
C-3 Somalia 1989 AY713415  
C-3 South Africa 1990 JN188292  
C-3 India 1993 AF067157  
C-3 India 1994 AF067159  
C-3 India 1994 AF286223  
C-3 India 1995 AF067155  
C-3 Botswana 1996 AF443075  
C-3 Tanzania 1997 AF361874  
C-3 South Africa 1997 AF286227  
C-3 Tanzania 1998 AF286235  
C-3 India 1998 AF286232  
C-3 Botswana 1998 AF443076  
C-3 South Africa 1998 AY162225  
C-3 South Africa 1999 EU293444  
C-3 South Africa 1999 EU293445  
C-3 South Africa 1999 EU293448  
C-3 Botswana 1999 AF443086  
C-3 South Africa 2000 AY463225  
C-3 Botswana 2000 AF443103  
C-3 South Africa 2000 AY463234  
C-3 Botswana 2000 AF443102  
C-3 Botswana 2000 AF443115  
C-3 Botswana 2000 AF443105  
C-3 South Africa 2000 AY585264  
C-3 Kenya 2000 AF457054  
C-3 Botswana 2000 AF443097  
C-3 Tanzania 2001 AY253317  
C-3 Tanzania 2001 AY253303  
C-3 South Africa 2002 DQ351220  
C-3 Zambia 2002 AB254142  
C-3 South Africa 2003 DQ011175  
C-3 South Africa 2003 AY772700  
C-3 South Africa 2003 DQ093593  
C-3 South Africa 2003 DQ369980  
C-3 South Africa 2003 DQ369981  
C-3 Georgia 2003 DQ207941  
C-3 South Africa 2003 DQ351237  
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C-3 South Africa 2003 DQ093591  
C-3 South Africa 2003 DQ351224  
C-3 South Africa 2003 AY901966  
C-3 South Africa 2003 DQ396367  
C-3 South Africa 2003 DQ164113  
C-3 South Africa 2003 DQ093597  
C-3 South Africa 2003 DQ396368  
C-3 South Africa 2003 DQ396376  
C-3 South Africa 2003 DQ369986  
C-3 Zambia 2003 FJ496185  
C-3 South Africa 2003 DQ164104  
C-3 South Africa 2003 DQ056404  
C-3 South Africa 2004 DQ164126  
C-3 South Africa 2004 DQ093590  
C-3 South Africa 2004 DQ056413  
C-3 Brazil 2004 AY727523  
C-3 South Africa 2004 DQ011178  
C-3 South Africa 2004 AY901979  
C-3 South Africa 2004 DQ056409  
C-3 South Africa 2004 DQ445637  
C-3 South Africa 2004 DQ164110  
C-3 South Africa 2004 DQ164117  
C-3 South Africa 2004 DQ093600  
C-3 Brazil 2004 AY727524  
C-3 South Africa 2004 AY703911  
C-3 Brazil 2004 AY727525  
C-3 South Africa 2004 DQ164114  
C-3 South Africa 2004 DQ351217  
C-3 South Africa 2004 DQ164129  
C-3 South Africa 2004 DQ093604  
C-3 South Africa 2004 AY901974  
C-3 South Africa 2004 DQ351232  
C-3 South Africa 2004 DQ011172  
C-3 South Africa 2004 AY901977  
C-3 South Africa 2004 DQ056405  
C-3 Brazil 2004 AY727522  
C-3 South Africa 2005 GQ999987  
C-3 South Africa 2005 GQ999984  
C-3 South Africa 2005 GQ999976  
C-3 South Africa 2005 GQ999989  
C-3 India 2005 KF766540  
C-3 South Africa 2005 GQ999982  
C-3 South Africa 2005 GQ999991  
C-3 Spain 2006 EU786673  
C-3 South Africa 2007 KT183264  
C-3 Malawi 2007 KC156122  
C-3 South Africa 2007 KC156127  
C-3 South Africa 2007 JX974245  
C-3 Malawi 2007 KC156213  
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C-3 South Africa 2008 KT183258  
C-3 Malawi 2008 KC156218  
C-3 South Africa 2008 KC156221  
C-3 South Africa 2008 JX140666  
C-3 South Africa 2008 KT183201  
C-3 Malawi 2008 KF527172  
C-3 Spain 2008 EU786681  
C-3 South Africa 2008 KT183336  
C-3 South Africa 2008 KT183128  
C-3 South Africa 2008 KT183078  
C-3 South Africa 2009 JX140668  
C-3 Malawi 2009 KP109523  
C-3 South Africa 2009 KT183289  
C-3 Zambia 2011 KP109495  
D DR Congo 1983 A07108  
D DR Congo 1984 U88822  
D Senegal 1990 AB485648  
D Uganda 1991 AB485650  
D Uganda 1993 AY713418  
D Uganda 1994 U88824  
D Uganda 1998 AF484505  
D Uganda 1998 AF484516  
D Uganda 1998 AF484502  
D Uganda 1998 AF484511  
D Uganda 1998 AF484506  
D Uganda 1998 AF484513  
D Uganda 1998 AF484514  
D Uganda 1998 AF484504  
D Uganda 1999 AF484499  
D Uganda 1999 AF484518  
D Uganda 1999 AF484489  
D Uganda 1999 AF484481  
D Uganda 1999 AF484490  
D Uganda 1999 AF484487  
D Uganda 1999 AF484498  
D Uganda 1999 AF484519  
D Uganda 1999 AF484494  
D Uganda 1999 AF484483  
D Uganda 1999 AF484497  
D Uganda 1999 AY304496  
D Uganda 1999 AF484485  
D Uganda 1999 AF484480  
D Uganda 1999 AF484477  
D Uganda 1999 AF484495  
D Uganda 1999 AF484486  
D Chad 1999 AJ488926  
D Chad 1999 AJ488927  
D Kenya 2001 AF457090  
D Yemen 2001 AY795903  
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D Yemen 2002 AY795907  
D Uganda 2005 JX236668  
D Uganda 2007 JX236670  
D Uganda 2007 JX236673  
D Uganda 2008 JX236672  
D Uganda 2010 KF716479  
D Brazil 2010 KJ787684  
D Cameroon 2010 JX140670  
D Kenya 2011 KF716476  
D Uganda 2011 KF716480  
G Nigeria 1992 U88826  
G Kenya 1993 AB485662  
G Sweden 1993 AF061642  
G Cameroon 1996 AY772535  
G Belgium 1996 AF084936  
G Cuba 1999 AY586548  
G Cuba 1999 AY586549  
G Spain 2000 AF423760  
G Nigeria 2001 DQ168575  
G Nigeria 2001 DQ168579  
G Nigeria 2001 DQ168573  
G Nigeria 2001 DQ168576  
G Cameroon 2001 FJ389367  
G Ghana 2003 AB231893  
G Cameroon 2004 FJ389363  
G Spain 2005 EU786670  
G Spain 2005 FJ670520  
G Cameroon 2006 KP718915  
G Cameroon 2007 KP718923  
G Nigeria 2008 JN248582  
G China 2008 JN106043  
G Cameroon 2008 KP718925  
G Spain 2008 FJ670530  
G Nigeria 2009 JN248591  
G Nigeria 2009 JN248586  
G Nigeria 2009 JN248593  
G Kenya 2009 KF716477  
G Spain 2009 GU362882  
G Nigeria 2009 JN248584  
G Cameroon 2010 KP109502  
G Cameroon 2010 JX140676  
G Spain 2014 KT276261  
01_AE-1 Central African Rep 1990 AF197341  
01_AE-1 Central African Rep 1990 U51188  
01_AE-1 Central African Rep 1990 AF197340  
01_AE-1 Thailand 1993 AB220944  
01_AE-1 Thailand 1993 U51189  
01_AE-1 Indonesia 1993 AB485652  
01_AE-1 Thailand 1995 AB032741  
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01_AE-1 Thailand 1997 AY713419  
01_AE-1 Viet Nam 1997 FJ185239  
01_AE-1 Viet Nam 1997 FJ185249  
01_AE-1 Viet Nam 1997 FJ185258  
01_AE-1 Viet Nam 1997 FJ185241  
01_AE-1 Viet Nam 1997 FJ185260  
01_AE-1 Thailand 1998 AY713422  
01_AE-1 Viet Nam 1998 FJ185236  
01_AE-1 Thailand 2000 DQ789392  
01_AE-1 China 2002 JX112866  
01_AE-1 China 2002 JX112863  
01_AE-1 China 2002 JX112862  
01_AE-1 China 2002 JX112861  
01_AE-1 Thailand 2004 JN248328  
01_AE-1 Hong Kong 2004 DQ234790  
01_AE-1 China 2005 GU564223  
01_AE-1 China 2005 EF036535  
01_AE-1 China 2005 EF036530  
01_AE-1 Thailand 2005 JN248342  
01_AE-1 Thailand 2005 JX447618  
01_AE-1 China 2005 GQ845125  
01_AE-1 China 2005 DQ859178  
01_AE-1 China 2005 GU564221  
01_AE-1 Thailand 2005 JX447077  
01_AE-1 China 2005 EF036527  
01_AE-1 Thailand 2005 JX447268  
01_AE-1 Thailand 2005 JX447589  
01_AE-1 Thailand 2005 JN248341  
01_AE-1 China 2005 GU564229  
01_AE-1 Thailand 2006 JX447315  
01_AE-1 Thailand 2006 JX447884  
01_AE-1 Thailand 2006 JX446853  
01_AE-1 Thailand 2006 JX447132  
01_AE-1 Thailand 2006 JX447638  
01_AE-1 Thailand 2006 JX447403  
01_AE-1 Thailand 2006 JX447678  
01_AE-1 China 2006 JX112858  
01_AE-1 China 2007 JX112840  
01_AE-1 Thailand 2007 JX447054  
01_AE-1 China 2007 KF835499  
01_AE-1 China 2007 JX112836  
01_AE-1 Thailand 2007 JN860766  
01_AE-1 China 2007 JX112813  
01_AE-1 China 2007 JX112855  
01_AE-1 Thailand 2007 JN860767  
01_AE-1 China 2007 JX112830  
01_AE-1 China 2007 JX112822  
01_AE-1 China 2007 JX112833  
01_AE-1 China 2007 KF835519  
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01_AE-1 China 2007 JX112826  
01_AE-1 Thailand 2007 JX446877  
01_AE-1 China 2007 JX112851  
01_AE-1 China 2007 JX112828  
01_AE-1 China 2007 JX112834  
01_AE-1 China 2007 JX112821  
01_AE-1 China 2007 JX112839  
01_AE-1 Thailand 2007 JX447028  
01_AE-1 China 2007 JX112820  
01_AE-1 Thailand 2007 JN860761  
01_AE-1 China 2007 JX112844  
01_AE-1 China 2007 KF835527  
01_AE-1 China 2007 JX112859  
01_AE-1 China 2007 JX112854  
01_AE-1 Thailand 2007 JN860763  
01_AE-1 China 2007 JX112856  
01_AE-1 China 2007 JX112831  
01_AE-1 China 2007 KF835502  
01_AE-1 China 2007 KF835513  
01_AE-1 China 2007 JX112811  
01_AE-1 Thailand 2007 JN860764  
01_AE-1 Thailand 2008 JX446755  
01_AE-1 Thailand 2008 JX447305  
01_AE-1 Thailand 2008 JX446848  
01_AE-1 Thailand 2008 JX447122  
01_AE-1 Thailand 2008 JX447359  
01_AE-1 China 2009 HQ215555  
01_AE-1 China 2009 HQ215553  
01_AE-1 Thailand 2009 JX448057  
01_AE-1 China 2010 JX112848  
01_AE-1 China 2010 JX112800  
01_AE-1 China 2010 KC870029  
01_AE-1 China 2010 KP109507  
01_AE-1 China 2010 JX112849  
01_AE-1 China 2010 JX112846  
01_AE-1 China 2010 JX112801  
01_AE-1 China 2010 JX112805  
01_AE-1 China 2010 JX112798  
01_AE-1 China 2010 JX112799  
01_AE-1 China 2010 JX112847  
01_AE-1 China 2010 JX112802  
01_AE-1 China 2010 KP109506  
01_AE-1 Sweden 2011 KP411842  
01_AE-1 China 2012 KP109508  
01_AE-2 Central African Rep 1990 AF197341  
01_AE-2 Thailand 1993 AF164485  
01_AE-2 Thailand 1993 U51189  
01_AE-2 Indonesia 1993 AB485652  
01_AE-2 Japan 1993 AB052995  
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01_AE-2 Thailand 1995 AB032741  
01_AE-2 Thailand 1996 AY713424  
01_AE-2 Viet Nam 1997 FJ185260  
01_AE-2 Viet Nam 1997 FJ185242  
01_AE-2 Viet Nam 1997 FJ185239  
01_AE-2 Viet Nam 1997 FJ185241  
01_AE-2 Viet Nam 1997 FJ185248  
01_AE-2 Viet Nam 1997 FJ185251  
01_AE-2 Viet Nam 1997 FJ185250  
01_AE-2 Viet Nam 1997 FJ185259  
01_AE-2 Thailand 1997 AY125894  
01_AE-2 Thailand 1999 AY713423  
01_AE-2 Thailand 2000 DQ789392  
01_AE-2 China 2002 JX112865  
01_AE-2 China 2002 JX112862  
01_AE-2 Thailand 2004 JN248327  
01_AE-2 Thailand 2004 JN248334  
01_AE-2 Thailand 2004 JN248328  
01_AE-2 Hong Kong 2004 DQ234790  
01_AE-2 Thailand 2004 JN248336  
01_AE-2 Thailand 2004 JN248330  
01_AE-2 Thailand 2005 JX447589  
01_AE-2 China 2005 EF036527  
01_AE-2 Thailand 2005 JX447268  
01_AE-2 China 2005 GU564227  
01_AE-2 China 2005 GU564228  
01_AE-2 Thailand 2005 JX447936  
01_AE-2 China 2005 EF036534  
01_AE-2 Thailand 2005 JN248339  
01_AE-2 China 2005 GU564223  
01_AE-2 China 2005 GU564229  
01_AE-2 China 2005 EF036530  
01_AE-2 Thailand 2005 JN248355  
01_AE-2 Thailand 2005 JX447618  
01_AE-2 Thailand 2006 JX447638  
01_AE-2 Thailand 2006 JX447678  
01_AE-2 Thailand 2006 JX446899  
01_AE-2 Thailand 2006 JX447403  
01_AE-2 Thailand 2006 JX447315  
01_AE-2 China 2006 GU564230  
01_AE-2 Thailand 2006 JX446736  
01_AE-2 China 2006 JX112857  
01_AE-2 Thailand 2006 JX447884  
01_AE-2 China 2007 JX112821  
01_AE-2 China 2007 JX112845  
01_AE-2 China 2007 JX112826  
01_AE-2 China 2007 JX112820  
01_AE-2 Thailand 2007 JX446987  
01_AE-2 China 2007 KF835503  
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01_AE-2 China 2007 KF835516  
01_AE-2 China 2007 JX112840  
01_AE-2 Thailand 2007 JN860761  
01_AE-2 China 2007 JX112825  
01_AE-2 China 2007 JX112856  
01_AE-2 China 2007 JX112841  
01_AE-2 China 2007 JX112810  
01_AE-2 China 2007 JX112855  
01_AE-2 China 2007 JX112813  
01_AE-2 China 2007 JX112839  
01_AE-2 China 2007 JX112828  
01_AE-2 China 2007 JX112827  
01_AE-2 China 2007 JX112833  
01_AE-2 Thailand 2007 JX447283  
01_AE-2 Thailand 2007 JN860766  
01_AE-2 China 2007 KF835499  
01_AE-2 China 2007 KF835542  
01_AE-2 China 2007 JX112814  
01_AE-2 China 2007 JX112837  
01_AE-2 Thailand 2007 JN860767  
01_AE-2 China 2007 JX112818  
01_AE-2 China 2007 JX112817  
01_AE-2 Thailand 2007 JX447054  
01_AE-2 China 2007 JX112823  
01_AE-2 Thailand 2007 JX447499  
01_AE-2 Thailand 2007 JN860764  
01_AE-2 Thailand 2008 JX447072  
01_AE-2 Thailand 2008 JX447454  
01_AE-2 Thailand 2008 JX447300  
01_AE-2 Thailand 2008 JX447122  
01_AE-2 China 2009 HQ215555  
01_AE-2 China 2010 JX112799  
01_AE-2 China 2010 JX112800  
01_AE-2 China 2010 JX112802  
01_AE-2 China 2010 KC870029  
01_AE-2 China 2010 JX112805  
01_AE-2 China 2010 JX112803  
01_AE-2 China 2010 KP109506  
01_AE-2 China 2010 JX112801  
01_AE-2 China 2010 JX112804  
01_AE-2 China 2010 JX112848  
01_AE-2 China 2010 JX112807  
01_AE-2 Sweden 2011 KP411842  
01_AE-2 Cameroon 2011 KP718930  
01_AE-2 China 2011 KC596065  
01_AE-2 China 2012 KP109508  
01_AE-3 Thailand 1990 AF259954  
01_AE-3 Central African Rep 1990 AF197340  
01_AE-3 Central African Rep 1990 U51188  
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01_AE-3 Japan 1993 AB070352  
01_AE-3 Thailand 1993 AB220946  
01_AE-3 Thailand 1993 U51189  
01_AE-3 Thailand 1995 AB032741  
01_AE-3 Viet Nam 1997 FJ185258  
01_AE-3 Viet Nam 1997 FJ185247  
01_AE-3 Viet Nam 1997 FJ185237  
01_AE-3 Viet Nam 1997 FJ185260  
01_AE-3 Viet Nam 1997 FJ185248  
01_AE-3 Viet Nam 1997 FJ185242  
01_AE-3 Viet Nam 1997 FJ185241  
01_AE-3 Viet Nam 1997 FJ185250  
01_AE-3 Thailand 1998 AY713422  
01_AE-3 Thailand 1999 AY713423  
01_AE-3 Thailand 2000 DQ789392  
01_AE-3 China 2002 JX112861  
01_AE-3 China 2002 JX112865  
01_AE-3 Thailand 2004 JN248334  
01_AE-3 Hong Kong 2004 DQ234790  
01_AE-3 Thailand 2004 JN248336  
01_AE-3 Thailand 2004 DQ314732  
01_AE-3 China 2005 GU564221  
01_AE-3 China 2005 GU564223  
01_AE-3 China 2005 EF036530  
01_AE-3 Thailand 2005 JX447936  
01_AE-3 Thailand 2005 JN248356  
01_AE-3 China 2005 GU564222  
01_AE-3 Thailand 2005 JN248341  
01_AE-3 China 2005 GU564227  
01_AE-3 Thailand 2005 JN248339  
01_AE-3 China 2005 EF036528  
01_AE-3 Thailand 2005 JX447618  
01_AE-3 China 2005 GU564224  
01_AE-3 China 2005 GQ845124  
01_AE-3 China 2005 DQ859178  
01_AE-3 Thailand 2005 JX447268  
01_AE-3 Thailand 2005 JX448019  
01_AE-3 Thailand 2006 JX447403  
01_AE-3 Thailand 2006 JX447638  
01_AE-3 China 2006 GU564230  
01_AE-3 China 2006 JX112857  
01_AE-3 Thailand 2006 JX447465  
01_AE-3 Thailand 2006 JX446853  
01_AE-3 China 2007 JX112828  
01_AE-3 China 2007 KF835543  
01_AE-3 China 2007 JX112839  
01_AE-3 China 2007 KF835503  
01_AE-3 China 2007 JX112837  
01_AE-3 China 2007 JX112831  
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01_AE-3 China 2007 JX112850  
01_AE-3 China 2007 JX112811  
01_AE-3 China 2007 KF835542  
01_AE-3 Thailand 2007 JX447283  
01_AE-3 China 2007 KF835502  
01_AE-3 China 2007 JX112859  
01_AE-3 Thailand 2007 JN860761  
01_AE-3 China 2007 KF835527  
01_AE-3 China 2007 JX112810  
01_AE-3 Thailand 2007 JX447054  
01_AE-3 China 2007 JX112823  
01_AE-3 China 2007 KF835499  
01_AE-3 China 2007 JX112845  
01_AE-3 China 2007 JX112853  
01_AE-3 Thailand 2007 JN860764  
01_AE-3 China 2007 KF835519  
01_AE-3 China 2007 JX112829  
01_AE-3 China 2007 JX112841  
01_AE-3 China 2007 JX112836  
01_AE-3 Afghanistan 2007 GQ477441  
01_AE-3 China 2007 JX112820  
01_AE-3 Thailand 2008 JX447072  
01_AE-3 Thailand 2008 JX447454  
01_AE-3 Thailand 2008 JN860768  
01_AE-3 Thailand 2008 JX446755  
01_AE-3 Thailand 2008 JX447305  
01_AE-3 Thailand 2008 JX447359  
01_AE-3 China 2009 KP109505  
01_AE-3 China 2009 JX112870  
01_AE-3 China 2009 JX112868  
01_AE-3 Thailand 2009 JX448057  
01_AE-3 China 2009 JX112867  
01_AE-3 Thailand 2009 JX447726  
01_AE-3 China 2009 HQ215555  
01_AE-3 China 2010 JX112805  
01_AE-3 China 2010 JX112801  
01_AE-3 Thailand 2010 KP109513  
01_AE-3 China 2010 JX112807  
01_AE-3 China 2010 KP109506  
01_AE-3 China 2010 JX112798  
01_AE-3 China 2010 JX112806  
01_AE-3 China 2010 JX112800  
01_AE-3 China 2010 JX112848  
01_AE-3 China 2010 KC870041  
01_AE-3 China 2010 JX112804  
01_AE-3 Sweden 2011 KP411842  
01_AE-3 China 2011 KC596065  
01_AE-3 Japan 2011 KF859741  
02_AG France 1991 AF063224  
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02_AG Sweden 1994 AF107770  
02_AG Ghana 1997 AB049811  
02_AG Cameroon 1997 AF377955  
02_AG Cameroon 1997 AF377954  
02_AG Senegal 1998 AJ251056  
02_AG Cameroon 1999 AY271690  
02_AG Cameroon 2001 GU201499  
02_AG Nigeria 2001 DQ168578  
02_AG Cameroon 2001 GU201498  
02_AG Cameroon 2001 GU201495  
02_AG Cameroon 2002 GU201514  
02_AG Cameroon 2002 GU201512  
02_AG Cameroon 2002 GU201513  
02_AG Ghana 2003 AB231898  
02_AG Ghana 2003 AB286862  
02_AG Ghana 2003 AB231896  
02_AG Guinea-Bissau 2004 FJ694791  
02_AG Spain 2006 EU786671  
02_AG Nigeria 2006 JN248580  
02_AG USA 2006 JF320297  
02_AG Spain 2006 EU884501  
02_AG South Korea 2007 JQ316136  
02_AG Cameroon 2008 JX140647  
02_AG Cameroon 2008 JX140646  
02_AG Nigeria 2009 JN248589  
02_AG Nigeria 2009 JN248585  
02_AG Nigeria 2009 JN248590  
02_AG Nigeria 2009 JN248592  
02_AG South Korea 2012 KF561435  
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Supplementary Figure S1. Dated phylogenetic trees obtained from the concatenate of all non-overlapping genomic regions of each subtype analyzed with BEAST, as 
obtained using the best-fitting demographic and molecular clock models. Node circles represent posterior probabilities >0.90. Time scale: years from present. 
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Supplementary Figure S1 (cont). Dated phylogenetic trees obtained from the concatenate of all non-overlapping genomic regions of each subtype analyzed with BEAST, as 
obtained using the best-fitting demographic and molecular clock models. Node circles represent posterior probabilities >0.90. Time scale: years from present. 
179 
 
 
 
 
Supplementary Figure S1 (cont). Dated phylogenetic trees obtained from the concatenate of all non-overlapping genomic regions of each subtype analyzed with BEAST, as 
obtained using the best-fitting demographic and molecular clock models. Node circles represent posterior probabilities >0.90. Time scale: years from present. 
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Supplementary Figure S1 (cont). Dated phylogenetic trees obtained from the concatenate of all non-overlapping genomic regions of each subtype analyzed with BEAST, as 
obtained using the best-fitting demographic and molecular clock models. Node circles represent posterior probabilities >0.90. Time scale: years from present. 
181 
 
 
 
 
Supplementary Figure S1 (cont). Dated phylogenetic trees obtained from the concatenate of all non-overlapping genomic regions of each subtype analyzed with BEAST, as 
obtained using the best-fitting demographic and molecular clock models. Node circles represent posterior probabilities >0.90. Time scale: years from present. 
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Supplementary Figure S1 (cont). Dated phylogenetic trees obtained from the concatenate of all non-overlapping genomic regions of each subtype analyzed with BEAST, as 
obtained using the best-fitting demographic and molecular clock models. Node circles represent posterior probabilities >0.90. Time scale: years from present. 
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Supplementary Figure S1 (cont). Dated phylogenetic trees obtained from the concatenate of all non-overlapping genomic regions of each subtype analyzed with BEAST, as 
obtained using the best-fitting demographic and molecular clock models. Node circles represent posterior probabilities >0.90. Time scale: years from present. 
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Supplementary Figure S1 (cont). Dated phylogenetic trees obtained from the concatenate of all non-overlapping genomic regions of each subtype analyzed with BEAST, as 
obtained using the best-fitting demographic and molecular clock models. Node circles represent posterior probabilities >0.90. Time scale: years from present. 
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Supplementary Figure S1 (cont). Dated phylogenetic trees obtained from the concatenate of all non-overlapping genomic regions of each subtype analyzed with BEAST, as 
obtained using the best-fitting demographic and molecular clock models. Node circles represent posterior probabilities >0.90. Time scale: years from present. 
186 
 
 
 
 
Supplementary Figure S1 (cont). Dated phylogenetic trees obtained from the concatenate of all non-overlapping genomic regions of each subtype analyzed with BEAST, as 
obtained using the best-fitting demographic and molecular clock models. Node circles represent posterior probabilities >0.90. Time scale: years from present. 
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Supplementary Figure S1 (cont). Dated phylogenetic trees obtained from the concatenate of all non-overlapping genomic regions of each subtype analyzed with BEAST, as 
obtained using the best-fitting demographic and molecular clock models. Node circles represent posterior probabilities >0.90. Time scale: years from present. 
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Supplementary Figure S1 (cont). Dated phylogenetic trees obtained from the concatenate of all non-overlapping genomic regions of each subtype analyzed with BEAST, as 
obtained using the best-fitting demographic and molecular clock models. Node circles represent posterior probabilities >0.90. Time scale: years from present. 
189 
 
 
 
 
Supplementary Figure S1 (cont). Dated phylogenetic trees obtained from the concatenate of all non-overlapping genomic regions of each subtype analyzed with BEAST, as 
obtained using the best-fitting demographic and molecular clock models. Node circles represent posterior probabilities >0.90. Time scale: years from present.
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Supplementary material 
Supplementary material (Fig S.1 and tables S1 to S6) is freely available at 
http://aac.asm.org/content/suppl/2016/03/16/AAC.02776-
15.DCSupplemental/zac004165065so1.pdf 
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Supplementary material 
Supplementary data to this article can be found online at 
http://dx.doi.org/10.1016/j.meegid.2017.01.010 
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Abstract 
Many viroids and RNA viruses have genomes that exhibit secondary structure, 
with paired nucleotides forming stems and loops. Such structures violate a key 
assumption of most methods of phylogenetic reconstruction, that sequence change is 
independent among sites. Despite this, phylogenetic analyses of these agents rarely 
utilize evolutionary models that account for RNA secondary structure. Here, we assess 
the effect of using RNA-specific nucleotide substitution models on the phylogenetic 
inference of viroids and RNA viruses. We obtained datasets comprising full-genome 
nucleotide sequences from 6 viroid and 10 single-stranded RNA virus species. For each 
dataset we inferred consensus RNA secondary structures, then evaluated different 
DNA and RNA substitution models for phylogenetic reconstruction. We used model 
selection to choose the best-fitting model and estimated Bayesian phylogenies. 
Further, for each dataset we generated and compared Robinson-Foulds (RF) statistics 
in order to test whether the distributions of trees generated under alternative models 
are different to each other. In all datasets, the best-fitting model was one which 
considers RNA secondary structure: RNA models that allow a non-zero rate of double 
substitution (RNA16A, RNA16C) fitted best both in viral and viroid datasets. In 14 of 16 
datasets, the use of an RNA-specific model led to significantly longer tree lengths, but 
only in 2 of 16 it had a significant effect on Robinson-Foulds statistics. In conclusion, 
the use of an RNA model for phylogenetic inference of viroids and RNA viruses 
provides a better fit in the reconstructed trees for these organisms and significantly 
affects branch length estimates.  
 224 
 
 
Introduction 
In order to avoid the problem of unobserved evolutionary changes and thereby 
accurately estimate genetic distances among taxa, modern molecular systematics 
relies upon the use of nucleotide (or codon or amino acid) substitution models. These 
models make assumptions about the process of molecular evolution, for example 
whether nucleotides vary in frequency, or whether substitution rates vary among 
nucleotides (Posada & Crandall 2001) or codon positions (Shapiro et al. 2006). 
The existence of RNA secondary structures, such as stems (also called hairpins) 
violates a key assumption made by most methods of phylogenetic reconstruction; that 
evolutionary changes are independent among sites (Nasrallah et al. 2011). Stems are 
comprised of nucleotide sequences that form base-pairings with complementary 
regions from the same strand. Among the 16 possible base-pairings that can 
potentially occur, only six (the Watson-Crick pairs AU, UA, GC, CG plus GU and UG) are 
stable enough to form actual base-pairs (the remaining base-pairings are called 
Mismatches, MM). RNA structures play important roles in RNA viruses and viroids, for 
example in viral/viroid replication (Hutchins et al. 1986; Damgaard et al. 2004), 
translation (Pelletier & Sonenberg 1988), and immune evasion (Tellam et al. 2008). 
Hence, nucleotide changes that disrupt the most stable Watson-Crick pairs are often 
deleterious and RNA secondary structures can impose strong evolutionary constraints 
on sequence evolution. In order to maintain RNA structure, change in one base of a 
pair must matched by a complementary, compensatory change in the other base. One 
consequence of this evolutionary constraint is that the number of nucleotide changes 
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estimated from unpaired sites is expected to be higher than that from paired sites 
(Nasrallah et al. 2011). An association between the presence of base pairing and amino 
acid conservation has been reported for HIV-1 (Sanjuán & Bordería 2011; Snoeck et al. 
2011). 
In order to accommodate the among-site correlations imposed by RNA 
secondary structure, various types of RNA-specific substitution models for 
phylogenetic inference have been developed. The 6-state (RNA6A-E) models discard all 
mismatched sites from analysis, whilst the 7-state (RNA7A-G) models pools all 
mismatched sites into a single state (Tillier & Collins 1998).16-state models (RNA16A-F, 
I-K) take into account all 16 possible pairs that the four nucleotides could form 
(Schöniger & von Haeseler 1994; Muse 1995). RNA16 models can be classified in three 
different types: (i) “all pairs” models (RNA16A, B, I, J and K), in which each of the 16 
dinucleotides has its own equilibrium frequency; (ii) “stable sets” models (RNA16D, E 
and F), in which the equilibrium frequencies of three different types of base pairs, MM, 
Watson-Crick and wobble (UG, GU), are different; and (iii) “stable pairs” model 
(RNA16C), considered as an extension of an RNA7 model, in which the 10 possible MM 
have a single equilibrium frequency (Savill et al. 2001; Allen & Whelan 2014).  
Previous studies of ribosomal RNA (rRNA) genes have concluded that RNA-
specific models outperform standard nucleotide substitution models when describing 
the evolution of structured RNA sequences (Savill et al. 2001; Kosakovsky Pond et al. 
2007), as assessed by model comparisons using the Akaike Information Criterion (AIC) 
(Linhart & Zucchini 1986). In agreement with these studies, Allen & Whelan (2014) 
compared different nucleotide and RNA models for 287 human RNA gene families, 
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most of them microRNAs and snoRNAs, and concluded that RNA models outperformed 
nucleotide substitution models in most cases, since the former yielded the lowest 
corrected AIC (AICc) values.  
Conserved RNA secondary structures have been reported to exist in the 
genomes of linear RNA viruses, such as in species of the Flaviviridae family (Thurner et 
al. 2004; Mauger et al. 2015) and HIV-1 (Watts et al. 2009).  Hepatitis Delta Virus (HDV) 
and viroids, which exist as circular RNA genomes, present exceptionally highly 
structured genomes, as >70% of sites in their genomes form base-pairs (Wang et al. 
1986; Sanjuán et al. 2006). Despite this, phylogenetic reconstructions of RNA viruses 
(including HDV) and viroids have not been generated using RNA models, thus ignoring 
the constraints that these structures impose on their genome evolution.  
The goal of this study is to investigate whether RNA-specific substitution 
models outperform standard nucleotide substitution models when applied to different 
sets of full-genome sequences from RNA viruses and viroids. Further, we measure the 
degree to which phylogenetic inference is affected, in terms of estimated branch 
lengths and tree topologies, when an RNA-specific model is used to describe the 
evolution of paired sites in the genomes of these pathogens. 
 
Materials and methods 
Datasets and alignments 
Full-genome nucleotide sequences from 6 viroid species [tomato apical stunt 
pospiviroid (TASVd), citrus exocortis viroid (CEVd), columnea latent viroid (CLVd), 
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grapevine yellow speckle viroid (GYSVd), Australian grapevine viroid (AGVd), potato 
spindle tuber viroid (PSTVd)] and 10 single-stranded RNA virus species [hepatitis delta 
virus (HDV), Sudan-ebolavirus (SUDV), dengue virus (DENV), hepatitis C virus (HCV), 
human immunodeficiency virus (HIV), foot and mouth disease virus (FMDV), measles 
virus (MeV), rabies virus (RV) rubella virus (RuV) and mumps virus (MuV)] were 
downloaded in April, 2015. Viroid and HDV sequences were downloaded from 
GenBank whilst viral genomes were obtained from the Virus Pathogen Database and 
Analysis Resource, VIPRBRC (http://www.viprbrc.org). Only full genome sequences, 
which included untranslated regions, were considered. Alignments for each species 
were generated using MAFFT (“align- G-ins- 1” progressive method strategy) (Katoh & 
Standley 2013b) and positions with a high proportion of gaps were removed with 
TrimAl (Capella-Gutiérrez et al. 2009). Given that “gappy” positions were rare and 
represented insertions absent in most taxa, excluding them had no influence on the 
overall inferred RNA secondary structure. 
RNA-secondary structure inference 
For each species, RNA minimum free-energy consensus secondary structures 
were predicted using RNAalifold, as implemented in the Vienna Package 2.0 (Lorenz et 
al. 2011). The folding temperature was set to 25° and 37° C for viroids and viruses, 
respectively, which, according to Sanjuán et al. (2006), corresponds to the 
temperatures at which these pathogens replicate. RNA molecules were assumed to be 
circular for HDV and viroids. Arc diagrams of the obtained structures, which represent 
base-paired nucleotides along each genome, were plotted with the R4RNA package for 
R (Lai et al. 2012; R Core Team 2014). 
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The conservation of the RNA secondary structure within each dataset was 
tested using RNAz (Gruber et al. 2007) by calculating the Structure Conservation Index 
(SCI). An SCI = 0 indicates that RNAalifold did not find a consensus structure, while a 
SCI ≈ 1 reflects a set of perfectly conserved structures (Washietl et al. 2005). 
Consequently, only those datasets with an overall SCI ≥ 0.70 were retained for further 
analysis, in order to ensure that the RNA secondary structures under investigation 
were evolutionary conserved.  
Model selection and phylogenetic analyses 
For each dataset, the best-fitting substitution model for phylogenetic 
reconstruction was chosen using a Perl script included in the package PHASE-3.0 
(“model_selection.pl”; Allen & Whelan 2014). The inputs to this script were (i) the 
sequence alignment, (ii) the inferred secondary structure and, (iii) an initial neighbor-
joining tree, estimated under the Tamura-Nei model using Mega version 5 (Tamura et 
al. 2011). The Perl script compares two DNA substitution models (HKY and GTR), 
sixteen different RNA substitution models (seven RNA7 and nine RNA16 models), and 
the inclusion or exclusion of a gamma distribution model of among-site rate variation. 
The script identifies the best-fitting model as that with the lowest corrected Akaike’s 
Information Criterion value (Akaike 1974; Burnham & Anderson 2002): AICc= - ln(L) +2k 
+2k(k+1)/(n-k-1), where K is the number of parameters, L is the likelihood, and n is 
sample size.  
Phylogenetic trees were estimated using the Bayesian Monte Carlo Markov 
Chain (MCMC) approach implemented in the program mcmcphase that is part of the 
package PHASE-3.0. This program allows the inference of a phylogenetic tree under a 
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“mixed model”, in which a DNA substitution model is assigned to unpaired positions 
and an RNA substitution model is assigned to paired positions. Phylogenetic trees were 
estimated using the best-fitting model, which was always a mixed model, or the DNA-
only model. At least two independent MCMC runs, each with >1,000,000 states, were 
computed and a 10% burn-in was removed from each before analysis.   
After combining the output of both MCMC runs, convergence was checked 
visually by plotting sampled values of the likelihood, posterior and priors. After 
convergence was confirmed, an extended majority rule consensus phylogenetic tree 
was obtained for each dataset using the program “mcmcsummarize” from the PHASE 
package. The phylogeny obtained under the mixed model (which, for all datasets, was 
found to be the best-fitting model) was then used as a fixed topology to estimate 
branch lengths, by running mcmcphase with either the DNA or the mixed substitution 
model. 
Next, sites in each sequence alignment were partitioned into two independent 
datasets that included only paired or unpaired sites. Branch lengths were estimated 
separately from these two partitions, using the same fixed topology as above. A DNA 
substitution model was used for the unpaired sites partition, and either the best-fitting 
DNA substitution model or the RNA substitution model was used for the paired sites 
partition.  
Comparison of branch lengths and tree topologies 
Tree lengths (the sum of all branch lengths in a phylogeny) were calculated 
from the consensus trees obtained from the complete alignments. Tree lengths 
obtained from paired sites (either under a DNA or RNA substitution model) and 
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unpaired sites (always under a DNA substitution model) were calculated in the same 
way. Branch lengths estimated under the DNA and mixed substitution models were 
compared by means of paired Wilcoxon tests. 
To assess the effects on tree topology of using or not an RNA specific model, we 
computed distributions of Robinson-Foulds (RF) distances. The RF distance between 
two tree topologies is a measure of how different they are (Robinson & Foulds 1981). 
We computed three different distributions of RF distances: (i) between pairs of tree 
topologies sampled from the same posterior distribution when an RNA substitution 
model was included in the analysis, (ii) between pairs of tree topologies sampled from 
the same posterior distribution, when an RNA substitution model was not included in 
the analysis, and (iii) between a tree from the posterior used in (i) and a tree from the 
posterior used in (ii). For cases (i) and (ii), trees were sampled without replacement, 
thus ensuring that a given MCMC state could not be compared with itself. A total of 
9000 pairwise tree comparisons were made. All RF distances from a given dataset were 
normalized according to the number of taxa 2 x number of taxa - 6, for unrooted 
trees). Distributions (i) and (ii) represent the degree of statistical uncertainty in tree 
topology arising from inference under a given substitution model, whereas distribution 
(iii) represents the degree of difference in tree topologies obtained by inference under 
two different models. Thus, a comparison of distribution (iii) with distributions (i) and 
(ii) allows us to determine whether the effect on tree topology of using an RNA-
substitution model is greater or less than estimation uncertainty alone. 
We assessed whether distributions (i) and (ii) were significantly different from 
distribution (iii) by performing 9000 pairwise comparisons between RF distances 
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randomly sampled from distributions (i) or (ii) and from distribution (iii). The 
probability that the two distributions are different is computed as the number of cases 
in which the value of RF distance from (iii) is larger than the value sampled from (i) or 
(ii) divided by the total number of comparisons (Abecasis et al. 2009). p-values 
obtained from the same virus/viroid were then corrected with the false discovery rate 
method (FDR; Benjamini & Hochberg 1995). The distributions of normalized RF 
distances and their statistical comparisons were computed using an R script (available 
on request) that utilizes the phangorn package for R (Schliep 2016). 
 
Results 
RNA secondary structure inference 
Structure Conservation Index (SCI) values were calculated with RNAz. Values of 
SCI ≤ 0.70 were found in only five viral datasets: HCV (SCI=0.40), DENV (0.40), HIV-1 
(0.66), RV (0.66) and HDV (0.66) which, correspondingly, were also the virus species 
with large average pairwise genetic distances (Table 1). For genetically diverse viruses 
like these, the evolutionary conservation of secondary structure will be higher at the 
sub-genomic level. Therefore, for DENV, HIV-1, RV and HDV we attempted to infer 
secondary structures separately for taxonomic units below the species level (e.g. 
subtypes, genotypes, etc.), with the aim of obtaining a consensus structure comprising 
paired-sites that are present in >75% of genotypes/subtypes within a species. 
However, for all cases except HDV, the percentage of paired sites along the genome 
that were conserved among genotypes was too low (≤12%). For HDV, we found 46% of 
paired sites along the genome were conserved among the 8 HDV genotypes in the 
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virus, each with SCI > 0.70 separately. Therefore, for HCV, HIV-1, DENV and RV, we 
analyzed a less diverse sub-genomic taxonomic unit rather than the whole viral species 
(subtype 1b for HCV, genotype 4 for DENV, subtype B for HIV-1 and lineage C1 for RV). 
All these genotype/subtype datasets had SCI > 0.70 and were therefore analyzed 
further. Arc diagrams representing the RNA minimum free-energy consensus 
secondary structures that were obtained with RNAalifold for each dataset with SCI > 
0.70 are shown in Supplementary Figure S.1. The percentage of nucleotides forming 
base-pairs of these alignments, which were further analyzed, ranged between 46% 
(HDV) and 78% (AGVd) (Table 1). 
Model selection and phylogenetic analyses 
For each analyzed dataset, the best-fitting model (i.e. the model with the 
lowest AICc value) was a mixed model which assigned a DNA substitution model 
(either GTR or HKY) to unpaired sites and a RNA16 substitution model to paired sites 
(Table 1). 
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Table 1. Size (number of taxa and sequence length), overall mean genetic distance, Structure Conservation 
Index (SCI), percentage of base-paired nucleotides and best-fitting evolutionary model of each viroid and 
virus dataset analyzed 
 
 
n 
(taxa) 
sequence 
length (nt) 
mean pairwise genetic 
distance (p-distance ± 
SE) SCI 
% nucleotides 
forming base-
pairs Best-fitting model 
Viroids             
TASVd 22 374 0.036 ± 0.004 0.91 68% HKY_Γ+RNA16C_Γ 
CeVd 178 369 0.041 ± 0.005 0.92 70% GTR_Γ+RNA16E_Γ 
CLVd 14 379 0.061 ± 0.008 0.88 68% GTR_Γ+RNA16A_Γ 
GYSVd 24 352 0.128 ± 0.012 0.84 65% GTR_Γ+RNA16C_Γ 
AGVd 27 368 0.020 ± 0.004 0.91 78% HKY_Γ+RNA16C 
PSTVd 88 356 0.019 ± 0.003 0.97 69% HKY_Γ+RNA16C_Γ 
Viruses       
HDV 121 1543 0.204 ± 0.005 0.66* 46%# GTR_Γ+RNA16D_Γ 
Sudan 
Ebolavirus 7 18875 0.032 ± 0.001 0,90 66% GTR_Γ+RNA16A 
DENV 23 10628 0.263 ± 0.003 0.40* NC NC 
DENV-4 8 10628 0.088 ± 0.002 0.75 63% GTR_Γ+RNA16A_Γ 
HCV 42 9584 0.292 ± 0.002 0.40* NC NC 
HCV-1b 20 9584 0.087± 0.001 0.82 67% GTR_Γ+RNA16A_Γ 
HIV-1 18 9681 0.126 ± 0.002 0.64* NC NC 
HIV-1B 33 9681 0.056 ± 0.001 0.74 59% GTR_Γ+RNA16D_Γ 
FMDV  19 8192 0.135 ± 0.002 0.75 61% GTR_Γ+RNA16D_Γ 
Measles 20 15893 0.042 ± 0.001 0.89 64% GTR_Γ+RNA16A_Γ 
Rubella 35 9758 0.060 ± 0.002 0.90 66% GTR_Γ+RNA16A_Γ 
Mumps 20 15355 0.045 ± 0.001 0.86 63% GTR_Γ+RNA16A_Γ 
Rabies 26 11923 0.111 ± 0.001 0.66 5%# GTR_Γ+RNA16A_Γ 
Rabies C1 20 11923 0.088 ± 0.001 0.74 64% GTR_Γ+RNA16A_Γ 
* SCI below 0.70. 
# Percentage of nucleotides forming base pairing, after obtaining a consensus structure comprising paired-
sites that are present in >75% of genotypes/subtypes within a species. 
NC: not computed 
 
Bayesian phylogenies were estimated using mcmcphase, which forms part of 
the PHASE-3.0 package. To examine the effect of including a RNA substitution model in 
the analysis, we estimated branch lengths on a fixed topology under two different 
substitution models: first, using the best-fit model (which, as noted above, was always 
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a mixed model), and second, using the best-fitting DNA substitution model. Tree 
lengths (the sum of all branch lengths) obtained under the two abovementioned 
models were statistically compared using paired Wilcoxon tests. Ratios of the tree 
lengths obtained the mixed and DNA models (i.e. L(mixed)/L(DNA)) were calculated 
and statistically compared (see Table 2). While the effect on branch length estimates 
of using a mixed model was near zero for PSTVd and AGvd (ratios= 0.99 and 1.00, 
respectively; p-values > 0.05), for the other viral and viroid datasets there was a 
significant increase in tree length of > 25% (p-values <0.05). The largest effects were 
observed for TasVd, CLVd and GYSVd, with L(mixed)/L(DNA) ratios of 6.532, 2.795, and 
2.675, respectively.  
We also compared the estimated tree lengths obtained independently for 
unpaired and paired sites. The L(paired)/L(unpaired) ratios obtained under the DNA 
model reported in Table 2 reflect the evolutionary constraints imposed by base-
pairing; with the exception of PSTVd, tree lengths estimated from paired sites were > 
29% shorter than those estimated from unpaired sites. However, when an RNA model 
was used for paired sites, the L(paired)/L(unpaired) ratios increased and, in several 
cases, paired sites under an RNA model yielded remarkably larger tree lengths than 
unpaired sites (AGVd, GYSVd, HDV, MeV, MuV, DENV-GT4, RV) (Table 2). 
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Table 2. Estimates and comparisons of tree lengths (L) estimated from DNA and mixed models, for all sites, paired sites, and unpaired sites  
 
L(DNA 
model) 
L(mixed 
model) 
Ratio 
(mixed/DNA) 
P value log(DNA 
vs mixed) 
L(unpaired 
sites) 
L(paired 
sites, DNA 
model) 
L(paired sites, 
RNA model) 
Ratio(paired-DNA 
model/unpaired) 
Ratio(paired-RNA 
model/unpaired) 
Viroids                   
TASVd 0.47 3.07 6.532 <0.001 3.05 0.51 1.82 0.167 0.597 
AGVd 4.91 4.93 1.004 0.341 0.55 0.31 1.13 0.563 2.055 
CeVd 30.41 33.81 1.111 <0.001 34.18 33.4 31.42 0.977 0.919 
CLVd 0.44 1.23 2.795 <0.001 1.36 0.74 1.01 0.544 0.743 
GYSVd 0.77 2.06 2.675 <0.001 2.11 0.88 2.21 0.417 1.047 
PSTVd 17.15 17.04 0.994 0.457 17.16 17.25 17.16 1.005 1.000 
Viruses                   
HDV 9.09 12.15 1.337 <0.001 12.44 7.50 15.35 0.603 1.234 
Sudan 
Ebolavirus 0.07 0.10 1.429 <0.001 0.10 0.05 0.13 0.500 1.300 
DENV-4 0.51 0.61 1.196 <0.001 0.66 0.45 0.89 0.682 1.348 
HCV-1b 1.16 1.74 1.500 <0.001 1.76 0.87 1.84 0.494 1.045 
HIV-1 B 1.49 2.15 1.443 <0.001 2.15 0.96 2.20 0.446 1.023 
FMDV  2.00 2.55 1.275 <0.001 2.61 1.48 2.65 0.567 1.015 
Measles 0.33 0.42 1.273 <0.001 0.42 0.30 0.79 0.714 1.881 
Rubella 0.71 1.06 1.493 <0.001 1.06 0.60 1.33 0.566 1.255 
Mumps 0.35 0.44 1.257 <0.001 0.44 0.31 0.84 0.705 1.909 
Rabies C1 0.94 1.15 1.223 <0.001 1.15 0.87 2.07 0.757 1.800 
*Topology could not be fixed for branch lengths inference due to unresolved bipartitions, and a Wilcoxon rank sum 
test was performed instead of a paired test.   
 236 
 
For each dataset analyzed, three different RF distance distributions were 
obtained as described above (Figure 1). The randomization tests evidenced that only 
for HDV and HCV-1b a significantly different distribution of RF distances was obtained 
when comparing tree states sampled from the same posterior (under a mixed model) 
than from comparing tree states from the two different posterior distributions, with 
shorter RF-distances under the mixed model in both cases (HDV: p-value=0.016; HCV: 
p-value= 0.027). In HCV, a significantly different distribution of shorter RF distances 
was also obtained when comparing tree states sampled under the DNA model with 
that obtained comparing both posterior distributions (p- value = 0.048). All the 
reported significant p-values were still significant after FDR correction. For these 
viruses, the consensus phylogenetic trees obtained under the mixed model presented 
more highly-supported nodes (defined by a posterior probability ≥ 0.90) than those 
obtained under a DNA-only model: 82 (mixed model) vs 68 (DNA model) in HDV, and 
14 vs 13 in HCV (Supplementary Figure S.2). In HIV-1 subtype B, the randomization test 
yielded a p-value = 0.065 and could not be considered significant. However, the use of 
a mixed model increased notably the number of well-supported clades in the 
consensus phylogenetic tree inferred, from 10 to 23 (Supplementary Figure S.2). The 
RF distances obtained when comparing the consensus trees (DNA vs mixed model) of 
these three viruses were 0.22 for HDV, 0.29 for HCV-1b and 0.40 for HIV-1 subtype B. 
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Figure 1. Density plots representing, for each dataset, the RF distributions obtained by 
comparing tree states from the same posterior distribution (either including or excluding the RNA 
model) or from the two different posterior distributions. The results of the randomization tests are 
shown as the proportion of cases when an RF value obtained comparing states from the same posterior 
(blue=under mixed model; red=under DNA model) was lower than the RF value obtained comparing 
states from the two different posterior distributions (black= mixed vs DNA models). Significant values 
after FDR correction are labelled with “*”.  
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Discussion  
In this work we assessed the effect of RNA substitution models on the 
phylogenetic inference of viroids and RNA viruses based on complete genome 
sequences. We first investigated whether using an RNA-specific model provides a 
better fit to the data than the conventional DNA substitution models that are widely 
used to study viral evolution. 
In all datasets the best-fit model was a mixed model that uses a nucleotide 
model for unpaired sites and an RNA model for paired sites. It is important to note that 
16-state RNA substitution models outperformed 7-state RNA models in all instances. 
The main difference between these families of RNA models is that 7-state models pool 
all mismatches (pairs of nucleotides that do not form stable base-pairs) in a single state 
in the Markov chain while 16-state models consider each mismatch as separate state. 
A special case is RNA16C, in which the 10 different MM have the same transition 
probabilities, thus being considered an extension of an RNA7 model (Savill et al. 2001; 
see also the PHASE 3.0 manual at https://github.com/james-monkeyshines/rna-phase-
3). 
For most of the analyzed viroids, the RNA16C model was chosen as the best-
fitting model, whereas for RNA viruses, RNA16A was chosen as the best-fitting model 
in most cases. RNA16A and C have been previously reported to fit best in different 
non-coding RNA datasets because, unlike other RNA16 models, they allow a non-zero 
rate of double substitutions, thus counting complementary changes as a single step 
(Savill et al. 2001). Allen & Whelan (2014) assessed the best-fitting models for 
analyzing the evolution of human non-coding RNAs and found that, for the majority of 
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RNA types, stable pairs models (RNA7A-G and RNA16C) and stable sets models 
(RNA16D, E, F) fitted the best for such data. They concluded that the former were 
usually selected in datasets where few changes occurred, while the later were selected 
when the consensus secondary structure contained higher proportions of paired sites. 
Our results suggest that models allowing non-zero rates of double substitutions fit best 
for viroids and viruses. 
 Bayesian phylogenies were inferred using the best-fitting mixed model and 
using a DNA substitution model. This allowed us to assess the differences in estimates 
of branch lengths and trees topologies when an RNA model is included in analysis. In 
all datasets (except PSTVd and AGVd), the use of a RNA model led to trees with longer 
branch lengths. Among those datasets where the use of an RNA model led to a 
significant increase in branch lengths, the increase in total tree length ranged between 
11% (CEVd) up to 653% (TASVd). Under a DNA model, the tree lengths estimated from 
paired sites were always much shorter than those estimated from unpaired sites, and 
such differences were reduced when the RNA model was used for paired sites. A lower 
number of substitutions at paired sites, compared to unpaired sites, is expected due to 
the likely higher evolutionary constraints at paired sites (Nasrallah et al. 2011). 
However, in some datasets tree lengths estimated from paired sites under a RNA 
model were considerably larger than those estimated from unpaired sites (especially in 
AGVd, measles, mumps and rabies virus; Table 2). These results suggest that, in such 
cases, while the use of DNA models strongly underestimates the number of 
substitutions, RNA models may lead to an overestimate of the number of substitutions 
along the inferred tree. It is important to note that PHASE-3.0 gives the estimated 
branch lengths as expected number of substitutions per nucleotide, even when a RNA 
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model is included (and not as expected number of substitutions per base-pair), thus 
allowing the comparison of branch lengths estimated under different models (Allen & 
Whelan 2014). 
Compared to viruses, viroid phylogenies were characterized by presenting 
larger values of RF distances between sampled from the posterior distributions, 
regardless of the evolutionary model used. Furthermore, the comparisons of RF 
distributions show that, with the exception of HCV and HDV, the use of a mixed model 
to infer viral and viroid phylogenies had no significant effect on the tree topologies. In 
those significant cases, including an RNA model was associated to an increase in the 
number of well-supported nodes from the resulting consensus phylogenetic tree. 
The RF distributions for SUDV, DENV-4 and HIV-1B were bimodal. In SUDV and 
DENV-4 this can be explained because there were few sequences, and RFs were either 
zero or very low, because tree states were either identical or very similar. In the case 
of HIV-1B, the RF distribution obtained from the posterior distribution sampled under 
the RNA model was much less bimodal than the others, and could be associated with a 
substantial reduction in the topologic uncertainty that was obtained under the mixed 
model: in the consensus tree, the number of well supported nodes increased from 10 
(DNA-only) to 23 (mixed model). 
One of the limitations that may hamper the use of RNA models for phylogenetic 
inference is the lack of reliable, and representative RNA structures at the taxonomic 
unit to be analyzed. In this work, we used consensus RNA structures inferred only by 
computational approaches as input, although the accuracy of the RNA structures used 
in the analyses could have been improved by using experimental approaches, such as 
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RNAse mapping or SHAPE reactivity (Wilkinson et al. 2006). However, to date there are 
very few secondary structures of complete viral genomes obtained experimentally and 
they have obtained from single genome sequences (Watts et al. 2009; Mauger et al. 
2015), thus ignoring the diversity in RNA secondary structure that is known to exist, 
even below the species level (Tuplin et al. 2004; Mauger et al. 2015). Because of this 
lack of representative, experimental RNA secondary structures, we used a 
computational method implemented in RNAalifold which allowed the inference of the 
consensus structure of alignments of different, yet related, RNA sequences. This 
method is known to improve the prediction of secondary structures compared to 
those obtained only with individual sequences, and allows to obtain a representative 
structure for the analyzed dataset (Hofacker et al. 2002; Bernhart et al. 2008). 
Furthermore, we only included in the analyses those datasets corresponding to 
taxonomic levels showing evolutionarily conserved structures, to ensure that the 
inferred structures fitted well for each dataset. However, it is important to mention 
that, in vivo, the same primary sequence can fold into alternative structures (Schultes 
& Bartel 2000). In this way, differences between RNA structures existing in vivo and 
those inferred computationally are expected to exist, and such differences should be 
larger in the case of viruses with linear RNA genomes than in HDV or viroids, which 
tend to form simpler, rod-like structures. For this reason, the discussed results should 
only be interpreted with some caution, as they have been derived in an in silico 
context. 
In conclusion, we found that in all viroid and RNA virus datasets analyzed, the 
selective constraints imposed by RNA secondary structures have significant impacts 
upon phylogenetic reconstructions. Model selection analyses concluded that, in all 
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cases, assigning an RNA model to paired sites outperformed the use of a DNA-only 
model for phylogenetic reconstruction from complete genome sequences. The effect 
of phylogenetic inference method on branch lengths is significant in most of the 
datasets analyzed. However, with some exceptions the use of an RNA model does not 
have a significant effect on the topology inferred. Furthermore, the high uncertainty 
that characterizes phylogenetic inference of viroid datasets did not decrease when 
these models were included. To date, viral and viroid phylogenies have always been 
reconstructed using DNA substitution models. However, in light of our results, we 
recommend that such analyses should consider the inclusion of RNA models, as they 
describe better the evolution of paired sites. In addition, it would be of particular 
importance for phylogeny software that implements molecular clock models, such as 
BEAST (Drummond & Rambaut 2007), to include the option of using RNA substitution 
models, as diversification dates and evolutionary rates inferred for RNA viruses under 
RNA models might be different from estimates obtained without considering 
secondary structure. 
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Supplementary material 
 
 
 
Supplementary Figure S.1. Arc plots representing the consensus RNA secondary structure 
inferred with RNAalifold of each dataset analyzed with PHASE-3.0. Arcs represent base-pairing 
relationships.
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Supplementary Figure S.2. Phylogenetic trees of HDV, HCV-1b and HIV-1B obtained with PHASE-3.0 either including or excluding the RNA model. Black circles 
represent nodes supported by PPs ≥0.90. 
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Supplementary Figure S.2 (cont). Phylogenetic trees of HDV, HCV-1b and HIV-1B obtained with PHASE-3.0 either including or excluding the RNA model. Black 
circles represent nodes supported by PPs ≥0.90. 
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Supplementary Figure S.2 (cont). Phylogenetic trees of HDV, HCV-1b and HIV-1B obtained with PHASE-3.0 either including or excluding the RNA model. Black 
circles represent nodes supported by PPs ≥0.90. 
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3. Discussion and conclusions 
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3.1- Discussion 
This thesis was aimed to address several questions about the molecular 
evolution of RNA viruses. Although the work has mainly focused on the molecular 
epidemiology of HIV and HCV, it also intended to address other topics: estimating and 
comparing the genomic evolutionary rates of the main HIV-1 subtypes and CRFs, 
elucidating the different selective constraints shaping the genomes of HCV-1a and 1b, 
and assessing the effect of RNA models on the phylogenetic inference of RNA viruses 
and viroids. 
HIV has caused one of the largest pandemics in the history of humankind, 
causing more than 36 million deaths (Cleves 2008; UNAIDS 2015) worldwide. Although 
efforts for HIV prevention and treatment have managed to stabilize the number of 
infections, its incidence is still growing in many countries, including Spain, particularly 
in risk groups such as MSM (ECDC 2013). In chapters 1, 2, 3 and 4, I performed 
molecular epidemiology analyses in two different Spanish regions: the Basque Country 
and the Comunitat Valenciana (CV), for which I had access to a total of 1,727 and 1,806 
HIV-1 sequences from different patients respectively. These datasets were analyzed by 
means of phylogenetic and coalescent analyses for detecting and characterizing local 
transmission clusters occurring in these regions. Also, univariate and multinomial 
comparisons were performed to detect epidemiological differences between HIV-1 
subtypes and population groups. 
 I found differences between both Spanish regions in the proportion of patients 
being included in transmission clusters (Basque Country < 30%; CV = 57%). Such 
differences could be due to different definitions for transmission cluster, more 
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stringent in the work from the Basque Country than in that from the CV. Furthermore, 
the inclusion of chronically infected patients in the analyses from the Basque Country 
may have hampered the identification of transmission clusters, due to the longer 
external branches that would represent these patients in the phylogenetic trees. 
However, Yebra et al. (2013) also found a low proportion of patients belonging to 
transmission clusters (<20%) following a similar cluster definition to the one used here. 
These results suggest that, in the different Spanish regions, the contribution of local 
transmissions to their HIV subepidemics may not be the same. 
In line with the epidemic scenario in Western Europe and with the results 
obtained by Yebra et al. (2013), MSM represented the most vulnerable group to HIV 
infections, both in the Basque Country and Valencia. They were significantly more 
prone to form transmission clusters than other risk groups, even in the Basque 
Country, where they were not the most common transmission risk group. MSM were 
also the majority group in large transmission clusters, especially in the most recent 
ones. The increased vulnerability of this group is evidenced by a very large 
transmission cluster found in the city of Valencia, affecting more than 100 patients 
between 2010 and 2014. Delgado et al. (2015) also found a very large (n = 100) HIV-1 
subtype F transmission cluster affecting MSM from different Spanish localities. 
Bezemer et al. (2015) analyzed the HIV-1 B epidemic among MSM in the Netherlands 
until 2013, and found an increasing HIV epidemic in which many of the subepidemics 
were longstanding. 
More than 15% of the patients from the CV were infected with non-B variants, 
revealing a diverse HIV epidemic. This result is in line with those obtained by González-
 255 
 
Alba et al. (2011) in Madrid. The high migration and tourism rates existing both in 
Madrid and the CV may explain the complexity of their HIV epidemics, and this appears 
to be evidenced in the significant association that I found between non-B subtypes and 
migrants. Interestingly, in this thesis I have also reported the detection of two 
transmission clusters of CRF19_cpx occurring in the CV among local MSM, as the first 
evidence of the expansion of this highly pathogenic variant outside Cuba. In this way, 
although my results suggest that non-B HIV-1 variants are not well established among 
locals yet, this situation could change soon without intensified HIV prevention 
campaigns in vulnerable groups, such as migrants and MSM.  
It is important to mention that no HIV-1 outbreaks had been reported until 
2016 in the CV, being undetected to the local public health officials when using 
traditional epidemiological analyses. By means of evolutionary analyses I have 
detected hundreds of local transmission clusters, each of them potentially 
representing an outbreak. These results provide evidence for the importance of 
evolutionary analyses in epidemiology, which should be used in combination with 
traditional epidemiology approaches for the correct detection of outbreaks. 
In Chapter 5, I estimated and compared the genomic evolutionary rates of 
some of the most prevalent HIV-1 subtypes (A1, B, C, D and G) and CRFs (CRF01_AE 
and CRF02_AG). Most previous estimates of tMRCA and substitution rate for HIV-1 
have been inferred from independent genes (most frequently pol and env; Abecasis et 
al. 2009; Wertheim et al. 2012), ignoring other genomic regions that may have 
different mutation rates and/or selective constraints. After obtaining independent and 
representative genomic datasets of each HIV-1 variant from a public database (LANL), 
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their tMRCAs and evolutionary rates were estimated using a Bayesian coalescent 
phylogenetic method. The estimates obtained in this project evidenced intersubtype 
differences in the genomic evolutionary rates of HIV-1, with subtypes A1, C and 
CRF01_AE having higher evolutionary rates than subtypes B, D, G and CRF02_AG. This 
reveals differences among subtypes and CRFs in their selective constraints, mutation 
rates, generation times and/or epidemic dynamics (Abecasis et al. 2009; Maljkovic 
Berry et al. 2007). Interestingly, tMRCA estimates obtained from genomes were 
congruent with previous estimates (Gray et al. 2009; Abecasis et al. 2009; Hemelaar 
2012; Yebra et al. 2016) but the 95% HPDs were usually narrower, which evidences 
that our estimates are more accurate for estimating evolutionary parameters as a 
consequence of analyzing more informative sequences. The results obtained provide 
estimates that can be used as prior distributions in future Bayesian coalescent analyses 
of specific HIV-1-subtypes and genes. 
A significant part of this thesis has been dedicated to investigate the molecular 
evolution of HCV, with special interest in assessing the clinical consequences of the 
genotypic diversity of HCV (7 genotypes and 67 subtypes) regarding their potential 
sensitivity to DAAs. In Chapter 6, I assessed whether the 6 genotypes causing the HCV 
pandemic, and their respective subtypes, presented differences in the frequency of 
naturally-occurring amino acid variants involved in resistance to DAAs (RAVs). To 
achieve this goal, I selected 2,901, 2,216 and 1,344 HCV sequences from the NS3, NS5A 
and NS5B genes, respectively (encoding the proteins that are targets of all approved 
DAAs) from different public databases: LANL, VIPRBC and EuHCVdb. With these 
sequences, I analyzed the prevalence of up to 103 RAVs as well as their phylogenetic 
history and genetic barrier, for each HCV genotype (and subtype). The results obtained 
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demonstrated that naturally occurring RAVs are common in all HCV genotypes, and 
that there are differences between genotypes in their susceptibility to different DAAs, 
either approved or under clinical trials. In addition to an overall low genetic barrier for 
the selection of RAVs in all HCV genotypes, we also found, by means of phylogenetic 
analyses, that some of them (such as NS3 Q80K in HCV-1a and HCV-6, and NS5B C316N 
in HCV-1b) have a high potential to be transmitted between at risk patients. It is 
important to point out that most DAAs have been developed for HCV genotype 1 (the 
most prevalent genotype worldwide), so that DAA susceptibility may be lower in 
patients infected with non-1 HCV genotypes, as appears to be the case of NS5B NNIs. 
Consequently, the results obtained could help in designing the optimal combinations 
of antiviral drugs for each HCV genotype. 
In chapter 7, I analyzed the distribution of positively selected sites along the 
genomes of the most prevalent HCV subtypes (1a and 1b). The detection of positively 
selected sites was performed with MEME, a powerful method based on a ML approach 
which allows dN/dS to vary among sites and among lineages from a given phylogeny 
(Murrell et al. 2012). Then, I assessed, using a logistic regression analysis, how these 
distributions could be affected by the presence of different factors (RNA and protein 
secondary structure and antibody, CD4 and CD8 T-cell epitopes) along the genomes of 
these HCV variants. The results obtained evidenced that, although both subtypes have 
some epidemiological and clinical differences with HCV-1b displaying higher genetic 
variability than HCV-1a, they share similar selective constraints. Interestingly, although 
the presence of CD8 T-cell epitopes was associated with positively selected sites, the 
presence of RNA secondary structure and CD4 T-cell epitopes was associated with 
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conservation. The results obtained from this study give information about the effect of 
some of the interactions between HCV and its host on HCV variability.  
Finally, in chapter 8 I assessed the effect of using RNA substitution models on 
the phylogenetic inference of viroids and RNA viruses. For each species, I obtained a 
dataset of genomic sequences, retrieved from two public databases (GenBank and 
VIPRBC). Then, I inferred their RNA secondary structure and performed a model 
comparison test. Finally, I performed different Bayesian phylogenetic analyses either 
including or excluding the RNA model. The results obtained reveal the importance of 
using RNA models for phylogenetic inference of RNA viruses and viroids. In all the 
species analyzed, the best-fitting model was one which takes into account the 
correlated evolution between both parties of base-pairs. Generally, the use of RNA 
models led to significantly longer branch length estimates than when only a DNA 
model is used. Thus, RNA models would correct underestimates of branch lengths 
made by DNA models. However, with some exceptions the use of an RNA model had 
no significant effect on tree topology inference. In light of the results obtained, it 
would be important for phylogeny software used for inferring tMRCAs and 
evolutionary rates, such as BEAST (Drummond & Rambaut 2007), R8s (Sanderson 
2002) or Physher (Fourment & Holmes 2014), to include the option of using RNA 
substitution models, as diversification dates and evolutionary rates inferred for RNA 
viruses and viroids under such models might be different from estimates obtained 
without considering RNA secondary structure.  
It is noteworthy that, for the HIV molecular epidemiology analyses performed 
in this PhD thesis, sequences were obtained by Sanger sequencing. However, along the 
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development of this PhD thesis, next-generation sequencing (NGS) has gained 
influence on viral molecular epidemiology. This technique overcomes some of the 
limitations of the traditional Sanger sequencing method, such as its relatively high cost 
and low throughput, and is specially promising for the characterization of intra-host 
variability.  
NGS technologies have a very high throughput, generating enormous number 
of sequences from an epidemic at a very high speed (Cruz-Rivera et al. 2013). Quick et 
al. recently sequenced Ebola isolates from the recent African epidemic in less than 60 
minutes using the MinIon sequencer, thus allowing real time surveillance of the 
epidemic (Quick et al. 2016) . NGS has also been applied to metagenomic procedures. 
This has allowed the detection of novel viruses, such as a new arenavirus affecting 
humans (Palacios et al. 2008). 
NGS allows more realistic analyses of the viral quasispecies that are generated 
within a given patient. This is especially interesting for the detection of rare resistant 
variants (those with prevalence < 1%, considering the whole intrahost diversity), 
something very difficult to explore by Sanger sequencing. Detecting these rare variants 
is very important, because their abundance in the viral population can increase quickly 
by means of shifts in the viral quasispecies distribution as result of the selective 
pressures imposed by antiviral treatments. The relevance of low frequency drug 
resistance variants in treatment failure has already been demonstrated, by means of 
NGS, to be clinically relevant for HCV and HIV (Nasu et al. 2011; Kyeyune et al. 2016).  
NGS can also be useful for the detection of viral outbreaks: the distribution of 
genetic distances between the viral populations of related cases is expected to be 
 260 
 
significantly lower than that obtained from comparing unrelated cases (Escobar-
Gutiérrez et al. 2012).  
For these reasons, NGS is a recommendable technology for future molecular 
epidemiology analyses of viruses.  
 In summary, part of the results obtained in this thesis have a direct application 
to public health, evidencing that the evolutionary analysis of RNA viruses can provide 
information regarding their epidemics, such as the detection and characterization of 
outbreaks and resistant variants, which is usually more difficult to obtain from 
traditional epidemiologic approaches only. Thus, when possible, both disciplines 
should be combined into molecular epidemiology approaches for the surveillance of 
infectious diseases. In addition, this work has also reported other results which can be 
useful to better understand the mechanics of evolution of RNA viruses, with possible 
applications in viral phylogenetics or antiviral research. 
3.2- Conclusions 
 The local expansion of HIV-1 transmission clusters, especially among 
MSM, plays a significant role in shaping the HIV epidemics in the Basque 
Country and the Comunitat Valenciana. This fact evidences 
shortcomings in HIV control measures in Spain, at least for specific, 
vulnerable population groups. 
 The high vulnerability of MSM to HIV infections is also reflected in their 
lower times between transmissions and their significantly higher 
association with large transmission clusters than other risk groups.  
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 The results from the molecular epidemiology analyses of HIV also stress 
the importance of implementing surveillance strategies that use viral 
sequence information derived from the genotypic analysis of resistance 
mutations in HIV-infected patients. 
 The analysis of nearly complete HIV-1 genomic coding regions leads to 
more accurate estimations of the viral evolutionary parameters, and has 
revealed significantly different genomic evolutionary rates between 
HIV-1 subtypes and CRFs. 
 Naturally occurring RAVs are common in all HCV genotytpes, with 
significant differences between genotypes regarding their susceptibility 
towards different DAAs. Interestingly, certain RAVs have been efficiently 
transmitted among individuals, in absence of antiviral treatment. 
 Although the most prevalent HCV subtypes (1a and 1b) present some 
epidemiological, clinical and biological differences, they are subjected to 
similar selective constrains. Specifically, the presence of secondary 
structures and CD4 T-cell epitopes is associated with conservation, while 
the presence of CD8 T-cell epitopes is associated with selection. 
 Including RNA evolutionary models for the phylogenetic inference of 
RNA viruses and viroids outfits their exclusion. Although the use of 
these models does not have a significant effect on topology inference, 
they usually lead to estimating longer branches. This could be important 
when estimating viral tMRCA and evolutionary rates. 
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